
<html lang="en"     class="pb-page"  data-request-id="b23c2910-bd98-454c-8bc8-6fc42ecad76c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-15;pageGroup:string:Publication Pages;article:article:10.1021/jm100482n;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design and Synthesis of Novel Tricyclic Benzoxazines as Potent 5-HT1A/B/D Receptor Antagonists Leading to the Discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)" /></meta><meta name="dc.Creator" content="Steven M.  Bromidge" /></meta><meta name="dc.Creator" content="Roberto  Arban" /></meta><meta name="dc.Creator" content="Barbara  Bertani" /></meta><meta name="dc.Creator" content="Silvia  Bison" /></meta><meta name="dc.Creator" content="Manuela  Borriello" /></meta><meta name="dc.Creator" content="Paolo  Cavanni" /></meta><meta name="dc.Creator" content="Giovanna  Dal Forno" /></meta><meta name="dc.Creator" content="Romano  Di-Fabio" /></meta><meta name="dc.Creator" content="Daniele  Donati" /></meta><meta name="dc.Creator" content="Stefano  Fontana" /></meta><meta name="dc.Creator" content="Massimo  Gianotti" /></meta><meta name="dc.Creator" content="Laurie J.  Gordon" /></meta><meta name="dc.Creator" content="Enrica  Granci" /></meta><meta name="dc.Creator" content="Colin P.  Leslie" /></meta><meta name="dc.Creator" content="Luca  Moccia" /></meta><meta name="dc.Creator" content="Alessandra  Pasquarello" /></meta><meta name="dc.Creator" content="Ilaria  Sartori" /></meta><meta name="dc.Creator" content="Anna  Sava" /></meta><meta name="dc.Creator" content="Jeannette M.  Watson" /></meta><meta name="dc.Creator" content="Angela  Worby" /></meta><meta name="dc.Creator" content="Laura  Zonzini" /></meta><meta name="dc.Creator" content="Valeria  Zucchelli" /></meta><meta name="dc.Description" content="Bioisoteric replacement of the metabolically labile N-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines which ar..." /></meta><meta name="Description" content="Bioisoteric replacement of the metabolically labile N-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines which ar..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 30, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100482n" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100482n" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100482n" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100482n" /></link>
        
    
    

<title>Design and Synthesis of Novel Tricyclic Benzoxazines as Potent 5-HT1A/B/D Receptor Antagonists Leading to the Discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100482n" /></meta><meta property="og:title" content="Design and Synthesis of Novel Tricyclic Benzoxazines as Potent 5-HT1A/B/D Receptor Antagonists Leading to the Discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0018.jpeg" /></meta><meta property="og:description" content="Bioisoteric replacement of the metabolically labile N-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines which are potent 5-HT1A/B/D receptor antagonists with and without concomitant human serotonin transporter (hSerT) activity. Optimizing against multiple parameters in parallel identified 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045) as a potent 5-HT1A/B/D receptor antagonist with a high degree of selectivity over human ether-à-go-go related gene (hERG) potassium channels, favorable pharmacokinetics, and excellent activity in vivo in rodent pharmacodynamic (PD) models. On the basis of its outstanding overall profile, this compound was progressed as a clinical candidate with the ultimate aim to assess its potential as a faster acting antidepressant/anxiolytic with reduced side-effect burden." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100482n"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100482n">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100482n&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100482n&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100482n&amp;href=/doi/10.1021/jm100482n" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 5827-5843</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm100649d" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm100478y" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design and Synthesis of Novel Tricyclic Benzoxazines as Potent 5-HT<sub>1A/B/D</sub> Receptor Antagonists Leading to the Discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxamide (GSK588045)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+M.++Bromidge">Steven M. Bromidge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roberto++Arban">Roberto Arban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Bertani">Barbara Bertani</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Silvia++Bison">Silvia Bison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Borriello">Manuela Borriello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paolo++Cavanni">Paolo Cavanni</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giovanna++Dal+Forno">Giovanna Dal Forno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Romano++Di-Fabio">Romano Di-Fabio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniele++Donati">Daniele Donati</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefano++Fontana">Stefano Fontana</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimo++Gianotti">Massimo Gianotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laurie+J.++Gordon">Laurie J. Gordon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Enrica++Granci">Enrica Granci</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colin+P.++Leslie">Colin P. Leslie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luca++Moccia">Luca Moccia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alessandra++Pasquarello">Alessandra Pasquarello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ilaria++Sartori">Ilaria Sartori</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anna++Sava">Anna Sava</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeannette+M.++Watson">Jeannette M. Watson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Worby">Angela Worby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Zonzini">Laura Zonzini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Zucchelli">Valeria Zucchelli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="affa"><span class="aff-symbol">†</span> <span class="aff-text">Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.</span></div><div class="aff-info" id="affb"><span class="aff-symbol">‡</span> <span class="aff-text">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: +44 (0)1279 627031. Fax: +44 (0)1279 622371. E-mail: <a href="/cdn-cgi/l/email-protection#becdcadbc8dbdcccd1d3d7dad9dbfed9d3dfd7d290ddd1d3"><span class="__cf_email__" data-cfemail="96e5e2f3e0f3f4e4f9fbfff2f1f3d6f1fbf7fffab8f5f9fb">[email protected]</span></a></div><div class="corresp-fn" id="fn1">§Present address: Nerviano Medical Sciences Srl, Via Pasteur 10, 20014 Nerviano, Milan, Italy.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100482n&amp;href=/doi/10.1021%2Fjm100482n" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 5827–5843</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 30, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 April 2010</li><li><span class="item_label"><b>Published</b> online</span>30 June 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 August 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100482n" title="DOI URL">https://doi.org/10.1021/jm100482n</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5827%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSteven%2BM.%2BBromidge%252C%2BRoberto%2BArban%252C%2BBarbara%2BBertani%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D15%26contentID%3Djm100482n%26title%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BTricyclic%2BBenzoxazines%2Bas%2BPotent%2B5-HT1A%252FB%252FD%2BReceptor%2BAntagonists%2BLeading%2Bto%2Bthe%2BDiscovery%2Bof%2B6-%257B2-%255B4-%25282-methyl-5-quinolinyl%2529-1-piperazinyl%255Dethyl%257D-4H-imidazo%255B5%252C1-c%255D%255B1%252C4%255Dbenzoxazine-3-carboxamide%2B%2528GSK588045%2529%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5843%26publicationDate%3DAugust%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100482n"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2496</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">26</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100482n" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design and Synthesis of Novel Tricyclic Benzoxazines as Potent 5-HT1A/B/D Receptor Antagonists Leading to the Discovery of 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;M. Bromidge&quot;},{&quot;first_name&quot;:&quot;Roberto&quot;,&quot;last_name&quot;:&quot;Arban&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Bertani&quot;},{&quot;first_name&quot;:&quot;Silvia&quot;,&quot;last_name&quot;:&quot;Bison&quot;},{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Borriello&quot;},{&quot;first_name&quot;:&quot;Paolo&quot;,&quot;last_name&quot;:&quot;Cavanni&quot;},{&quot;first_name&quot;:&quot;Giovanna&quot;,&quot;last_name&quot;:&quot;Dal Forno&quot;},{&quot;first_name&quot;:&quot;Romano&quot;,&quot;last_name&quot;:&quot;Di-Fabio&quot;},{&quot;first_name&quot;:&quot;Daniele&quot;,&quot;last_name&quot;:&quot;Donati&quot;},{&quot;first_name&quot;:&quot;Stefano&quot;,&quot;last_name&quot;:&quot;Fontana&quot;},{&quot;first_name&quot;:&quot;Massimo&quot;,&quot;last_name&quot;:&quot;Gianotti&quot;},{&quot;first_name&quot;:&quot;Laurie&quot;,&quot;last_name&quot;:&quot;J. Gordon&quot;},{&quot;first_name&quot;:&quot;Enrica&quot;,&quot;last_name&quot;:&quot;Granci&quot;},{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;P. Leslie&quot;},{&quot;first_name&quot;:&quot;Luca&quot;,&quot;last_name&quot;:&quot;Moccia&quot;},{&quot;first_name&quot;:&quot;Alessandra&quot;,&quot;last_name&quot;:&quot;Pasquarello&quot;},{&quot;first_name&quot;:&quot;Ilaria&quot;,&quot;last_name&quot;:&quot;Sartori&quot;},{&quot;first_name&quot;:&quot;Anna&quot;,&quot;last_name&quot;:&quot;Sava&quot;},{&quot;first_name&quot;:&quot;Jeannette&quot;,&quot;last_name&quot;:&quot;M. Watson&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Worby&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Zonzini&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Zucchelli&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;5827-5843&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100482n&quot;},&quot;abstract&quot;:&quot;Bioisoteric replacement of the metabolically labile N-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines which are potent 5-HT1A/B/D receptor antagonists with and without concomitant human serotonin transporter (hSerT) activity. Optimizing against multiple parameters in parallel identified 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4H-imidazo[5,1-c][1,4]benzoxazine-3-carboxamide (GSK588045) as a potent 5-HT1A/B/D receptor antagonist with a high degree of selectivity over human ether-à-go-go related gene (hERG) potassium channels, favorable pharmacokinetics, and excellent activity in vivo in rodent pharmacodynamic (PD) models. On the basis of its outstanding overall profile, this compound was progressed as a clinical candidate with the ultimate aim to assess its potential as a faster acting antidepressant/anxiolytic with reduced side-effect burden.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100482n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100482n" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100482n&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100482n" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100482n&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100482n" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100482n&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100482n&amp;href=/doi/10.1021/jm100482n" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100482n" /></input><a href="/doi/pdf/10.1021/jm100482n" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100482n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100482n%26sid%3Dliteratum%253Aachs%26pmid%3D20590088%26genre%3Darticle%26aulast%3DBromidge%26date%3D2010%26atitle%3DDesign%2Band%2BSynthesis%2Bof%2BNovel%2BTricyclic%2BBenzoxazines%2Bas%2BPotent%2B5-HT1A%252FB%252FD%2BReceptor%2BAntagonists%2BLeading%2Bto%2Bthe%2BDiscovery%2Bof%2B6-%257B2-%255B4-%25282-methyl-5-quinolinyl%2529-1-piperazinyl%255Dethyl%257D-4H-imidazo%255B5%252C1-c%255D%255B1%252C4%255Dbenzoxazine-3-carboxamide%2B%2528GSK588045%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D15%26spage%3D5827%26epage%3D5843%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jmcmar.2010.53.issue-15/production/jmcmar.2010.53.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Bioisoteric replacement of the metabolically labile <i>N</i>-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines which are potent 5-HT<sub>1A/B/D</sub> receptor antagonists with and without concomitant human serotonin transporter (hSerT) activity. Optimizing against multiple parameters in parallel identified 6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxamide (GSK588045) as a potent 5-HT<sub>1A/B/D</sub> receptor antagonist with a high degree of selectivity over human ether-à-go-go related gene (hERG) potassium channels, favorable pharmacokinetics, and excellent activity in vivo in rodent pharmacodynamic (PD) models. On the basis of its outstanding overall profile, this compound was progressed as a clinical candidate with the ultimate aim to assess its potential as a faster acting antidepressant/anxiolytic with reduced side-effect burden.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14046" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14046" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Over the past decades, a wealth of preclinical and clinical evidence has confirmed a link between extracellular levels of serotonin (5-HT) and a plethora of psychiatric indications, in particular anxiety and depression.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In fact, enhanced serotonergic neurotransmission has become the unifying mechanism of action of modern day antidepressants and the selective serotonin reuptake inhibitors (SSRIs<a class="ref internalNav" href="#fn2" aria-label="a">a</a><div class="NLM_fn" id="fn2">a<p class="last">Abbreviations: hSerT, human serotonin transporter; hERG, human ether-à-go-go related gene; SSRIs, selective serotonin reuptake inhibitors; SAR, structure−activity relationships; PD, pharmacodynamic; PK, pharmacokinetic; TI, therapeutic index; LHS, left-hand side; IA, intrinsic activity; CYP450, cytochrome P450; DDI, drug−drug interactions; Vss, volumes of distribution; HEK, human embryo kidney; GSH, glutathione; CHO, Chinese hamster ovary.</p></div>) have become established as the most effective antidepressant agents in current clinical use.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Despite the success of SSRIs, one undesirable characteristic is a long latency to therapeutic onset which is hypothesized to be due to the requirement for desensitization of 5-HT<sub>1</sub> autoreceptors to maintain increased 5-HT levels.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> This is consistent with preclinical neurochemical studies which have demonstrated that SSRIs such as paroxetine require chronic dosing (14 to 21 days) in order to enhance extracellular 5-HT levels in guinea pig dentate gyrus and rat frontal cortex but have no effect after acute administration.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">5-HT<sub>1</sub> autoreceptors are located on both the cell bodies (5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptor subtypes) and nerve terminals (5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> receptor subtypes) of 5-HT neurons.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> They are widely distributed in the brain and in addition to serotonin transporters (SerT) are known to have a major role in the control of synaptic 5-HT levels.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Blockade of 5-HT<sub>1A/B/D</sub> autoreceptors, with or without concomitant SerT inhibition, rapidly increases brain 5-HT levels and consequently should provide a fast onset of antidepressant/anxiolytic action relative to current therapies.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">We have previously reported several series of potent 5-HT<sub>1A/B/D</sub> receptor antagonists both with and without additional hSerT reuptake inhibitory activity including <b>1</b> (SB-649915) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> More recently we disclosed a series of 6- and 8-[2-(4-aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones with interesting in vitro and in vivo profiles (such as <b>2</b>−<b>5</b>).<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> This article reports the further optimization and evolution of these compounds which has resulted in the identification of novel series of tricyclic benzoxazines culminating in the identification of <b>20</b> (GSK588045). This compound demonstrated an outstanding overall profile with in vivo activity in different animal models of anxiety and depression and has been progressed as a clinical candidate.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of different series of 5-HT <sub>1A/B/D</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i2" class="anchor-spacer"></div><h3 class="article-section__title" id="_i2"> Chemistry</h3><div class="NLM_p">The synthesis of the 6-substituted (<b>2</b> and <b>3</b>) and 8-substituted (<b>4</b> and <b>5</b>) compounds has been previously described.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> The unsubstituted 4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine <b>6</b> was prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Thus, 8-(2-propen-1-yl)-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-one<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a><b>30</b> was converted into the 3-(methylthio)-2<i>H</i>-1,4-benzoxazine <b>32</b> via the corresponding thione <b>31</b>. Reaction of <b>32</b> with amino acetaldehyde dimethyl acetal afforded the aminoacetal <b>33</b>, which readily cyclized to the desired 6-(2-propen-1-yl)-4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine <b>34</b> on heating with HCl. Oxidative cleavage of the pendant vinyl of <b>34</b> with osmium tetraoxide/sodium periodate to the aldehyde <b>35</b> followed by reductive amination with 2-methyl-5-(1-piperazinyl)quinoline completed the synthesis. The 2-methyl analogue <b>7</b> was similarly prepared from <b>30</b> but by an alternative cyclization strategy via the ketone <b>36</b> which was condensed with ammonium acetate to <b>37</b>, followed by oxidative cleavage of the vinyl and reductive amination as above to afford <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Lawesson’s reagent, toluene, reflux, 1 h; (b) MeI, KOH, acetone, reflux, 2 h; (c) NH<sub>2</sub>CH<sub>2</sub>CH(OMe)<sub>2</sub>, EtOH, reflux, 9 h; (d) conc HCl, MeOH, reflux, 3 h; (e) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N</i>-oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) aq Na<sub>2</sub>SO<sub>3</sub>, room temp, 30 min; (f) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (g) NaH, 1-chloro-2-propanone, DMF, 0 °C to room temp, 7 h; (h) NH<sub>4</sub>OAc, AcOH, microwave 150 °C, 10 min; (i) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h.</p></p></figure><div class="NLM_p">The 1,2-dimethyl <b>8</b> and 2-trifluoromethyl <b>9</b> 4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine analogues were also prepared indirectly from <b>30</b> via the corresponding ketones <b>39</b> and <b>46</b>, respectively, as described above for <b>7</b> except that cyclization of the imidazole ring was carried out as the final steps (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3-Chloro-2-butanone, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4 h; (b) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (c) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (d) NH<sub>4</sub>OAc, AcOH, microwave 150 °C, 10 min; (e) NaH, methyl bromoacetate, DMF, 0 °C to room temp, 6 h; (f) NaOH, MeOH, room temp, 4 h; (g) (i) oxalyl chloride, DMF, toluene, 60 °C, 3 h; (ii) trifluoroacetic anhydride, pyridine, room temp, 2 h.</p></p></figure><div class="NLM_p">The unsubstituted 4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine <b>10</b> was also prepared from the key intermediate <b>30</b> as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Thus, treatment of <b>30</b> with diethyl chlorophosphate and potassium <i>t</i>-butoxide followed by ethyl isocyanoacetate smoothly afforded the 4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]-benzoxazine-3-ethylcarboxylate <b>47</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Saponification gave the acid <b>48</b>, which was decarboxylated to <b>49</b> and converted to the desired product <b>10</b> as described above. The acid <b>48</b> also served as a key intermediate for the preparation of the amides <b>17</b> and <b>24</b>. The 4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-ethylcarboxylate <b>47</b> was itself converted to the final compound <b>14</b> (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Compounds <b>10</b>, <b>14</b>, <b>17</b>, and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KO<sup>t</sup>Bu, diethyl chlorophosphate, DMF, 0 °C, 10 min then ethyl isocyanoacetate, 60 °C, 6 h; (b) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (c) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (d) NaOH, MeOH, 60 °C, 30 min; (e) 1,2-dichlorobenzene, microwave 250 °C, 10 min; (f) HOBT, EDC, NHR<sub>1</sub>R<sub>2</sub>, DMF/CH<sub>2</sub>Cl<sub>2</sub>, room temp, 4 h; (g) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N-</i>oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) NaIO<sub>4</sub>, THF/H<sub>2</sub>O, room temp, 1 h.</p></p></figure><div class="NLM_p">To rapidly investigate the amidic portion of this class of compounds, a slightly modified route was set up starting from the advanced ester intermediate <b>14</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>): amides <b>17</b>, <b>19</b>−<b>23</b>, <b>25</b>−<b>29</b> were obtained via the acid <b>65</b> by standard coupling methods. In addition, the methyl ketone <b>15</b> and oxime <b>16</b> were prepared via the Weinreb amide <b>66</b>, while the nitrile <b>18</b> was obtained via the corresponding primary amide <b>20</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route for Compound <b>15</b>−<b>16</b>, <b>18−19</b>, <b>21</b>−<b>23</b>, and <b>25</b>−<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaOH, MeOH/H<sub>2</sub>O, microwave 120 °C, 5 min; (b) DIPEA, TBTU, hexamethyldisilazane, DMF, room temp, 1 h; (c) (CF<sub>3</sub>)<sub>2</sub>CO, pyridine/THF, 0 °C, 1 h; (d) DIPEA, TBTU, NHR<sub>1</sub>R<sub>2</sub>, DMF, room temp, 1 h; (e) DIPEA, TBTU, NHMeOMe·HCl, DMF, room temp, 1 h; (f) MeMgBr, THF, 0 °C, 1 h; (g) NH<sub>2</sub>OMe·HCl, pyridine/EtOH, reflux, 2 h.</p></p></figure><div class="NLM_p">The next step of the exploration was directed to the investigation of different fused heterocyclic moieties. Thus, the 1-methyl-4<i>H</i>-[1,2,4]triazolo[3,4-<i>c</i>][1,4]benzoxazine <b>11</b> and the 4<i>H</i>-tetrazolo[5,1-<i>c</i>][1,4]benzoxazine <b>13</b> were prepared starting from the benzoxazine-3(4<i>H</i>)-thione <b>31</b> prepared as described above. Thus, <b>31</b> was converted to the hydrazone <b>54</b>, which was treated with trimethyl orthoacetate or sodium nitrite respectively to afford the triazole <b>55</b> or the tetrazole <b>57</b>, which were then converted by the methods described above to the final compounds <b>11</b> and <b>13</b>, respectively (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route for Compounds <b>11</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, 80 °C, 2 h; (b) MeC(OMe)<sub>3</sub>, microwave 150 °C, 10 min; (c) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N</i>-oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) NaIO<sub>4</sub>, THF/H<sub>2</sub>O, room temp, 1 h; (d) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (e) NaNO<sub>2</sub>, aq HCl, 5 °C, 4 h; (f) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h.</p></p></figure><div class="NLM_p">An elegant route was established to the 1,2,3-triazole <b>12</b> starting with alkylation of 2-nitro-6-(2-propen-1-yl)phenol <b>59</b> with 1-bromo-2-butyne followed by functional group transformation of the nitro to the azide <b>62</b>. Heating the azide <b>62</b> gave smooth intramolecular 1,3-dipolar cycloaddition, generating the tricyclic system <b>63</b> in a single step.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Oxidative cleavage and reductive amination with 2-methyl-5-(1-piperazinyl)quinoline according to the general procedures described above completed the synthesis (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route for Compound <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, 1-bromo-2-butyne, acetone, reflux, 4 h; (b) Fe powder, AcOH, room temp, 16 h; (c) (i) NaNO<sub>2</sub>, aq HCl, 0 °C, 30 min; (ii) NaN<sub>3</sub>, H<sub>2</sub>O, 5 °C, 30 min; (d) toluene, reflux, 2.5 h; (e) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (f) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h.</p></p></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04464" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04464" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We recently disclosed a series of 6-[2-(4-aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones as potent 5-HT<sub>1A/B/D</sub> receptor antagonists, a number of which had additional hSerT reuptake inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Modulation of the balance between the different target affinities allowed us to identify compounds with interesting in vitro and in vivo profiles. Unfortunately, the progression of these molecules was precluded by the finding that they had significant inhibitory activity at hERG potassium channels which has been associated with increases in the QT interval prolongation and the induction of potentially life-threatening ventricular arrhythmias in the clinic (Torsades de Pointes).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For example, 2 had p<i>K</i><sub>i</sub> of 7.2 in a hERG binding assay which translated to potent functional inhibition of hERG tail current in whole cell electrophysiology studies.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Interestingly, the corresponding NMe analogue <b>3</b> showed 10-fold reduced hERG affinity relative to <b>2</b> despite increased lipophilicity, which was somewhat surprising since lipohilicity has been positively correlated with hERG.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This finding led us to speculate a specific binding interaction between the lactam N−H and the hERG channel, and we subsequently discovered that transposing the substitution point of the linker from the 6- to the 8-position of the benzoxazinone ring selectively disrupted binding to the hERG channel while maintaining the key target interactions.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Thus, the 8-substituted analogues <b>4</b> and <b>5</b> were found to have similar or improved pan 5-HT<sub>1A/B/D</sub> antagonist potencies relative to <b>2</b> and <b>3</b> with significantly reduced hERG affinities (40- and 5-fold, respectively). Of particular note, the structure−activity relationships (SAR) for hSerT was reversed with respect to the 6-substituted series, and whereas the 6-substituted NH analogue <b>2</b> demonstrated 15-fold higher hSerT affinity than the corresponding NMe analogue <b>3</b>, the 8-substituted NH analogue <b>4</b> showed 30-fold lower hSerT affinity compared to the corresponding NMe analogue <b>5</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Functional Activity (<i>f</i>-p<i>K</i><sub>i</sub> or pEC<sub>50</sub>)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> for Human 5-HT<sub>1A/B/D</sub> Receptors with Intrinsic Activity (IA), hSerT and hERG Binding Affinities (p<i>K</i><sub>i</sub>)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> and Rat PK Parameters for Benzoxazinones (<b>2</b>−<b>5</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0011.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="left" /></col><col width="7.147962830593279%" align="char" char="." /></col><col width="7.147962830593279%" align="char" char="." /></col><col width="10.50750536097212%" align="left" /></col><col width="6.4331665475339515%" align="char" char="." /></col><col width="6.504646175839884%" align="char" char="." /></col><col width="6.4331665475339515%" align="char" char="." /></col><col width="6.504646175839884%" align="char" char="." /></col><col width="6.4331665475339515%" align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center"><i>f</i>-p<i>K</i><sub>i</sub> or *pEC<sub>50</sub><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">p<i>K</i><sub>i</sub>,<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="5" align="center" char=".">rat PK parameters<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">sub</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">5-HT<sub>1A</sub> (IA)</th><th class="colsep0 rowsep0" align="center">5-HT<sub>1B</sub> (IA)</th><th class="colsep0 rowsep0" align="center">5-HT<sub>1D</sub> (IA)</th><th class="colsep0 rowsep0" align="center" char=".">hSerT</th><th class="colsep0 rowsep0" align="center" char=".">hERG</th><th class="colsep0 rowsep0" align="left">Cli rat; hum<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> mL/min/g liver</th><th class="colsep0 rowsep0" align="center" char=".">CLb mL/min/kg</th><th class="colsep0 rowsep0" align="center" char=".">Vss L/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> h</th><th class="colsep0 rowsep0" align="center" char=".">Fpo %</th><th class="colsep0 rowsep0" align="center" char=".">Br:Bl</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10.2 (0.0)</td><td class="colsep0 rowsep0" align="left">6.6 (0.0)</td><td class="colsep0 rowsep0" align="left">*9.3 (0.6)</td><td class="colsep0 rowsep0" align="char" char=".">8.9</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="left">1.3; <0.5</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">10.1 (0.3)</td><td class="colsep0 rowsep0" align="left">8.7 (0.3)</td><td class="colsep0 rowsep0" align="left">10.0 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="left">0.8; 1.1</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.6 (0.0)</td><td class="colsep0 rowsep0" align="left">9.0 (0.0)</td><td class="colsep0 rowsep0" align="left">10.3 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="left">0.7; 1.0</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">9.8 (0.0)</td><td class="colsep0 rowsep0" align="left">8.4 (0.0)</td><td class="colsep0 rowsep0" align="left">9.5 (0.0)</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">5.4</td><td class="colsep0 rowsep0" align="left">1.0; 2.4</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Data from the agonist mode (pEC<sub>50</sub>)* are reported for those compounds with intrinsic activity (IA) ≥ 0.4 in this mode (i.e., partial or full agonists), whereas, for those compounds with IA < 0.4 in the agonist mode (i.e., antagonists), data from the antagonist mode is reported (<i>f</i>-p<i>K</i><sub>i</sub>). See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Each determination lies within 0.3 log units of the mean with a minimum of 3 replicates. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Intrinsic clearance in liver microsomes. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">In vivo data determined by 0.5 mg/kg iv and 1 mg/kg po administration in rat. Br:Bl at 1 h following iv dosing.</p></div></div></div><div class="NLM_p">Although <b>4</b> and <b>5</b> possessed interesting and distinct pharmacological profiles (additional hSerT component in the case of <b>5</b>) of potential therapeutic utility with reduced hERG/QT risk, pharmacokinetic (PK) studies revealed nonideal in vivo profiles. Thus, in rat PK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), <b>4</b> demonstrated high oral bioavailability combined with low blood clearance, a good half-life, but a relatively modest brain to blood ratio (0.7). In contrast, the corresponding <i>N</i>-methyl analogue <b>5</b> achieved a higher brain to blood ratio (1.5) and good brain exposures but was more rapidly cleared than <b>4</b>, resulting in modest half-life and bioavailability. Further investigation determined that <i>N</i>-demethylation was a principle route of metabolism in rat as evidenced by the detection of high circulating levels of the des-methyl analogue <b>4</b> following oral dosing of <b>5</b>. In addition, the observation that <b>5</b> was also efficiently converted to <b>4</b> in vitro in the presence of both rat and human liver microsomes with a higher intrinsic clearance, with the latter suggested a potentially higher rate of metabolism in man.</div><div class="NLM_p">As a result of the above findings, we designed and implemented medicinal chemistry strategies aimed at circumventing metabolic amide dealkylation of <b>5</b> with the ultimate objective of identifying potent metabolically stable and brain penetrant 5-HT<sub>1A/B/D</sub> receptor antagonists with or without additional hSerT reuptake inhibitory activity together with further increased therapeutic index (TI) over hERG. Several approaches were investigated to this end including modification of the nature of the <i>N</i>-alkyl group and modulation of the electronic properties of the benzoxazinone system, but the most successful tactic proved to be incorporation of the amide <i>N</i>-methyl into a fused heterocyclic ring.</div><div class="NLM_p">We initially targeted a range of tricyclic fused heterocycles based on electrostatic potential similarity to <b>5</b> in combination with chemical feasibility. This exploration was undertaken with the left-hand side (LHS) of the molecule fixed as the 5-(4-ethyl-1-piperazinyl)-2-methylquinoline since we had previously found that this conferred a favorable overall balance of properties and in particular afforded low intrinsic activity (IA) at 5-HT<sub>1A/B/D</sub> receptors.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Encouragingly, a number of new heterotricyclic ring systems rapidly emerged with interesting profiles such as the fused imidazo, triazolo, and tetrazolo-benzoxazines (<b>6</b>−<b>12</b>). The isomeric 1,2- and 1,5-fused imidazobenzoxazines (<b>6</b> and <b>10</b>) demonstrated similar target profiles to <b>5</b>, displaying excellent 5-HT<sub>1A/B/D</sub> antagonist potencies and moderate hSerT affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, the hERG affinities and the microsomal human intrinsic clearances were similar or increased relative to <b>5</b>. In addition, significant human cytochrome P450 (CYP450) inhibitory activities emerged, particularly in the case of <b>10</b>, indicating a high risk of potential drug−drug interactions (DDI) in a clinical setting.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Functional Activity (<i>f</i>-p<i>K</i><sub>i</sub> or pEC<sub>50</sub>)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> for Human 5-HT<sub>1A/B/D</sub> Receptors with Intrinsic Activity (IA), hSerT and hERG Binding Affinities (p<i>K</i><sub>i</sub>),<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> Microsomal Intrinsic Clearance and Human CYP450 Activity for Tricyclobenzoxazines (<b>6</b>−<b>13</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0012.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0013.gif" alt="" id="fx3" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Data from the agonist mode (pEC<sub>50</sub>)* are reported for those compounds with intrinsic activity (IA) ≥ 0.4 in this mode (i.e., partial or full agonists), whereas for those compounds with IA <0.4 in the agonist mode (i.e., antagonists), data from the antagonist mode is reported (<i>f</i>-p<i>K</i><sub>i</sub>). See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Each determination lies within 0.3 log units of the mean with a minimum of 3 replicates. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">CYPEX assay: IC<sub>50</sub> ≥ 5 μM against different isoforms unless stated. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Intrinsic clearance in liver microsomes. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div></div></div><div class="NLM_p">The 1,3,4- and 1,2,3-triazoles (<b>11</b> and <b>12</b>) showed increased 5-HT<sub>1A/B/D</sub> antagonist potencies together with clean CYP450 profiles and reduced intrinsic clearance in rat and human microsomes compared to <b>5</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Whereas <b>12</b> had similar hSerT and hERG affinities to <b>5</b>, compound <b>11</b> had reduced affinities at both. On the basis of the increased separation between 5-HT<sub>1A/B/D</sub> potencies and hERG, <b>11</b> was progressed to rat PK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Encouragingly, the lower microsomal clearance translated to reduced in vivo clearance and increased oral bioavailability and half-life relative to <b>5</b>, although the brain to blood ratio was significantly reduced.</div><div class="NLM_p">The fused tetrazolo-benzoxazine <b>13</b> also maintained a good overall target profile together with low intrinsic clearance although 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and hSerT potencies were somewhat reduced relative to <b>5</b> and a significant increase in hERG affinity was evident (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The increased hERG affinity of <b>13</b> (and the 1,2,3-triazole <b>12</b>) compared to the 2-methyltriazole <b>11</b> is suggestive of a specific H-bond interaction between the additional nitrogen in the tetrazole ring system and the hERG channel.</div><div class="NLM_p">On the basis of the above promising results, the fused imidazobenzoxazines (<b>6</b> and <b>10</b>) were selected for further optimization and the introduction of different substituents into key positions of the imidazole rings was undertaken with the aim of increasing metabolic stability by blocking putative sites of metabolism and reducing CYP450 interactions. Substitution of the 4 and 5 position of the fused 1,2-imidazo-benzoxazine system with methyl (<b>8</b> and <b>7</b>) maintained target potencies but increased hERG with no reduction in intrinsic clearance. The 4-trifluoromethyl analogue <b>9</b> did show significantly reduced intrinsic clearance combined with a promising target profile but at the cost of dramatically increased hERG affinity.</div><div class="NLM_p">The 3 position of the fused 1,5-imidazo-benzoxazine <b>10</b> was hypothesized to be a site of potential metabolism, and therefore the introduction of small electron withdrawing groups such as nitrile, ketones, and amides was undertaken in order to reduce lipohilicity with the aim of addressing both the clearance and CYP450 issues and further increasing selectivity over hERG. Encouragingly, the ethyl ester <b>14</b>, methyl ketone <b>15</b>, ketoxime ether <b>16</b>, and the dimethyl amide <b>17</b> all maintained very similar target profiles across 5-HT<sub>1A/B/D</sub> and hSerT compared to <b>10</b> but demonstrated significantly reduced hERG affinity together with reduced intrinsic clearance and favorable CYP450 inhibitory profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The cyano derivative <b>18</b> also maintained a good overall profile, although hSerT affinity and selectivity between 5-HT<sub>1A/B/D</sub> and hERG were reduced.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Functional Activity (<i>f</i>-p<i>K</i><sub>i</sub> or pEC<sub>50</sub>)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> for human 5-HT<sub>1A/B/D</sub> Receptors with Intrinsic Activity (IA), hSerT and hERG binding affinities (p<i>K</i><sub>i</sub>),<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> Microsomal Intrinsic Clearance and Human CYP450 Activity for 3-Substituted-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazines (<b>14</b>−<b>18</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0014.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top"><td><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0015.gif" alt="" id="_i13" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Data from the agonist mode (pEC<sub>50</sub>)* are reported for those compounds with intrinsic activity (IA) ≥ 0.4 in this mode (i.e., partial or full agonists), whereas for those compounds with IA <0.4 in the agonist mode (i.e., antagonists), data from the antagonist mode is reported (<i>f</i>-p<i>K</i><sub>i</sub>). See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Each determination lies within 0.3 log units of the mean with a minimum of 3 replicates. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">CYPEX assay: IC<sub>50</sub> ≥ 5 μM against different isoforms unless stated. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Intrinsic clearance in liver microsomes. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div></div></div><div class="NLM_p">On the basis of their favorable in vitro profiles, <b>15</b>, <b>17</b>, and <b>18</b> were evaluated in rat PK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Whereas <b>17</b> had comparable in vivo clearance to <b>5</b>, in the case of <b>15</b> and <b>18</b>, the lower microsomal clearance translated to reduced in vivo clearance and, in combination with increased volumes of distribution (Vss), afforded significant increases in terminal half-life. All three imidazobenzoxazines demonstrated good bioavailability and favorable brain to blood ratios (consistent with higher Vss). In an attempt to explain the disconnect between the rat in vitro and in vivo clearance for <b>17</b>, we hypothesized that the dimethyl amide may be subject to metabolic demethylation in vivo. This putative route of metabolism was supported by the detection of high levels of a (M<sup>+</sup>-14) metabolite in rat PK samples and led us to prepare a series of amide analogues including cyclic tertiary amides (<b>26</b>−<b>29</b>), secondary amides (<b>19</b>, <b>21</b>−<b>25</b>) and the primary amide <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Functional Activity (<i>f</i>-p<i>K</i><sub>i</sub> or pEC<sub>50</sub>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> for Human 5-HT<sub>1A/B/D</sub> Receptors with Intrinsic Activity (IA), hSerT and hERG Binding Affinities (p<i>K</i><sub>i</sub>),<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a> Microsomal Intrinsic Clearance and Human CYP450 Activity for 3-Amido-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazines (<b>19</b>−<b>29</b>)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0016.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0017.gif" alt="" id="fx7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Data from the agonist mode (pEC<sub>50</sub>)* are reported for those compounds with intrinsic activity (IA) ≥ 0.4 in this mode (i.e., partial or full agonists), whereas for those compounds with IA <0.4 in the agonist mode (i.e., antagonists), data from the antagonist mode is reported (<i>f</i>-p<i>K</i><sub>i</sub>). See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Each determination lies within 0.3 log units of the mean with a minimum of 3 replicates. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">CYPEX assay: IC<sub>50</sub> ≥ 5 μM against different isoforms unless stated. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Intrinsic clearance in liver microsomes. See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a> for assay details.</p></div></div></div><div class="NLM_p">The secondary <i>N</i>-methyl amide <b>19</b> had an excellent overall in vitro profile which was similar to that of <b>17</b> but with even further reduced hERG affinity. Increasing the size and lipophilicity of the secondary <i>N</i>-alkyl substituent (<b>21</b>−<b>25</b>) maintained exquisitely high 5-HT<sub>1A/B/D</sub> antagonist potencies and afforded modest gains in hSerT but with concomitant increases in hERG affinities and increased intrinsic clearance (particularly by human microsomes). The 4, 5, and 6-membered cyclic tertiary amides (<b>26</b>−<b>28</b>) also maintained impressive 5-HT<sub>1A/B/D</sub> antagonist potencies together with increased hSerT and hERG affinities, which, as above, was consistent with increased lipohilicity. The morpholino analogue <b>29</b> was of particular interest, affording the lowest hERG affinity yet observed in this series and low CYP450 inhibitory potencies together with low intrinsic clearance. In addition, <b>29</b> displayed subnanomolar antagonist potencies against 5-HT<sub>1A/B/D</sub> receptors even though it had relatively modest hSerT affinity. The primary amide <b>20</b> also displayed a superb overall in vitro profile, comparable to that of <b>17</b> but with 10-fold reduced hERG affinity together with lower human intrinsic clearance.</div><div class="NLM_p">On the basis of their outstanding in vitro profiles, <b>19</b>, <b>20</b>, and <b>29</b> were selected for further detailed characterization initially in rat PK studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Encouragingly, all three compounds showed good oral bioavailability and reduced blood clearance, relative to <b>17</b>, together with brain to blood ratios >1 and high brain concentrations. The secondary amide <b>19</b> achieved the most impressive brain ratio (2.4), which may be due to the formation of an intramolecular H-bond between the amide NH and the imidazo nitrogen.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The availability of <b>19</b> allowed us to definitively confirm that this was a major metabolite produced from the <i>N</i>-dimethyl tertiary amide <b>17</b> both in vitro and in vivo (see above). In contrast, <b>19</b> was relatively metabolically stable to demethylation as evidenced by the detection of only minor traces of the corresponding primary amide <b>20</b> both in vitro and in vivo.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Rat Pharmacokinetic Profile for Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CLb<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> mL/min/kg</th><th class="colsep0 rowsep0" align="center" char=".">Vss L/kg</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> h</th><th class="colsep0 rowsep0" align="center" char=".">Fpo %</th><th class="colsep0 rowsep0" align="center" char=".">Br:Bl</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">26</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">5.1</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">In vivo data determined by 0.5 mg/kg iv and 1 mg/kg po administration in rat. Br:Bl at 1 h following iv dosing.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Intrinsic clearance in liver microsomes.</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Herg/QT risk</h3><div class="NLM_p last">Compounds <b>19</b>, <b>20</b>, and <b>29</b> were originally progressed on the basis of their low affinities for hERG channels as assessed by a dofetilide binding assay. To better understand their relative cardiovascular safety profiles in terms of potential for QT interval prolongation, the effects of the compounds on human cardiac potassium channels stably expressed in HEK293 cells were investigated using a manual patch clamp electrophysiology assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The compounds inhibited hERG tail current with pIC<sub>50</sub> values of 5.8, <5.0, and 6.0, respectively, in broad agreement with dofetilide binding affinities. Compound <b>20</b> in particular demonstrated remarkably low inhibitory potency affording insufficient inhibition of hERG tail current at the highest concentration tested to allow IC<sub>50</sub> calculation (pIC<sub>25</sub> ∼6.2). Furthermore, when administered by iv infusion, <b>20</b> had no effect on QT interval duration in an anaesthetised guinea pig model<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> up to the maximum tested concentration of 7.7 μg/mL (solubility limited). Taken together, these data suggest that <b>20</b> possesses an excellent therapeutic index between biologically active concentrations (see below) and those likely to evoke QT prolongation via effects upon cardiac K<sup>+</sup> ion channels.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> DDI and Bioactivation Risk</h3><div class="NLM_p">Although both <b>19</b> and <b>20</b> exhibited comparable direct inhibition profiles against the major human CYP450 enzymes during preliminary profiling (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), different profiles emerged with respect to bioactivation and DDI risk during further detailed CYP3A4 inhibition profiling in human liver microsomes using three different clinical probes (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). The secondary amide <b>19</b> and the primary amide <b>20</b> both displayed a low potential for interacting with human CYP3A4, with <b>20</b> exhibiting the highest IC<sub>50</sub> values for all three probes (IC<sub>50</sub> >88 μM). However, the results indicated a decrease in IC<sub>50</sub> values for the secondary amide <b>19</b> against the midazolam probe (IC<sub>50</sub> fold-change = 4) and the atorvastatin probe (IC<sub>50</sub> fold-change = 3), suggesting that <b>19</b> was a metabolism-dependent inhibitor of CYP3A4 for midazolam and atorvastatin in this assay. In contrast, the primary amide <b>20</b> gave no evidence of metabolism-dependent inhibition, up to 100 μM concentration.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro Metabolism-Dependent Inhibition of Three Clinical Probes for Human CYP3A4 Using Human Liver Microsomes for Compounds <b>19</b> and <b>20</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center" char="."><b>19</b></th><th class="colsep0 rowsep0" colspan="3" align="center" char="."><b>20</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">clinical probe</th><th class="colsep0 rowsep0" align="center" char=".">initial IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">final IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">fold-change</th><th class="colsep0 rowsep0" align="center" char=".">initial IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">final IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">fold-change</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">midazolam</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">atorvastatin</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">nifedipine</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Following incubation.</p></div></div></div><div class="NLM_p last">To qualitatively access the risk of reactive metabolite formation, which is considered a risk factor for idiosyncratic toxicity, the propensity of <b>19</b> and <b>20</b> to form glutathione conjugates was also investigated.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Despite the closely related chemical structures, in the case of <b>19</b> a glutathione adduct (parent + GSH) was observed following incubation with GSH in the presence of human liver microsomes, with the bioactivation site determined to be the methyl amidic group. For the primary amide <b>20</b>, the same GSH conjugate could not be detected, highlighting a lower bioactivation risk relative to <b>19</b>. On the basis of its superior overall profile, <b>20</b> was selected for detailed in vitro and in vivo biological evaluation.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 5-HT<sub>1A/1B/1D</sub> Radioligand Binding and Functional Studies</h3><div class="NLM_p">The affinities of <b>20</b> for human (h) recombinant 5-HT<sub>1</sub> autoreceptors as assessed against Chinese hamster ovary (CHO) cells expressing h5-HT<sub>1A</sub> or h5-HT<sub>1B</sub> or h5-HT<sub>1D</sub> receptors using [<sup>3</sup>H]-WAY100635 (5-HT<sub>1A</sub>) and [<sup>3</sup>H]-5-HT (5-HT<sub>1B</sub> and 5-HT<sub>1D</sub>) were high and in good agreement with the functional potencies (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). Comparable potencies were also obtained for native tissue 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptors in rat, guinea pig, and marmoset cortex using [<sup>3</sup>H]-WAY100635 and the 5-HT<sub>1B/1D</sub> receptor antagonist radioligand [<sup>3</sup>H]-GR125743, respectively. Under these conditions, 5-HT<sub>1D</sub> receptors are unlikely to contribute to the binding of [<sup>3</sup>H]-GR125743 due to their relatively low expression in this brain region.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Summary of the Affinity (p<i>K</i><sub>i</sub>) of <b>20</b> for Human Recombinant and Native Tissue 5-HT<sub>1A/1B/1D</sub> Receptors Determined Using Radioligand Binding (Mean ± SEM) and Human Functional Potency (pA<sub>2</sub>) Using [<sup>35</sup>S]-GTPγS-SPA Binding</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="4" align="center" char="±">p<i>K</i><sub>i</sub> for 5-HT<sub>1A/1B/1D</sub> receptors</th><th class="colsep0 rowsep0" align="center" char="±"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±">rat<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">guinea pig<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">marmoset<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±">human<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">human functional potency<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a> p<i>A</i><sub>2</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="char" char="±">10.16 ± 0.14</td><td class="colsep0 rowsep0" align="char" char="±">10.24 ± 0.09</td><td class="colsep0 rowsep0" align="char" char="±">10.18 ± 0.12</td><td class="colsep0 rowsep0" align="char" char="±">9.94 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">9.69 ± 0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="char" char="±">8.49 ± 0.03</td><td class="colsep0 rowsep0" align="char" char="±">9.80 ± 0.07</td><td class="colsep0 rowsep0" align="char" char="±">9.81 ± 0.13</td><td class="colsep0 rowsep0" align="char" char="±">9.10 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">8.93 ± 0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1D</sub></td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±"> </td><td class="colsep0 rowsep0" align="char" char="±">10.00 ± 0.08</td><td class="colsep0 rowsep0" align="char" char="±">9.77 ± 0.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Native tissue binding to 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptors in rat, guinea pig, and marmoset cortex using [<sup>3</sup>H]-WAY100635 and the 5-HT<sub>1B/1D</sub> receptor antagonist radioligand [<sup>3</sup>H]-GR125743, respectively.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">CHO cells expressing h5-HT<sub>1A</sub> or h5-HT<sub>1B</sub> or h5-HT<sub>1D</sub> receptors using [<sup>3</sup>H]-WAY100635 (5-HT<sub>1A</sub>) and [<sup>3</sup>H]-5-HT (5-HT<sub>1B</sub> and 5-HT<sub>1D</sub>).</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">[<sup>35</sup>S]-GTPγS-SPA binding to h5-HT<sub>1A</sub> (HEK), h5-HT<sub>1B</sub> (CHO) and h5-HT<sub>1D</sub> (CHO).</p></div></div></div><div class="NLM_p last">In vitro determination of function using [<sup>35</sup>S]-GTPγS-SPA binding to h5-HT<sub>1A</sub> (HEK), h5-HT<sub>1B</sub> (CHO), and h5-HT<sub>1D</sub> (CHO) cell membranes was also assessed. Increasing concentrations of <b>20</b> produced parallel rightward-shift of the agonist (5-HT) concentration−response curves with the same maximal response in the presence and absence of the antagonist to afford p<i>A</i><sub>2</sub> values in good agreement with the affinity constants (p<i>K</i><sub>i</sub>) from receptor binding studies for all three receptors (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). <b>20</b> alone did not stimulate [<sup>35</sup>S]-GTPγS binding at any of the receptors (at concentrations up to 1 μM), indicating that this compound does not have agonist properties at human recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Selectivity Profile</h3><div class="NLM_p last">Compound <b>20</b> displayed good selectivity (>100-fold) in a Cerep battery of more than 90 biological targets including GPCRs, ion channels, transporters, and enzymes with the exception of h-SERT and h-α<sub>1A</sub> adrenoceptors. Subsequently, <b>20</b> was determined to have a p<i>K</i><sub>i</sub> values of 7.54 ± 0.07 (<i>n</i> = 3) and 8.56 ± 0.03 (<i>n</i> = 6) in h-SERT (ligand [<sup>3</sup>H]-citalopram) and h-α<sub>1A</sub> adrenoceptor (ligand [<sup>3</sup>H]-prazosin) filtration binding assays respectively.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo PD Profile</h3><div class="NLM_p">Compound <b>20</b> was determined to have potent activity in both 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> agonist driven PD models in rat and guinea pig, respectively. In the 5-HT<sub>1A</sub> driven PD model,<a onclick="showRef(event, 'cit7b'); return false;" href="javascript:void(0);" class="ref cit7b">(7b)</a><b>20</b> significantly reversed 8-OH-DPAT-induced hyperlocomotion in rats in a dose-dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), with an ED<sub>50</sub> of 0.05 mg/kg po (plasma EC<sub>50</sub> = 3.1 ng/mL). In the 5-HT<sub>1B</sub> driven PD model<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a><b>20</b> significantly reversed SKF-99101-induced hypothermia in the guinea pig in a dose dependent manner (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), with an ED<sub>50</sub> of 0.11 mg/kg po (extrapolated EC<sub>50</sub> = 2.3 ng/mL in plasma). In 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub>, ex vivo receptor occupancy (RO) studies in guinea pig using [<sup>3</sup>H]-WAY100635 (5-HT<sub>1A</sub>) and [<sup>3</sup>H]-GR125743 (5-HT<sub>1B</sub>) as radioligands, compound <b>20</b> afforded ED<sub>50</sub> values of 0.2 and 0.1 mg/kg, respectively, (EC<sub>50</sub> 9.0 and 4.5 ng/g in cortex) which are in line with the above PD data (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>20</b> on 8-OH-DPAT-induced hyperlocomotion in rat. Data represent mean ± SEM of 8 animals per group; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, ANOVA for completely randomized measures versus 8-OH-DPAT group, followed by Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>20</b> on SKF-99101H-induced hypothermia in guinea pig. Data represent mean ± SEM of 8 animals per group; ** = <i>p</i> < 0.01, ANOVA for completely randomized measures versus vehicle treated animals, followed by Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Occupancy at 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptors by <b>20</b> in guinea pig cortex together with brain and plasma exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. ED<sub>50</sub> and EC<sub>50</sub> for <b>20</b> in ex Vivo 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> Receptor Occupancy Studies in Guinea Pig Cortex</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">ED<sub>50</sub> mg/kg</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> ng/mL</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub> ([<sup>3</sup>H]-WAY100635 binding)</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1B</sub>([<sup>3</sup>H]-GR125743 binding)</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">4.5</td></tr></tbody></table></div></div><div class="NLM_p last">Evidence supporting fast-onset antidepressant/anxiolytic activity was obtained from both neurochemical studies and validated rodent and primate animal models of anxiety which will be the subject of a separate publication.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, the bioisosteric replacement of the metabolically labile <i>N</i>-methyl amide group of a series of benzoxazinones with small heterocyclic rings has led to novel series of fused tricyclic benzoxazines, many of which are potent 5-HT<sub>1A/B/D</sub> receptor antagonists both with and without concomitant hSerT activity. On the basis of their initial profiles fused imidazobenzoxazines (<b>6</b> and <b>10</b>) were selected for further exploration. Optimizing against multiple parameters in parallel identified several promising molecules which were progressed into more extensive characterization to enable the selection of the highest quality development candidate possible. In particular, <b>20</b> emerged as a potent 5-HT<sub>1A/B/D</sub> receptor antagonist with a high degree of selectivity over hERG potassium channels, favorable PK, and excellent activity in vivo in rodent PD models. On the basis of its outstanding overall profile, <b>20</b> was selected for progression as a clinical candidate with the ultimate aim to assess its potential as a faster acting antidepressant/anxiolytic with reduced side-effect burden.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Biological Test Methods</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> In Vitro Studies</h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28">a Functional Potency: Primary Screen at Human Recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptors</h5><div class="NLM_p last">The functional potency of the compounds was determined by the following GTPγS binding assay. Cells used in the study are Chinese hamster ovary (CHO) cells and human embryo kidney (HEK293) cells transfected with DNA coding for human receptors as follows: HEK293_5-HT<sub>1A</sub>, CHO_5-HT<sub>1B</sub>, and CHO_5-HT<sub>1D</sub>. Test compounds were initially dissolved in 100% dimethyl sulfoxide (DMSO) to a concentration of 10 mM. Serial dilution of the test compounds in 100% DMSO was carried out using a Biomek FX in 384 well assay plates so that the final top concentration of test compound was 3 μM in the assay. Test compounds were added at 1.0% total assay volume (TAV) to a solid, white, 384-well assay plate (Costar). Fifty percent TAV of precoupled (for 90 min at RT) membranes (5 ug/well), wheatgerm agglutinin polystyrene scintillation proximity assay beads (RPNQ0260 Amersham International) (0.25 mg/well) in 20 mM HEPES pH 7.4, 100 mM NaCl, 3 mM MgCl<sub>2</sub>, and 10 μM GDP were added. The third addition was a 20% TAV addition of either buffer (agonist format) or EC<sub>80</sub> of the agonist 5HT, prepared in assay buffer (antagonist format). The assay was started by the addition of 29% TAV of GTPγ[<sup>35</sup>S] 0.38 nM final (37 MBq/ml, 1160 Ci/mmol, Amersham). After all additions, assay plates were spun down for 1 min at 1000 rpm. Assay plates were counted on a Viewlux, 613/55 filter, for 5 min, between 2 and 6 h after the final addition.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29">b Receptor Affinities at Human Recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptors</h5><div class="NLM_p last">The affinities of the compounds for the human recombinant 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors were determined by the following assays. Cell pellets deriving from three clones of Chinese hamster ovary (CHO) cells stably transfected with the human 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> receptors were resuspended in 10 volumes of 50 mM HEPES, 1 mM EDTA pH 7.4 in the presence of 1 μM leupeptin, 25 μg/mL bacitracin, 1 mM PMSF, and 2 μM pepstain A (homogenization buffer). The cells were homogenized by a Glass Waring blender, and the resulting suspension spun at 500<i>g</i> for 20 min. The supernatant was then centrifuged at 48000<i>g</i> for 30 min and the final pellet was resuspended in homogenization buffer and homogenized again. The final suspension was distributed into aliquots and store at −80 °C. Protein content in the membrane preparations was evaluated with BioRad protein assay. The day of the experiment, membrane aliquots were thawed and resuspended in Tris-Mg buffer (50 mM Tris/HCl, pH 7.7, 10 mM MgCl<sub>2</sub>, 1 g/L ascorbic acid, and 5 μM pargiline) and homogenized with Polytron immediately before use. Assays were performed into deep-well 96-well plates in a total volume of 0.5 mL/well. For 5-HT<sub>1A</sub> binding assay, 10 μg of protein of membranes were incubated with 0.5−1 nM [<sup>3</sup>H]-WAY100635 (TRK1034, 2.85 TBq/mmol, Amersham) and test drug, at 37 °C for 45 min, in Tris-Mg buffer supplemented with 30 μM GppNHp (guanosine 5′-[β,γ-imido]triphosphate). For 5-HT<sub>1B</sub> and 5-HT<sub>1D</sub> binding assays, 10 μg protein of membranes were incubated with 3 nM [<sup>3</sup>H]-5-HT (TRK1006, 4.00 TBq/mmol, Amersham) and test drug, at 37 °C for 45 min, in Tris-Mg buffer. Nonspecific binding (NSB) was defined using 10 μM of WAY100635 or 5-HT for 5-HT<sub>1A</sub> and 5-HT<sub>1B/D</sub>, respectively. Incubation was stopped by rapid filtration and washes with ice-cold 50 mM Tris buffer, pH 7.7, onto GF/B Unifilter plate (Perkin-Elmer) using a Perkin-Elmer Harvester. Radioactivity was measured by Topcount (Perkin-Elmer) scintillation counting. p<i>K</i><sub>i</sub> values of test drugs were calculated according to the Cheng−Prusoff equation from the IC<sub>50</sub>, generated by an iterative least-squares curve fitting program (GraphPad Prism) and the <i>K</i><sub>D</sub> (equilibrium dissociation constant of the radioligand) determined at each receptor type (5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub>) through saturation experiments.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30">c Receptor Affinity at Native 5-HT<sub>1A</sub> and 5-HT<sub>1B/D</sub> Receptors Determined in Brain Cortex Tissue from Rat, Guinea Pig, and Marmoset</h5><div class="NLM_p">Frozen brain cortex tissue samples from rat, guinea pig, and marmoset were thawed and resuspended in 20 volumes (v/w) of 50 mM Tris buffer, pH 7.7. Each tissue was homogenized with a Potter homogenizer and then spun at 48000<i>g</i> for 15 min. The pellet was resuspended in 20 volumes of 50 mM Tris buffer and homogenized with a Polytron homogenizer. The homogenate was incubated at 37 °C in a shaking water bath for 20 min. After a further homogenization, the tissue homogenate was centrifuged again at 48000<i>g</i> for 15 min. The supernatant was discarded, and the membrane pellet was finally resuspended in 4 volumes of 50 mM Tris buffer, distributed into tubes, and immediately frozen on dry ice and stored at −80 °C until use. Protein content was evaluated with BioRad protein assay.</div><div class="NLM_p">The affinity of test compounds for 5-HT<sub>1A</sub> receptor in rat, guinea pig, and marmoset brain cortex was assessed through competition binding experiments using the 5-HT<sub>1A</sub>-selective antagonist radioligand [<sup>3</sup>H]-WAY100635 in low agonist affinity conditions, i.e. in thepresence of 100 μM GPP(NH)p, a GTP analogue which promotes the transition of receptors to the inactive (G-protein uncoupled) state. Competition binding experiments were carried out in deep-well 96-plate format in a final volume of 0.5 mL/well of assay buffer (Tris 50 mM, pH 7.7 containing 0.2 mM ascorbic acid and 100 μM Gpp(NH)p) in the presence of 0.4−0.7 nM [<sup>3</sup>H]-WAY100635. NSB was determined in the presence of 10 μM WAY100635. The binding reaction was started through the addition of the membranes (∼30−40 μg brain cortex membrane protein/well) and allowed to proceed for 45 min at 37 °C in a shaking water bath. At the end of the incubation, the reaction was stopped by filtration through glass fiber sheet (GF/C) presoaked in 0.3% PEI, followed by washes with ice cold 50 mM Tris buffer, pH 7.7, using a 96 way-harvester (Brandel M96/R). Radioactivity retained on the filters was determined by conventional liquid scintillation spectrometry.</div><div class="NLM_p">The affinity of test compound for native 5-HT<sub>1B/D</sub> receptors in brain cortex was assessed through competition binding experiments essentially as described before but using the 5-HT<sub>1B/D</sub> antagonist radioligand [<sup>3</sup>H]-GR125743 (0.3 nM, TRK-1046, 2.96 TBq/mmol, Amersham) in an assay buffer containing: Tris 50 mM, pH 7.7, 10 mM MgCl<sub>2</sub>, 0.2 mM ascorbic acid, and 100 nM of a cocktail of four blockers (8-OH-DPAT, SB-243213, SB-258585, and SB-269970) of serotonergic receptors (5-HT<sub>1A</sub>, 5-HT<sub>2C</sub>, 5-HT<sub>6</sub>, and 5-HT<sub>7</sub>, respectively). NSB was determined in presence of 10 μM serotonin.</div><div class="NLM_p last">p<i>K</i><sub>i</sub> value of the test drug was calculated according to the Cheng−Prusoff equation from the IC<sub>50</sub> and the <i>K</i><sub>D</sub> determined in the three animal species evaluated (rat, guinea pig, and marmoset) through saturation experiments.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31">d [<sup>3</sup>H]Citalopram Binding Assay for Human Recombinant Serotonin Transporter (SERT)</h5><div class="NLM_p">The affinity of the compounds to bind the reuptake site of serotonin transporter (SERT) was assessed by using [<sup>3</sup>H]citalopram binding assay performed in recombinant epithelial pig kidney cells stably transfected with human SERT (hSERT/LLCPK). Cell pellet was homogenized in 30−50 volumes of assay buffer (50 mM Tris, 120 mM NaCl, 5 mM KCl, 10 μM pargyline, 0.1% ascorbic acid, pH = 7.7) and centrifuged at 48000<i>g</i> for 20 min at 4 °C. The pellet was then resuspended in the same volume of assay buffer and after incubation at 37 °C for 20 min centrifuged as before. The final pellet was resuspended in assay buffer at ∼0.2 mg protein/mL (as determined with BioRad protein assay).</div><div class="NLM_p">The binding assay was performed in deep-well 96-well plate and the following additions were used up to a total assay volume of 400 μL: 100 μL of compound dilution or assay buffer (to define total binding, TB) or 10 μM fluoxetine (NSB), 100 μL of [<sup>3</sup>H]-citalopram (0.25 nM, TRK-1068, 296TBq/mmol, Amersham) and 200 μL of membranes diluted in assay buffer (2 μg of protein/well). Membranes were added last to initiate the reaction and incubated at room temperature for 2 h. The reaction was then stopped by rapid filtration through GF/B filter-plate (Unifilter, Perkin-Elmer), presoaked in 0.5% polyethylenimmine (PEI) using a Perkin-Elmer harvester. Wells were washed three times with cold 0.9% NaCl solution. The dried plates were counted using TopCount (Perkin-Elmer) liquid scintillation counter.</div><div class="NLM_p last">p<i>K</i><sub>i</sub> values were calculated according to the Cheng−Prusoff equation from the IC<sub>50</sub> and the <i>K</i><sub>D</sub> determined at human SERT through saturation experiments.</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Receptor Selectivity</h4><div class="NLM_p last">The receptogram screen was performed by Cerep assessing the binding of 10 μM on 83 G-Protein coupled receptors, channels, enzymes, and transporters.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> hERG-[<sup>3</sup>H]-Dofetilide Binding Assay</h4><div class="NLM_p last">hERG activity was measured using [<sup>3</sup>H]-dofetilide binding in a scintillation proximity assay (SPA) format. The activity was measured with a PerkinElmer Viewlux imager.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> CYP450 Inhibition CYPEX Assay</h4><div class="NLM_p last">Inhibition (IC<sub>50</sub>) of human CYP1A2, 2C9, 2C19, 2D6, and 3A4 was determined using Cypex Bactosomes expressing the major human P450s. A range of concentrations (0.1, 0.2, 0.4, 1, 2, 4, and 10 μM) of test compound were prepared in methanol and preincubated at 37 °C for 10 min in 50 mM potassium phosphate buffer (pH 7.4) containing recombinant human CYP450 microsomal protein (0.1 mg/mL; Cypex Limited, Dundee, UK) and probe-fluorescent substrate. The final concentration of solvent was between 3 and 4.5% of the final volume. Following preincubation, NADPH regenerating system (7.8 mg glucose-6-phosphate, 1.7 mg NADP, and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 25 μL) was added to each well to start the reaction. Production of fluorescent metabolite was then measured over a 10 min time-course using a Spectrafluor plus plate reader. The rate of metabolite production (AFU/min) was determined at each concentration of compound and converted to a percentage of the mean control rate using Magellan (Tecan software). The inhibition (IC<sub>50</sub>) of each compound was determined from the slope of the plot using Grafit v5 (Erithacus software, UK). Miconazole was added as a positive control to each plate. CYP450 isoform substrates used were ethoxyresorufin (ER; 1A2; 0.5 μM), 7-methoxy-4-triflouromethylcoumarin-3-acetic acid (FCA; 2C9; 50 μM), 3-butyryl-7-methoxycoumarin (BMC; 2C19; 10 μM), 4-methylaminomethyl-7-methoxycoumarin (MMC; 2D6; 10 μM), diethoxyflourescein (DEF; 3A4; 1 μM), and 7-benzyloxyquinoline (7-BQ; 3A4; 25 μM). The test was performed in three replicates.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> CYP450 Inhibition Gentest Assay</h4><div class="NLM_p last">Inhibition potential (IC<sub>50</sub>) of test compound for inhibition of human CYP1A2, 2C9, 2C19, 2D6, and 3A4 was determined. A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of test compound prepared in methanol were preincubated at 37 °C for 10 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.1, 0.16, 0.2, or 0.4 mg recombinant human CYP450 microsomal protein mL<sup>−1</sup> (Gentest Corporation, USA) and substrate. Following preincubation, 25 μL mL<sup>−1</sup> of a NADPH regenerating system (7.8 mg glucose 6-phosphate, 1.7 mg NADP, and 6 U glucose-6-phosphate dehydrogenase mL<sup>−1</sup> 2% w/v NaHCO<sub>3</sub>) was added to each well to start the reaction. Production of fluorescent metabolite was then measured over a 10 min time-course using a Spectrafluor plus plate reader (Tecan). The rate of metabolite production (AFU/min) was determined for each concentration of compound and converted to a percentage of the mean control rate using Magellan v3.0 (Tecan software). The inhibitory potential (IC<sub>50</sub>) was determined from the slope of the plot using Grafit v4.12 (Erithacus software, UK). Miconazole was added as a positive control to each plate.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> CYP450 Inhibition Using Human Liver Microsomes</h4><div class="NLM_p">A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of test compound were prepared in methanol. These were preincubated at 37 °C for 20 min in 50 mM potassium phosphate buffer (pH 7.4) containing pooled human liver microsomal protein (0.1 mg/mL; Xenotech) and CYP3A4 substrate (midazolam, atorvastatin or nifedipine; 2.5, 10, or 50 μM, respectively). To start the reaction, NADPH regenerating system (7.8 mg glucose-6-phosphate, 1.7 mg NADP and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 50 μL/mL) was added. Following a 5 min incubation, reactions were terminated with the addition of 250 μL acetonitrile.</div><div class="NLM_p last">Quantification of 1′-hydroxy midazolam, <i>o</i>-hydroxy atorvastatin, and oxidized nifedipine metabolites was carried out using validated HPLC-MS analytical methods. Inhibition (IC<sub>50</sub>) was determined using Grafit (Erithacus software, UK).</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Metabolism-Dependent Inhibition of CYP3A4 in Human Liver Microsomes</h4><div class="NLM_p">A range of concentrations (0.1, 0.33, 1, 3.3, 10, 33, and 100 μM) of the test compound and troleandomycin (positive control) were prepared in methanol. These were pre-incubated at 37 °C for 20 min in 50 mM potassium phosphate buffer (pH 7.4) containing pooled human liver microsomal protein (0.1 mg/mL; Xenotech) and NADPH regenerating system (7.8 mg glucose-6-phosphate, 1.7 mg NADP, and 6 units glucose-6-phosphate dehydrogenase/mL of 2% (w/v) NaHCO<sub>3</sub>; 50 μL/mL) [Cofactor preincubation samples] or CYP3A4 substrate (midazolam, atorvastatin, or nifedipine; 2.5, 10, or 50 μM, respectively) [substrate preincubation samples]. To start the reaction, CYP3A4 substrate (midazolam, atorvastatin, or nifedipine; 2.5, 10, or 50 μM, respectively) was added to the cofactor preincubation samples and NADPH regenerating system (50 μL/mL) to the substrate preincubation samples. Following 5 min incubation for midazolam and 10 min incubation for atorvastatin or nifedipine, reactions were terminated with the addition of 250 μL of acetonitrile.</div><div class="NLM_p last">Quantification of 1′-hydroxy midazolam, <i>o</i>-hydroxy atorvastatin and oxidized nifedipine metabolites was carried out using validated HPLC-MS analytical methods. Inhibition (IC<sub>50</sub>) was determined using Grafit (Erithacus software, UK) and TDI assessed comparing the difference in IC<sub>50</sub> between the cofactor and substrate preincubation samples for each CYP3A4 substrate.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> GSH Trapping</h4><div class="NLM_p last">Incubations were carried out with human liver microsomes (1 mg/mL), glutathione (10 mM), MgCl<sub>2</sub> (3 mM), NADPH generating system (7.8 mg glucose-6-phosphate, 1.7 mg NADP, 6 U glucose-6-phosphate dehydrogenase per mLof 2% sodium bicarbonate), one positive substrate (acetaminophen). Test compound and acetaminophen as positive control were incubated at 100 μM at 37 °C for 1.5 h. Incubation mixtures were collected at 0and 90in and quenched with 6% acetic acid in acetonitrile. Assay mixtures were centrifuged (900<i>g</i>, 10 mn, 4 °C), and 10 μL of the resulting supernatants were injected into the HPLC-MS system.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Intrinsic Clearance (Cli) Assay</h4><div class="NLM_p last">Intrinsic clearance (CLi) values were determined in rat and human liver microsomes. Test compounds (0.5 μM) were incubated at 37 °C for 30 min in 50 mM potassium phosphate buffer (pH 7.4) containing 0.5 mg microsomal protein/mL. The reaction was started by addition of cofactor (NADPH; 8 mg/mL). The final concentration of solvent was 1% of the final volume. At 0, 3, 6, 9, 15, and 30 min, an aliquot (50 μL) was taken, quenched with acetonitrile containing an appropriate internal standard, and analyzed by HPLC-MS/MS. The intrinsic clearance (CLi) was determined from the first-order elimination constant by nonlinear regression using Grafit v5 (Erithacus software, UK), corrected for the volume of the incubation, and assuming 52.5 mg microsomal protein/g liver for all species. Values for CLi were expressed as mL/min/g liver. The lower limit of quantification of clearance was determined to be when <15% of the compound had been metabolized by 30 min and this corresponded to a CLi value of 0.5 mL/min/g liver. The upper limit was 50 mL/min/g liver.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Patch Clamp hERG Electrophysiology Assay</h4><div class="NLM_p">On the days of experimentation, a weighed amount of the test substance was formulated in dimethyl sulfoxide (DMSO; lot no. U10781; Sigma-Aldrich, UK), by shaking, to give a stock concentration of 10 mM of the test compound. The 10 mM stock solution was serially diluted in DMSO to give further stock solutions of 1 and 0.1 mM. Aliquots of these stock solutions were added to bath solution to achieve final perfusion concentrations of 0.1, 1, and 10 μM test compound. The corresponding vehicle concentration in all test substance perfusion solutions was 0.1% DMSO. Test substance stock formulations were freshly prepared on each day of experimentation, stored at room temperature, and protected from light.</div><div id="sec4_1_10_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Reference Substance</h5><div class="NLM_p last">E-4031 (batch no. MLE9446; Wako Pure Chemical Industries Ltd.). Stock solutions of E-4031 (100 μM) were prepared in reverse osmosis water, aliquoted, and stored at approximately −20 °C until use. On the day of use, the 100 μM stock solution was added to bath solution to give a final perfusion concentration of 100 nM.</div></div><div id="sec4_1_10_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> Bath and Pipette Solutions</h5><div class="NLM_p last">The composition of bath solution was (mM): NaCl 137, KCl 4, CaCl<sub>2</sub> 1.8, MgCl<sub>2</sub> 1.0, <span class="smallcaps smallerCapital">d</span>-glucose 10, <i>N</i>-2-hydroxyethylpiperazine-<i>N</i>′-2-ethanesulfonic acid (HEPES) 10, pH 7.4 with 1 M NaOH. Pipette solution was prepared in batches, aliquoted, and stored frozen until the day of use. The composition of pipet solution was (mM): KCl 130, MgCl<sub>2</sub> 1.0, ethylene glycol-bis(ss-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetraacetic acid (EGTA) 5, MgATP 5, HEPES 10, pH 7.2 with 1 M KOH.</div></div><div id="sec4_1_10_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> Study Design</h5><div class="NLM_p last">Cells (passage number: 48) were transferred to the recording chamber and continuously perfused (at approximately 1−2 mL/min) with bath solution at room temperature. High resistance seals (seal resistances >1.5 GΩ) were formed between the patch electrodes (resistance range: 1.4−5.5 MΩ) and individual cells. The membrane across the electrode tip was then ruptured and the whole-cell patch-clamp configuration was established. Once a stable patch had been achieved, recording commenced in voltage-clamp mode, with the cell initially clamped at −80 mV. Currents were evoked by stepping the membrane potential to +20 mV and then to −50 mV (tail current). Test compound at 10, 1, and 0.1 μM was used to produce (if any) inhibition of hERG tail current and therefore to investigate the concentration−response relationship (<i>n</i> = 3 cells/concentration). The effect of the vehicle (0.1% DMSO) was investigated in three cells. The effect of 100 nM E-4031 was investigated in two of the vehicle treated cells to confirm the sensitivity of the test system to an agent known to block hERG current. All perfusion solutions were applied for approximately 10 min.</div></div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> In Vivo Studies</h4><div class="NLM_p last">All experimental procedures were carried out in accordance with Italian law (Legislative Decree no. 116, 27 January 1992), which acknowledges the European Directive 86/609/EEC and were fully compliant with GlaxoSmithKline policy and codes of practice on the care and use of laboratory animals. Animals were housed under standard laboratory conditions (23 ± 1 °C; lights on 0600−1800 h) with food and water ad libitum.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 8-OH-DPAT-Induced Hyperlocomotion.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></h4><div class="NLM_p">Male Sprague−Dawley rats (250−350 g, Charles River, Italy) were used. Rat locomotory activity was assessed as the total distance (cm) traveled by each rat in the test arena over a 30 min period using Digiscan analyzer system (Omnitech, model RXYZCM-8, Columbus, OH). Rats were placed individually into clear plexiglas boxes, measuring 40 cm × 40 cm × 30.5 cm and covered with a perforated plexiglas lid. Infrared monitoring sensors were located around the perimeter walls. Data were collected and analyzed by a Digiscan analyzer (Omnitech, model DCM-4, Columbus, OH), which in turn transferred information to a computer. Total distance was recorded during 30 min test period.</div><div class="NLM_p last">The animals were treated orally with vehicle or compound <b>20</b> at 0.03, 0.1, or 0.3 mg/kg 120 min before a subcutaneous (sc) injection of 0.2 mg/kg of 8-OH-DPAT. The standard 5-HT<sub>1A</sub> receptor antagonist WAY-100,635 (Fletcher, 1996) was used as positive control (0.03 mg/kg sc 30 min before test).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> SKF99101H-Induced Hypothermia</h4><div class="NLM_p">Male Dunkin Hartley guinea pigs (300−400 g, Harlan, Germany) were used. Core body temperature was monitored on freely moving animals by using a telemetric transponders (IPTT-200 BioMedic Data System, Seaford, DE) implanted sc in the dorso-cervical area four days before test. Body temperature was recorded by placing the scanner (DAS 5007 BioMedic Data System, Seaford, DE) above the transponder until a stable reading was achieved.</div><div class="NLM_p last">The animals were treated orally with vehicle or compound <b>20</b> at 0.1, 0.3, or 1 mg/kg 60 min before sc administration of 10 mg/kg of SKF-99101H a standard 5-HT<sub>1/7</sub> agonist. Temperature measurements were taken immediately prior to SKF-99101H dosing (time 0) and every 30 min for a total of 180 min. Data are expressed as a fall in the peak temperature (°C) compared to body temperature at time 0 (just before SKF-99101H administration).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Drugs</h4><div class="NLM_p last">Compound <b>20</b> was suspended in Methocel 0.5% (w/v, HPCM Colorcon, Dow Chemical Company, Midland, MI). 8-OH-DPAT was purchased by Sigma (Italy) and dissolved in saline before use. WAY-100,635 (<i>N</i>-{2-[4-(2-methoxyphenyl)-1-piperaziny]ethyl}-<i>N</i>-(2-pyridinyl) cyclohexane-carboxamide trihydrochloride) was synthesized in house and dissolved in sterile water before use. SKF-99101H (3-2-dimethylaminoethyl-4-chloro-5-propoxyindole hemifumarate) was synthesized in house and dissolved in saline before use. All compounds were prepared with correction for salt form such that doses cited refer to mg/kg of active principle.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Measurement of the Occupancy at 5-HT<sub>1A</sub> and 5-HT<sub>1B/D</sub> Receptors Using ex Vivo Binding on Guinea Pig Brain Cortex Homogenate</h4><div class="NLM_p">The test compound was dissolved in 0.5% methocel and administered per os (po) to male guinea pigs (about 250 g, strain DH, Harlan), dosed at 0.03, 0.1, 1, and 3 mg/kg po; a further group was run with vehicle. For each dose condition, four animals were used. The receptor occupancy determination was performed 1 h after the administration. Animals were sacrificed by decapitation, and the brain was quickly removed and the cerebral cortex was dissected. One-fourth of the tissue was used by the DMPK Department for the analytical quantification of the amount of the test compound in the cortex. Remaining tissue was processed for binding experiments. The cortex sample from each single animal of the different experimental groups was weighed and homogenized in 30 mL of 50 mM Tris Buffer pH 7.7 using a glass−glass Potter homogenizer. The homogenate was diluted to a final volume of 100-fold the original wet weight of tissue and further homogenized by using a Polytron homogenizer. The resulting homogenate was directly used for the 5-HT<sub>1B/D</sub> binding, while for 5-HT<sub>1A</sub> binding it was further diluted 1:1. For each cortex sample, the protein concentration was determined by using the Bio-Rad Protein Assay. Occupancy of 5-HT<sub>1A</sub> and 5-HT<sub>1B/D</sub> receptors was assessed through binding experiments using [<sup>3</sup>H]-WAY100635 and [<sup>3</sup>H]-GR125743, as described previously.</div><div class="NLM_p last">Each single animal of the different groups (vehicle and compound-treated) generated from each binding assay four values: two total bound (TB) and two nonspecific bound (NSB). The average of the NSB was subtracted from the TB of each brain sample to obtain the specific binding (SB). Maximal SB values were from the vehicle-treated animals and SB gradually decreased in the drug-treated animals with the increase of the dose. Percentage of specific binding in drug-treated animals (% SB) was then calculated and the % of receptor occupancy (RO) inversely correlates with the % SB (i.e., 0% RO is in the vehicle group and 100% RO is when the drug completely blocks the radioligand binding). The ED<sub>50</sub> values were estimated by nonlinear regression between % RO and the dose of compound administered. EC<sub>50</sub>s were estimated using % RO vs compound concentration in the brain or in the plasma, as analytically determined by DMPK.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Anesthetized Guinea Pig Model for the Assessment of QT Prolongation</h4><div class="NLM_p last">Prior to the experiment, six male Hartley guinea pigs (Charles River, France), weighing between 564 and 605 g on the day of the test, were anaesthetised with urethane (1−1.5 g/kg ip), tracheotomized, artificially ventilated with a tidal volume of approximately 1 mL/100 g at a rate of 54 cycles/min, and surgically prepared for the experiment (i.e., insertion of catheters in appropriate blood vessels, see below, and placement of surface electrodes for lead II electrocardiogram recording). The animal’s temperature was kept constant between 36.8 and 38.0 °C. Once physiological parameters were stabilized (approximately 30 min following surgery), each animal was given either the vehicle (5% w/v dextrose in aqueous 0.9 w/v sodium chloride) or test compound by the intravenous route (via the jugular vein) over 15 min/treatment. The following parameters were recorded: arterial pressure (via the carotid artery), heart rate, electrocardiography (i.e., RR, PQ, QRS, and QT interval duration; the QT interval was corrected for heart rate changes according to Fridericia, Bazett and Van de Water’s formula). Parameters were recorded prior to dosing to establish baseline measurements and continuously during the infusion period but data were reported every 5 min during each infusion period. In addition, blood samples (0.3 mL) were collected via the femoral artery at the end of each infusion period for toxicokinetic evaluations.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> In Vivo Pharmacokinetics in Rat</h4><div class="NLM_p last">The pharmacokinetics and oral bioavailability of test compounds were determined following iv (bolus) and po administration to male Sprague−Dawley rats of the at 0.5 and 1 mg free base/kg, respectively. Blood samples were assayed for test compound concentration using a method based on protein precipitation followed by HPLC-MS/MS analysis.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> General Methods</h4><div class="NLM_p">Proton magnetic resonance (NMR) spectra were recorded either on Varian instruments at 300, 400, or 500 MHz, or on a Bruker instrument at 300 MHz. Chemical shifts are reported in ppm (δ) using the residual solvent line as internal standard. Splitting patterns are designed as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; b, broad. The NMR spectra were recorded at a temperature ranging from 25 to 90 °C. When more than one conformer was detected, the chemical shifts for the most abundant one is reported. Mass spectra (MS) are typically taken on a 4 II triple quadrupole mass spectrometer (Micromass UK) or on a Agilent MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode or on an Agilent LC/MSD 1100 mass spectrometer, operating in ES (+) and ES (−) ionization mode coupled with HPLC instrument Agilent 1100  series. LC/MS-ES (+): analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase: 100% [water + 0.1% HCO<sub>2</sub>H] for 1 min, then from 100% [water + 0.1% HCO<sub>2</sub>H] to 5% [water + 0.1% HCO<sub>2</sub>H] and 95% [CH<sub>3</sub>CN] in 5 min, finally under these conditions for 2 min; T = 40 °C; flux = 1 mL/min; LC/MS-ES (−): analysis performed on a Supelcosil ABZ +Plus (33 mm × 4.6 mm, 3 μm) (mobile phase: 100% [water + 0.05% NH<sub>3</sub>] for 1 min, then from 100% [water +0.05% NH<sub>3</sub> to 5% [water + 0.05% NH<sub>3</sub>] and 95% [CH<sub>3</sub>CN] in 5 min, finally under these conditions for 2 min; <i>T</i> = 40 °C; flux = 1 mL/min]; in the mass spectra, only one peak in the molecular ion cluster is reported.</div><div class="NLM_p">DAD chromatographic traces, mass chromatograms, and mass spectra were taken on a UPLC/MS AcquityTM system coupled with a Micromass ZQTM mass spectrometer operating in ESI positive or negative. The phases used are: (A) H<sub>2</sub>O/ACN 95/5 + 0.1% TFA; (B) H<sub>2</sub>O/ACN 5/95 + 0.1% TFA. The gradient was: (<i>t</i> = 0 min) 95%A 5%B, (<i>t</i> = 0.25) 95%A 5%B, (<i>t</i> = 3.30) 100%B, (<i>t</i> = 4.0) 100%B, followed by 1 min of reconditioning. Flash silica gel chromatography was carried out on silica gel 230−400 mesh (supplied by Merck AG Darmstadt, Germany) or over Varian Mega Be−Si prepacked cartridges or over prepacked Biotage silica cartridges. SPE-SCX cartridges are ion exchange solid phase extraction columns supplied by Varian. The eluent used with SPE-SCX cartridges is methanol followed by 2N ammonia solution in methanol. In a number of preparations, purification was performed using either Biotage manual flash chromatography (Flash+) or automatic flash chromatography (Horizon, SP1) systems. All these instruments work with Biotage Silica cartridges. SPE-Si cartridges are silica solid phase extraction columns supplied by Varian. Microwave reactions were carried out in a Personal Chemistry Emrys Optimiser (300 W). All reactions were carried out under anhydrous nitrogen or argon atmosphere using standard Schlenk techniques. Most chemicals and solvents were analytical grade and used without further purification.</div><div class="NLM_p last">The purity of the compounds reported in the manuscript was established through HPLC methodology. All the compounds reported in the manuscript have a purity >95%.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> General Synthetic Procedures</h4><div class="NLM_p">The preparation of compounds <b>6</b>−<b>29</b> are shown in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>−<a class="ref internalNav" href="#sch6" aria-label="6">6</a>. Experimental and analytical data for compounds <b>6</b>, <b>10</b>, <b>11</b>−<b>13</b>, and <b>19</b>−<b>20</b> are described below.</div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 8-(2-Propen-1-yl)-2<i>H</i>-1,4-benzoxazine-3(4<i>H</i>)-thione (<b>31</b>)</h5><div class="NLM_p last">A mixture of 8-(2-propen-1-yl)-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-one <b>30</b> (2 g, 10.5 mmol) and Lawesson’s reagent (2.2 g, 5.3 mmol) in dry toluene (35 mL) was heated at reflux for 1 h. The mixture was cooled to room temperature and the solvent evaporated in vacuo. The crude material was purified by chromatography on silica gel eluting with 10% cyclohexane in AcOEt to afford the title compound (1.9 g, 88%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.6 (s, 1H), 6.85 (m, 2H), 6.75 (m, 1H), 5.8 (m, 1H), 5.05 (m, 2H), 4.75 (s, 2H), 3.35 (d, 2H).</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 3-(Methylthio)-8-(2-propen-1-yl)-2H-1,4-benzoxazine (<b>32</b>)</h5><div class="NLM_p last">To a mixture of intermediate <b>31</b> (100 mg, 0.49 mmol) and KOH (69 mg, 1.23 mmol) in acetone (2 mL) was added methyl iodide (46 μL, 0.74 mmol) in two portions 15 min apart. The reaction mixture was heated under reflux for 2 h, cooled, filtered to remove KI, and evaporated in vacuo. The crude material was purified by chromatography on silica gel eluting with 10% cyclohexane in AcOEt to afford the title compound (70 mg, 65%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl3) δ: 7.2 (m, 1H), 6.9 (bs, 2H), 5.9 (m, 1H), 5 (m, 2H), 4.5 (s, 2H), 3.3 (d, 2H), 2.5 (s, 3H). MS: <i>m</i>/<i>z</i> 220.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> <i>N</i>-[2,2-Bis(methyloxy)ethyl]-8-(2-propen-1-yl)-2<i>H</i>-1,4-benzoxazin-3-amine (<b>33</b>)</h5><div class="NLM_p last">A mixture of intermediate <b>32</b> (180 mg, 0.82 mmol) and aminoacetaldehyde dimethylacetal (134 μL, 1.23 mmol) in dry EtOH (5 mL) was heated at reflux for 9 h. The volatiles were evaporated in vacuo and the crude product was purified by chromatography on silica gel eluting with 40% AcOEt in cyclohexane to afford the title compound (93 mg, 41%) as a colorless oil. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.2 (m, 1H), 6.9 (bs, 2H), 5.9 (m, 1H), 5 (m, 2H), 4.5 (s, 2H), 3.3 (d, 2H), 2.5 (s, 3H). MS: <i>m</i>/<i>z</i> 277.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 6-(2-Propen-1-yl)-4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine (<b>34</b>)</h5><div class="NLM_p last">A mixture of intermediate <b>33</b> (90 mg, 0.33 mmol) and conc HCl (0.8 mL) in MeOH (1 mL) was heated at reflux for 3 h. After concentration in vacuo the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL), washed with an aqueous saturated solution of NaHCO<sub>3</sub> (15 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and evaporated in vacuo. The crude material was purified by chromatography on silica gel eluting with 35% AcOEt in cyclohexane to afford the title compound (65 mg, 92%) as a yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.4 (bs, 1H), 7.2 (bs, 2H), 7.05 (bs, 2H), 5.95 (m, 1H), 5.3 (s, 2H), 5.1 (m, 2H), 3.45 (d, 2H). MS: <i>m</i>/<i>z</i> 213.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 4<i>H</i>-Imidazo[2,1-<i>c</i>][1,4]benzoxazin-6-ylacetaldehyde (<b>35</b>)</h5><div class="NLM_p">4-Methylmorpholine <i>N</i>-oxide (218 mg, 1.87 mmol) and osmium tetroxide (225 μL of a 4% by wt solution in water, 0.035 equiv) were added to a solution of intermediate <b>34</b> (200 mg, 0.94 mmol) in a 8:1 mixture of acetone/water (17.5 mL). The reaction was left under stirring overnight before additional osmium tetroxide (200 μL, 0.03 equiv) and 4-methylmorpholine <i>N</i>-oxide (250 mg, 2.1 mmol) were added to drive the reaction to completion. After a further 24 h, the reaction was quenched with a saturated aqueous solution of sodium sulfite (75 mL). After 30 min stirring, the mixture was extracted with AcOEt (3 × 75 mL) and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give a 7:3 mixture (by NMR) of the desired product <b>35</b> and 4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine-6-carbaldehyde, which was used without purification in the next step.</div><div class="NLM_p">4<i>H</i>-Imidazo[2,1-<i>c</i>][1,4]benzoxazin-6-ylacetaldehyde <b>35</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.8 (s, 1H), 7−7.4 (m, 5H), 5.25 (s, 2H), 3.8 (s, 2H). MS <i>m</i>/<i>z</i> 215.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">4<i>H</i>-Imidazo[2,1-<i>c</i>][1,4]benzoxazine-6-carbaldehyde. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 10.5 (s, 1H), 7.7 (m, 1H), 7.5 (m, 1H), 7−7.4 (m, 3H), 5.4 (s, 2H). MS <i>m</i>/<i>z</i> 201.3 3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine Dihydrochloride (<b>6</b>)</h5><div class="NLM_p">2-Methyl-5-piperazin-1-yl-quinoline (68 mg, 0.25 mmol) was added to a 7:3 mixture of intermediate <b>35</b> and 4<i>H</i>-imidazo-[2,1-<i>c</i>][1,4]benzoxazine-6-carbaldehyde (50 mg, 0.2 mmol) in dry 1,2-dichloroethane (5 mL) at room temperature. After 15 min, sodium triacetoxyborohydride (52 mg, 0.25 mmol) was added and the resulting reaction mixture was stirred for 3 h, then quenched with a saturated aqueous solution of NH<sub>4</sub>Cl (20 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 20 mL). The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude products were separated by chromatography on silica gel eluting with 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford the free base of the title compound (14 mg; 20% yield) and the byproduct 6-{[4-(2-methyl-5-quinolinyl)-1-piperazinyl]methyl}-4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine (14 mg, 50% yield). The free base of <b>6</b> was dissolved in dry MeOH (0.5 mL), and HCl (2.2 equiv of a 1.25 M solution in methanol) was slowly added at 0 °C. The resulting suspension was stirred at 0 °C for 4 h, followed by evaporation of the volatiles and trituration with Et<sub>2</sub>O to give the title compound as a yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.07 (bs, 1H), 8.78 (m, 1H), 8.05 (s, 1H), 7.88 (m, 2H), 7.7 (m, 2H), 7.38 (m, 1H), 7.25 (bs, 1H), 7.24 (d, 1H), 7.18 (t, 1H), 5.43 (s, 2H), 3.8−3.2 (m, 12H), 2.84 (s, 3H). MS <i>m</i>/<i>z</i> 426.3 [M + H]<sup>+</sup>.</div><div class="NLM_p last">6-{[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]methyl}-4<i>H</i>-imidazo[2,1-<i>c</i>][1,4]benzoxazine dihydrochloride. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.64 (bs, 1H), 8.8 (bs, 1H), 8.0 (m, 1H), 7.9 (bs, 3H), 7.8 (bs, 1H), 7.7 (d, 1H), 7.1−7.4 (m, 3H), 5.5 (s, 2H), 4.5 (s, 2H), 3.8−3.1 (m, 8H), 2.7 (s, 3H). MS <i>m</i>/<i>z</i>: 412.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Ethyl 6-(2-Propen-1-yl)-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxylate (<b>47</b>)</h5><div class="NLM_p last">Diethyl chlorophosphate (0.15 mL, 1.8 mmol) was added to a solution of intermediate <b>30</b> (170 mg, 0.9 mmol) and potassium <i>t</i>-butoxide (110 mg, 0.9 mmol) in dry DMF (5 mL) at 0 °C. After 10 min, a solution of ethyl isocyanoacetate (0.15 mL, 1.35 mmol) and potassium <i>t</i>-butoxide (152 mg, 1.35 mmol) in dry DMF (2 mL) was added. The reaction mixture was stirred at 60 °C for 6 h and then cooled and quenched with water (5 mL). The DMF was evaporated in vacuo and the crude product purified by SPE-SI cartridge eluting with 30% AcOEt in cyclohexane to afford the title compound (132 mg, 52%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.2 (s, 1H), 7.55 (d, 1H), 7.3 (d, 1H), 7.2 (t, 1H), 6.25 (m, 1H), 5.7 (s, 2H), 5.2−5.3 (m, 2H), 4.65 (q, 2H), 3.65 (d, 2H), 1.6 (t, 3H). MS <i>m</i>/<i>z</i> 285.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> Ethyl 6-(2-Oxoethyl)-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxylate (<b>51</b>)</h5><div class="NLM_p last">Intermediate <b>47</b> (77 mg, 0.27 mmol) was treated with osmium tetroxide according to the general procedure described for <b>38</b> (D28) to afford the title compound (52 mg, 67%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.8 (s, 1H), 8 (s, 1H), 7.4 (t, 1H), 7−7.1 (m, 2H), 5.5 (s, 2H), 4.35 (q, 2H), 3.8 (s, 2H), 1.4 (t, 3H).</div></div><div id="sec4_2_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> Ethyl 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxylate (<b>14</b>)</h5><div class="NLM_p">A mixture of intermediate <b>51</b> (D6) (50 mg, 0.17 mmol) was reacted with 2-methyl-5-piperazin-1-yl-quinoline (58 mg, 0.21 mmol) as in the general procedure described for <b>6</b> of to afford the free base of the title compound (61 mg, 70%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.4 (d, 1H), 8 (s, 1H), 7.7 (d, 1H), 7.55 (t, 1H), 7.3 (d, 1H), 7.2 (m, 1H), 7.1 (d, 1H), 6.95−7.05 (m, 2H), 5.55 (s, 2H), 4.4 (q, 2H), 2.7−3.15 (m, 12H), 3.7 (s, 3H), 1.4 (t, 3H). MS <i>m</i>/<i>z</i> 498.5 [M + H]<sup>+</sup>.</div><div class="NLM_p last">The free base (20 mg, 0.04 mmol) was dissolved in dry MeOH (1 mL) and treated with HCl (0.068 mL of a 1.25N solution in MeOH, 0.084 mmol) at 0 °C. The resulting suspension was stirred at 0 °C for 4 h. Evaporation of the volatiles and trituration with Et<sub>2</sub>O gave the dihydrochloride of the title compound (20 mg, 87%) as a yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.67 (bs, 1H), 8.8−8.6 (bs, 1H), 7.89 (dd, 1H), 7.82 (s, 2H), 7.64 (bs, 1H), 7.35 (s, 1H), 7.29 (dd, 1H), 7.2 (d, 1H), 4.3 (q, 2H), 3.76 (dd, 2H), 3.6−3.3 (m, 8H), 2.8 (s, 3H), 1.33 (t, 3H).</div></div><div id="sec4_2_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 6-(2-Propen-1-yl)-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxylic Acid (<b>48</b>)</h5><div class="NLM_p last">A solution of intermediate <b>47</b> (900 mg, 3.17 mmol) in a 1:1 mixture of MeOH and 1 M solution of NaOH (60 mL) was stirred at 60 °C for 30 min. The cooled reaction mixture was neutralized with AcOH and then cooled to 0 °C. The crude product was collected by filtration, washed with MeOH, and dried to afford the title compound (570 mg, 70%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.55 (s, 1H), 7.75 (d, 1H), 7.05−7.15 (m, 2H), 5.8 (m, 1H), 5.5 (s, 2H), 5.0−5.1 (m, 2H), 3.45 (d, 2H).</div></div><div id="sec4_2_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 6-(2-Propen-1-yl)-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine (<b>49</b>)</h5><div class="NLM_p last">A mixture of intermediate <b>48</b> (120 mg, 0.47 mmol) in 1,2-dichlorobenzene (1.5 mL) was irradiated in a microwave reactor (300 W, 250 °C, 10 min). The solvent was removed by SPE-SCX cartridge (eluting with MeOH followed by 2N ammonia solution in MeOH) to afford the title compound (61 mg, 100%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 8.6 (s, 1H), 7.6 (d, 1H), 7.2−7.35 (m, 3H), 6.25 (m, 1H), 5.5 (s, 2H), 5.35 (m, 2H), 3.65 (d, 2H). MS <i>m</i>/<i>z</i> 213.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> 4<i>H</i>-Imidazo[5,1-<i>c</i>][1,4]benzoxazin-6-ylacetaldehyde (<b>50</b>)</h5><div class="NLM_p last">The title compound was prepared in 30% yield according to the general oxidation procedure described for <b>38</b> starting from intermediate <b>49</b> (60 mg, 0.28 mmol). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.8 (s, 1H), 8.15 (s, 1H), 7.7 (d, 1H), 7.3−7.45 (m, 3H), 5.5 (s, 2H), 3.75 (s, 2H).</div></div><div id="sec4_2_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine Dihydrochloride (<b>10</b>)</h5><div class="NLM_p last">The title compound was prepared in 40% yield following the general reductive amination procedure described for <b>6</b> starting from intermediate <b>50</b> (20 mg, 0.08 mmol) and 2-methyl-5-piperazin-1-yl-quinoline (20 mg, 0.1 mmol). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.64 (bs, 1H), 8.64 (s, 1H), 8.47 (d, 1H), 7.81 (d, 1H), 7.7 (s, 2H), 7.48 (d, 1H), 7.3−7.1 (m, 3H), 7.07 (s, 1H), 5.35 (s, 2H), 3.8−3.1 (m, 12H), 2.68 (s, 3H). MS <i>m</i>/<i>z</i> 426.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxylic Acid (<b>65</b>)</h5><div class="NLM_p last">To a solution of compound <b>14</b> (220 mg, 0.44 mmol) in MeOH (3 mL) was added NaOH (3 mL of a 10% aq solution), and the resulting white suspension was heated for 5 min under microwave irradiation at 120 °C. The resulting pale-yellow solid was filtered off, suspended in water (15 mL), and the solution was neutralized with an aqueous solution of AcOH. The resulting off-white solid precipitate was filtered and washed with Et<sub>2</sub>O (3 × 20 mL) affording the title compound (0.168 g, 81%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 8.49 (bs, 1H), 8.3(d, 1H), 7.7(d, 1H), 7.55 (bs, 1H), 7.35(d, 1H), 7.2(d, 1H), 7.07 (m, 2H), 5.5 (s, 2H), 3.05−2.75 (m, 15H). MS <i>m</i>/<i>z</i> 470.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxamide Dihydrochloride (<b>20</b>)</h5><div class="NLM_p last">To a stirred solution of compound <b>65</b> (30 mg, 0.06 mmol) and DIPEA (0.012 mL) in DMF (1 mL) was added TBTU (22.6 mg, 0.07 mmol), and the resulting solution was stirred for 1 h at room temperature. Hexamethyldisilazane (0.013 mL, 0.07 mmol) was added and the solution stirred for 1 h. The excess of amine was scavenged by using a PS-isocyanate resin, and after filtration of the resin and evaporation of the solvent, the crude product was purified by SPE cartridge (silica gel) eluting with 3% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford the free base of the title compound as a white solid. The free base was dissolved in dry MeOH and treated with HCl (2.1 equiv of 1N solution in Et<sub>2</sub>O) at 0 °C. Evaporation of solvent and trituration with Et<sub>2</sub>O gave the final compound (22 mg, 65%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.4 (bs, 1H), 9.05 (d, 1H), 8.59 (s, 1H), 8.08 (d, 1H), 8.01 (t, 1H), 7.91 (d, 1H), 7.84 (dd, 1H), 7.51−7.49 (bd, 2H), 7.33 (bs, 1H), 7.26 (d, 1H), 7.15 (t, 1H), 5.59 (s, 2H), 3.81−3.72 (bd, 2H), 3.53−3.49 (bd, 4H), 3.43−3.39 (bd, 4H), 3.22−3.17 (m, 2H), 2.97 (s, 3H). MS <i>m</i>/<i>z</i> 469.4 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> General Procedure for Amide Formation (<b>19</b>, <b>21</b>−<b>23</b> and <b>25</b>−<b>29</b>)</h4><div class="NLM_p">To a stirred solution of intermediate <b>65</b> (1 equiv) and DIPEA (1.1 equiv) in DMF was added TBTU (1.1 equiv) and the resulting solution was stirred for 1 h at room temperature. The desired amine (1.1 equiv) was added and the solution stirred for 1 h. The crude solution was applied to a SPE-SCX cartridge (eluting with MeOH followed by 2N ammonia solution in MeOH). After evaporation of solvent from the ammonia fractions and trituration with Et<sub>2</sub>O, the free base of the desired compound was isolated in pure form. The free base was dissolved in dry MeOH and treated with HCl (2.1 equiv of 1N solution in Et<sub>2</sub>O) at 0 °C. Evaporation of solvent and trituration with Et<sub>2</sub>O gave the final compounds in pure form.</div><div id="sec4_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> <i>N</i>-Methyl-6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-imidazo[5,1-<i>c</i>][1,4]benzoxazine-3-carboxamide Dihydrochloride (<b>19</b>)</h5><div class="NLM_p last">The title compound was prepared in 44% yield from intermediate <b>65</b> following the general procedure for amide formation using methylamine (2N solution in THF). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.29 (bs, 1H), 9.05 (d, 1H), 8.60 (s, 1H), 8.07−7.97 (m, 2H), 7.89 (d, 1H), 7.83 (dd, 1H), 7.49 (d, 1H), 7.37 (bs, 1H), 7.24 (t, 1H), 7.15 (t, 1H), 5.59 (s, 2H), 3.70−3.38 (m, 10H), 3.22−3.15 (m, 2H), 2.96 (s, 3H), 2.74(d, 3H). MS <i>m</i>/<i>z</i> 483.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 1-Methyl-6-(2-propen-1-yl)-4<i>H</i>-[1,2,4]triazolo[3,4-<i>c</i>][1,4]benzoxazine (<b>55</b>)</h5><div class="NLM_p last">A solution of intermediate <b>31</b> (1.38 g, 6.71 mmol) in absolute EtOH (50 mL) was added dropwise over 1 h to a solution of hydrazine monohydrate (8 mL) in absolute EtOH (50 mL) at 80 °C. The resulting reaction mixture was stirred at reflux for a further 40 min and concentrated in vacuo to afford (3<i>E</i>)-8-(2-propen-1-yl)-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-one hydrazone <b>54</b>, which was immediately used in the following step without purification. The hydrazone <b>54</b> was mixed with trimethyl orthoacetate (15 mL) and heated with stirring at 150 °C for 10 min under microwave irradiation. The resulting reaction mixture was evaporated in vacuo and purified by flash chromatography on silica gel, eluting with 5% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to give the title compound (0.78 g, 51%) as a pale-yellow solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.36 (d, 1H), 7.11−7.03 (m, 2H), 6.01−5.84 (m, 1H), 5.25 (s, 2H), 5.08−5.01 (m, 2H), 3.43 (d, 2H), 2.76 (s, 3H). MS <i>m</i>/<i>z</i> 228.20 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> (1-Methyl-4<i>H</i>-[1,2,4]triazolo[3,4-<i>c</i>][1,4]benzoxazin-6-yl)acetaldehyde (<b>56</b>)</h5><div class="NLM_p last">Intermediate <b>55</b> (D24) (142 mg, 0.62 mmol) was treated with 4-methylmorpholine <i>N</i>-oxide (145 mg, 1.24 mmol) and osmium tetroxide (0.20 mL of 4% by wt solution in water) according to the procedure described for <b>53a</b> to give the title compound (50 mg, 35%) as a white solid which was used without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.78 (s, 1H), 7.49 (d, 1H), 7.15−7.12 (m, 2H), 5.28 (s, 2H), 3.82 (s, 2H), 2.79 (s, 3H). MS <i>m</i>/<i>z</i> 230.20 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 1-Methyl-6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-[1,2,4]triazolo[3,4-<i>c</i>][1,4]benzoxazine dihydrochloride (<b>11</b>)</h5><div class="NLM_p last">The title compound was prepared in 71% yield following the general reductive amination procedure described for <b>6</b> starting from intermediate <b>56</b> (45 mg, 0.2 mmol) and 2-methyl-5-piperazin-1-yl-quinoline (54 mg, 0.24 mmol). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 11.21 (bs, 1H), 8.92 (bs, 1H), 7.97 (bs, 2H), 7.81 (bd, 1H), 7.72 (d, 1H), 7.45 (bd, 1H), 7.34 (d, 1H), 7.25 (t, 1H), 5.46 (s, 2H), 3.75 (d, 2H), 3.3−3.6 (m, 8H), 3.24 (m, 2H), 2.91 (s, 3H), 2.74 (s, 3H). MS <i>m</i>/<i>z</i> 441.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 6-(2-Propen-1-yl)-4<i>H</i>-tetrazolo[5,1-<i>c</i>][1,4]benzoxazine (<b>57</b>)</h5><div class="NLM_p last">A solution of hydrazine hydrate (380 μL, 12.2 mmol) in dry THF (2 mL) was treated dropwise with a solution of intermediate <b>31</b> (500 mg, 2.44 mmol) in THF (25 mL) at 20 °C. After stirring for 1.5 h, the solvent was removed under reduced pressure to afford the intermediate hydrazone <b>54</b>, which was used in the following step without any further purification. To a suspension of hydrazone <b>54</b> (495 mg, 2.44 mmol) in 0.5N HCl (15 mL), a solution of NaNO<sub>2</sub> (252 mg, 3.66 mmol) in water (2 mL) was added dropwise at 5 °C. After stirring for 4 h, the mixture was neutralized with a saturated aqueous solution of NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 30 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The crude product was purified by flash chromatography on silica gel eluting with 20% EtOAc in cyclohexane to afford the title compound (235 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ: 7.85 (d, 1H), 7.28−7.16 (m, 2H), 6.01−5.94 (m, 1H), 5.65 (s, 2H), 5.14−5.08 (m, 2H), 3.47 (d, 2H). MS <i>m</i>/<i>z</i> 215.10 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 4<i>H</i>-Tetrazolo[5,1-<i>c</i>][1,4]benzoxazin-6-ylacetaldehyde (<b>58</b>)</h5><div class="NLM_p last">The title compound was prepared following the procedure of <b>38</b> from intermediate <b>57</b> (235 mg, 1.09 mmol). The crude product was purified by flash chromatography on silica gel eluting with AcOEt/cyclohexane (4/6) to afford the title compound (144 mg, 61%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 3.77 (s, 2H) 5.56 (s, 2H) 7.14 (d, 2H) 7.90 (t, 1H) 9.72 (s, 1H).</div></div><div id="sec4_2_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 6-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-tetrazolo[5,1-<i>c</i>][1,4]benzoxazine Dihydrochloride (<b>13</b>)</h5><div class="NLM_p last">The title compound was prepared in 77% yield following the general reductive amination procedure described for <b>6</b> starting from intermediate <b>58</b> (47 mg, 0.218 mmol) and 2-methyl-5-(1-piperazinyl)quinoline (74 mg, 0.326 mmol). The crude product was purified by flash chromatography on silica gel eluting with 2% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford the free base of the title compound (72 mg, 77%). Treatment with HCl (2.2 equiv of 1.25 M solution in MeOH) in 2:1 MeOH/CH<sub>2</sub>Cl<sub>2</sub> (3 mL) at 0 °C gave the title compound as a yellow solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 2.72 (s, 3H) 3.18−3.56 (m, 10H) 3.66−3.78 (m, 2H) 5.84−5.97 (m, 2H) 7.22−7.32 (m, 2H) 7.43 (d, 1H) 7.47−7.63 (m, 1H) 7.67−7.83 (m, 2H) 7.89 (dd, 1H) 8.36−8.75 (m, 1H) 11.24 (bs, 1H). MS <i>m</i>/<i>z</i> 428.00 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 2-(2-Butyn-1-yloxy)-1-nitro-3-(2-propen-1-yl)benzene (<b>60</b>)</h5><div class="NLM_p last">A mixture of 2-nitro-6-(2-propen-1-yl)phenol <b>59</b> (500 mg, 2.79 mmol), 1-bromo-2-butyne (269 μL, 3.07 mmol, 1.1 equiv), and K<sub>2</sub>CO<sub>3</sub> (424 mg, 3.07 mmol, 1.1 equiv) in acetone (20 mL) was heated at reflux for 4 h. The mixture was cooled to room temperature before the solids were filtered off and washed with acetone (30 mL). The combined organics were concentrated in vacuo, and the crude product was purified by flash chromatography on silica gel eluting with 10% AcOEt in cyclohexane to afford the title compound (640 mg, 99%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.65 (m, 1H), 7.39 (m, 1H), 7.13 (m, 1H), 5.90 (m, 1H), 5.11−5.02 (m, 2H), 4.60 (m, 2H), 3.49 (m, 2H), 1.77 (s, 3H).</div></div><div id="sec4_2_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> [2-(2-Butyn-1-yloxy)-3-(2-propen-1-yl)phenyl]amine (<b>61</b>)</h5><div class="NLM_p last">To a solution of intermediate <b>60</b> (640 mg, 2.77 mmol) in glacial AcOH (10 mL) was added iron powder (619 mg, 11.1 mmol, 4 equiv) at room temperature and the mixture was stirred for 16 h. The solvent was evaporated in vacuo, and AcOEt (50 mL) was added to the residue. The precipitate was removed by filtration, and the filtrate was extracted successively with 1N NaOH (10 mL) and brine (10 mL) before drying over MgSO<sub>4</sub> and evaporation in vacuo to afford the title compound (540 mg, 97%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 6.86 (m, 1H), 6.61−6.53 (m, 2H), 5.94 (m, 1H), 5.10−5.01 (m, 2H), 4.44 (m, 2H), 3.82 (bs, 2H), 3.40 (m, 2H), 1.87 (m, 3H). MS <i>m</i>/<i>z</i> 202.10 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 1-Azido-2-(2-butyn-1-yloxy)-3-(2-propen-1-yl)benzene (<b>62</b>)</h5><div class="NLM_p last">A solution of NaNO<sub>2</sub> (72 mg, 1.05 mmol, 1.05 equiv) in water (1 mL) was added dropwise to a suspension of intermediate <b>61</b> (201 mg, 1 mmol) in 4N HCl (3 mL) under vigorous stirring and ice/water cooling. The mixture was then neutralized by addition of aqueous NaHCO<sub>3</sub>, and a solution of sodium azide (65 mg, 1 mmol, 1 equiv) in water (1 mL) was slowly added at 5 °C. After 30 min, the mixture was extracted with Et<sub>2</sub>O (3 × 20 mL) and the combined organics dried over MgSO<sub>4</sub> and evaporated under reduced pressure to give the title azide (222 mg, 98%), which was used for the next step without further purification. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.02 (m, 1H), 6.96−6.87 (m, 2H), 5.90 (m, 1H), 5.10−4.95 (m, 2H), 4.55 (s, 2H), 3.45 (m, 2H), 1.80 (s, 3H).</div></div><div id="sec4_2_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 3-Methyl-6-(2-propen-1-yl)-4<i>H</i>-[1,2,3]triazolo[5,1-<i>c</i>][1,4]benzoxazine (<b>63</b>)</h5><div class="NLM_p last">A solution of intermediate <b>62</b> (222 mg, 0.98 mmol) in toluene (8 mL) was heated at reflux for 2.5 h. The solvent was then evaporated under reduced pressure, and the residue was purified by flash chromatography on silica gel eluting with 20% AcOEt in cyclohexane to afford the title compound (183 mg, 82%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 7.86 (m, 1H), 7.10−7.00 (m, 2H), 5.90 (m, 1H), 5.25 (s, 2H), 5.05−4.98 (m, 2H), 3.39 (m, 2H), 2.33 (s, 3H). MS <i>m</i>/<i>z</i> 228.20 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> (3-Methyl-4<i>H</i>-[1,2,3]triazolo[5,1-<i>c</i>][1,4]benzoxazin-6-yl)acetaldehyde (<b>64</b>)</h5><div class="NLM_p last">The title compound was prepared in 66% yield according to the procedure of intermediate <b>38</b> starting from intermediate <b>63</b> (183 mg, 0.806 mmol). The product was purified by flash chromatography on silica gel using AcOEt/cyclohexane (2/3) as eluent. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ: 9.72 (s, 1H), 7.97 (m, 1H), 7.1 (m, 2H), 5.26 (s, 2H), 3.74 (s, 2H), 2.33 (s, 3H). MS <i>m</i>/<i>z</i> 230.10 [M + H]<sup>+</sup>.</div></div><div id="sec4_2_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i82" class="anchor-spacer"></div><h5 class="article-section__title" id="_i82"> 3-Methyl-6-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}-4<i>H</i>-[1,2,3]triazolo [5,1-<i>c</i>][1,4]benzoxazine dihydrochloride (<b>12</b>)</h5><div class="NLM_p last">The title compound was prepared in 81% yield following the general reductive amination procedure described for <b>6</b> starting from intermediate <b>64</b> (60 mg, 0.262 mmol). The crude product was purified by flash chromatography on silica gel eluting with a gradient of 1−3% MeOH in CH<sub>2</sub>Cl<sub>2</sub> to afford the free base of the title compound (93 mg, 81%). Treatment with HCl (2.2 equiv of 1.25N solution in MeOH) in 4:1 MeOH/CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at 0 °C gave the title compound as a solid. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ: 10.51 (bs, 1H), 8.62 (bs, 1H), 7.93 (d, 1H), 7.78 (bs, 2H), 7.60 (bs, 1H), 7.37 (d, 1H), 7.32 (bs, 1H), 7.24 (t, 1H), 5.58 (s, 2H), 3.75−3.10 (m, 12H), 2.76 (s, 3H), 2.34 (s, 3H). MS <i>m</i>/<i>z</i> 441.20 [M + H]<sup>+</sup>.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84"><a href="/doi/suppl/10.1021/jm100482n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental and supporting data for compounds <b>7</b>−<b>9</b>, <b>15</b>−<b>18</b>, and <b>21</b>−<b>29</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100482n/suppl_file/jm100482n_si_001.pdf">jm100482n_si_001.pdf (110.23 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100482n" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven M. Bromidge</span> - <span class="hlFld-Affiliation affiliation">Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c1b2b5a4b7a4a3b3aeaca8a5a6a481a6aca0a8adefa2aeac"><span class="__cf_email__" data-cfemail="b9cacddccfdcdbcbd6d4d0dddedcf9ded4d8d0d597dad6d4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roberto Arban</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Bertani</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Silvia Bison</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Borriello</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paolo Cavanni</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giovanna Dal Forno</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romano Di-Fabio</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniele Donati</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefano Fontana</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimo Gianotti</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laurie J. Gordon</span> - <span class="hlFld-Affiliation affiliation">Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Enrica Granci</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin P. Leslie</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luca Moccia</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alessandra Pasquarello</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ilaria Sartori</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anna Sava</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeannette M. Watson</span> - <span class="hlFld-Affiliation affiliation">Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Worby</span> - <span class="hlFld-Affiliation affiliation">Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Zonzini</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Zucchelli</span> - <span class="hlFld-Affiliation affiliation">Medicines Research Centre, Via A. Fleming 4, Verona 37135, Italy</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Carla Marchioro and her analytical group for the high quality support received and all other colleagues who helped in generating the data reported in this manuscript.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirschfeld, R. M. A.</span><span> </span><span class="NLM_article-title">History and evolution of the monoamine hypothesis of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 6</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=10775017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=4-6&issue=Suppl.+6&author=R.+M.+A.+Hirschfeld&title=History+and+evolution+of+the+monoamine+hypothesis+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">History and evolution of the monoamine hypothesis of depression</span></div><div class="casAuthors">Hirschfeld, Robert M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">4-6</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review, with 24 refs.  The symptoms of depression can be improved by agents that act by various mechanisms to increase synaptic concns. of monoamines.  This finding led to the adoption of the monoamine hypothesis of depression, first put forward over 30 yr ago, which proposes that the underlying biol. or neuroanatomical basis for depression is a deficiency of central noradrenergic and/or serotonergic systems and that targeting this neuronal lesion with an antidepressant would tend to restore normal function in depressed patients.  The hypothesis has enjoyed considerable support, since it attempts to provide a pathophysiol. explanation of the actions of antidepressants.  However, in its original form it is clearly inadequate, as it does not provide a complete explanation for the actions of antidepressants, and the pathophysiol. of depression itself remains unknown.  The hypothesis has evolved over the years to include, for example, adaptive changes in receptors to explain why there should be only a gradual clin. response to antidepressant treatment when the increase in availability of monoamines is rapid.  Still, the monoamine hypothesis does not address key issues such as why antidepressants are also effective in other disorders such as panic disorder, obsessive-compulsive disorder, and bulimia, or why all drugs that enhance serotonergic or noradrenergic transmission are not necessarily effective in depression.  Despite these limitations, however, it is clear that the development of the monoamine hypothesis has been of great importance in understanding depression and in the development of safe and effective pharmacol. agents for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZF-M-PX4Qp7Vg90H21EOLACvtfcHk0lj95fhCRzaMoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D&md5=0bddf7611fade8f2fd1148ec216066f2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirschfeld%26aufirst%3DR.%2BM.%2BA.%26atitle%3DHistory%2520and%2520evolution%2520of%2520the%2520monoamine%2520hypothesis%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26issue%3DSuppl.%25206%26spage%3D4%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The spectrum of behaviors influenced by serotonin</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0006-3223%2898%2900139-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=9693387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=151-162&author=I.+Lucki&title=The+spectrum+of+behaviors+influenced+by+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of behaviors influenced by serotonin</span></div><div class="casAuthors">Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 110 refs., on the diverse array of behavioral effects of serotonin form the basis for understanding its potential role as an etiol. marker in psychiatric disorders and for the successful pharmacol. intervention of drugs regulating serotonin neurotransmission in behavior.  General theories of the behavioral functions of serotonin have implicated serotonin as a general inhibitor of behavioral responding and in modulating motor behavior.  The ability of serotonin to regulate behavioral satiety and macronutrient selection provides the basis for pharmacol. treatment of obesity and eating disorders.  The role of serotonin in behavioral suppression may be important in social behavior involving aggression and anxiety.  The role of serotonin in neuroendocrine regulation provides a basis for understanding serotonin dysregulation in depression.  Animal behavior tests are being used to better understand the neural substrates underlying the behavioral effects of antidepressant drugs and to address important issues in clin. treatment.  The integration of information between basic and clin. studies provides the basis for future development of more sophisticated pharmacol. treatments of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHI5Ew2l3Y7Vg90H21EOLACvtfcHk0lj95fhCRzaMoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D&md5=888b9d7d85a45ed3e65e0ef718b5b288</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900139-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900139-5%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520spectrum%2520of%2520behaviors%2520influenced%2520by%2520serotonin%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Naughton, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulrooney, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">A review of the role of serotonin receptors in psychiatric disorders</span> <span class="citation_source-journal">Human Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12404302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=397-415&author=M+Naughtonauthor=J.+B.+Mulrooneyauthor=B.+E.+Leonard&title=A+review+of+the+role+of+serotonin+receptors+in+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of serotonin receptors in psychiatric disorders</span></div><div class="casAuthors">Naughton, Marie; Mulrooney, Jane B.; Leonard, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-415</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Serotonin (5-hydroxytryptamine, 5-HT) mediates a wide variety of physiol. functions by activating multiple receptors, and abnormalities of these receptor systems was implicated in many psychiatric disorders including anxiety, depression, psychosis, migraine, disorders of sexual functioning, sleep, cognition, and feeding.  Many of the currently used treatments for these disorders act by affecting the serotonergic system.  Observation of serotonin receptor alterations, before and following effective treatments, may yield important insights into the etiol. of these psychiatric disorders and may ultimately lead to more selective and effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhSNrDcM0h7Vg90H21EOLACvtfcHk0lj95fhCRzaMoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D&md5=18be55930836492c6f605103ea4cc7b1</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1077%2528200008%252915%253A6%253C397%253A%253AAID-HUP212%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNaughton%26aufirst%3DM%26aulast%3DMulrooney%26aufirst%3DJ.%2BB.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520serotonin%2520receptors%2520in%2520psychiatric%2520disorders%26jtitle%3DHuman%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26spage%3D397%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Vaswani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linda, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, S.</span><span> </span><span class="NLM_article-title">Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review</span> <span class="citation_source-journal">Prog. Neuro-Psychopharm. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0278-5846%2802%2900338-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12551730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2003&pages=85-102&author=M.+Vaswaniauthor=F.+K.+Lindaauthor=S.+Ramesh&title=Role+of+selective+serotonin+reuptake+inhibitors+in+psychiatric+disorders%3A+a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review</span></div><div class="casAuthors">Vaswani, Meera; Linda, Farzana Kadar; Ramesh, Subramanyam</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-102</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The selective serotonin reuptake inhibitors (SSRIs) have emerged as a major therapeutic advance in psychopharmacol.  As a result, the discovery of these agents marks a milestone in neuropsychopharmacol. and rational drug design, and has launched a new era in psychotropic drug development.  Prior to the SSRIs, all psychotropic medications were the result of chance observation.  In an attempt to develop a SSRI, researchers discovered a no. of nontricyclic agents with amine-uptake inhibitory properties, acting on both noradrenergic and serotonergic neurons with considerable differences in potency.  A given drug may affect one or more sites over its clin. relevant dosing range and may produce multiple and different clin. effects.  The enhanced safety profile includes a reduced likelihood of pharmacodynamically mediated adverse drug-drug interactions by avoiding affects on sites that are not essential to the intended outcome.  SSRIs were developed for inhibition of the neuronal uptake pump for serotonin (5-HT), a property shared with the TCAs, but without affecting the other various neuroreceptors or fast sodium channels.  The therapeutic mechanism of action of SSRIs involves alteration in the 5-HT system.  The plethora of biol. substrates, receptors and pathways for 5-HT are candidates to mediate not only the therapeutic actions of SSRIs, but also their side effects.  A hypothesis to explain these immediate side effects is that 5-HT is increased at specific 5-HT receptor subtypes in discrete regions of the body where the relevant physiol. processes are regulated.  Marked differences exist between the SSRIs with regard to effects on specific cytochrome P 450 (CYP) enzymes, and thus the likelihood of clin. important pharmacokinetic drug-drug interactions.  Although no clear relationship exists between the clin. efficacy, plasma concn. of SSRIs, nor any threshold that defines toxic concns., but therapeutic drug monitoring (TDM) may be useful in special populations, such as in elderly patients, poor metabolizers (PM) of sparteine (CYP2D6) or mephenytoin (CYP2C19), and patients with liver and kidney impairment.  Several meta-analyses have reviewed the comparative efficacy of TCAs and SSRIs, and concluded that both TCAs and SSRIs have similar efficacy in the treatment of depression.  SSRIs have demonstrated better efficacy and tolerability in the treatment of obsessive compulsive disorder (OCD).  They have also been found to be effective in the treatment for social anxiety disorder both in reducing total levels of social anxiety and in improving overall clin. condition.  The benefit of SSRIs in anorexia nervosa (AN) is apparently short-term unless medication is given in the context of nutritional or behavioral therapy.  No single antidepressant can ever be recommended for every patient, but in a vast majority of patients, SSRIs should be considered as one of the first-line drugs in the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4vX5ZOlhe7Vg90H21EOLACvtfcHk0ljnPbrsHe4Q9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFakuw%253D%253D&md5=d54426dbfceb38e9808ab7ca5faaaa07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2802%2900338-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252802%252900338-X%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DM.%26aulast%3DLinda%26aufirst%3DF.%2BK.%26aulast%3DRamesh%26aufirst%3DS.%26atitle%3DRole%2520of%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520in%2520psychiatric%2520disorders%253A%2520a%2520comprehensive%2520review%26jtitle%3DProg.%2520Neuro-Psychopharm.%2520Biol.%2520Psychiatry%26date%3D2003%26volume%3D27%26spage%3D85%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of serotonin antagonists in depressive disorders</span> <span class="citation_source-journal">Exp. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=457-467&author=M.+D.+Woodauthor=D.+R.+Thomasauthor=J.+M.+Watson&title=Therapeutic+potential+of+serotonin+antagonists+in+depressive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520potential%2520of%2520serotonin%2520antagonists%2520in%2520depressive%2520disorders%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=91-98S&author=P.+Blierauthor=C.+De+Montigny&title=Serotonin+and+drug-induced+therapeutic+responses+in+major+depression%2C+obsessive-compulsive+and+panic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DSerotonin%2520and%2520drug-induced%2520therapeutic%2520responses%2520in%2520major%2520depression%252C%2520obsessive-compulsive%2520and%2520panic%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D21%26spage%3D91%26epage%3D98S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boikess, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in vivo microdialysis study</span> <span class="citation_source-journal">J. Psychopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1177%2F026988110201600403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12503828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=297-304&author=C.+E.+Beyerauthor=S.+Boikessauthor=B.+Luoauthor=L.+A.+Dawson&title=Comparison+of+the+effects+of+antidepressants+on+norepinephrine+and+serotonin+concentrations+in+the+rat+frontal+cortex%3A+an+in+vivo+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span></div><div class="casAuthors">Beyer, Chad E.; Boikess, Steve; Luo, Bin; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">The present study employed in-vivo microdialysis techniques in the freely moving rat to systematically compare the neurochem. effects of various antidepressant agents on extracellular concns. of norepinephrine (NE) and serotonin (5-HT) in the frontal cortex.  We found that acute administration of the tricyclic antidepressant, desipramine (3-30 mg/kg, s.c.) and the dual serotonin/norepinephrine reuptake inhibitor, venlafaxine (3-30 mg/kg, s.c.), produced dose-dependent and robust increases in cortical NE concns. (498% and 403%, resp.).  Conversely, acute injection of the selective serotonin reuptake inhibitors, fluoxetine (30 mg/kg, s.c.) and paroxetine (1-10 mg/kg, s.c.), did not alter forebrain NE concns.  However, paroxetine did produce a significant increase in cortical NE concns. (164%) when administered at 30 mg/kg.  These changes in NE were not paralleled by 5-HT, which showed no increase following administration of desipramine, venlafaxine, paroxetine or fluoxetine.  Combination treatment with the 5-HT1A receptor antagonist, WAY-100635 (0.3 mg/kg, s.c.), significantly enhanced extracellular 5-HT concns. following venlafaxine (10 and 30 mg/kg), fluoxetine (30 mg/kg) and paroxetine (3-30 mg/kg).  Alternatively, WAY-100635 produced no augmentation of the antidepressant-induced changes in extracellular NE.  Collectively, these studies show that paroxetine, at low to intermediate doses, and fluoxetine are selective for 5-HT vs. NE systems, whereas venlafaxine produces similar effects on both 5-HT and NE levels at the EDs tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKBQ9tr1B2rVg90H21EOLACvtfcHk0lg010ChKr3gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D&md5=a1675211169ec4b13feb6ae7e5803f64</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1177%2F026988110201600403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600403%26sid%3Dliteratum%253Aachs%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DBoikess%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520antidepressants%2520on%2520norepinephrine%2520and%2520serotonin%2520concentrations%2520in%2520the%2520rat%2520frontal%2520cortex%253A%2520an%2520in%2520vivo%2520microdialysis%2520study%26jtitle%3DJ.%2520Psychopharm.%26date%3D2002%26volume%3D16%26spage%3D297%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Ligands for the investigation of 5-HT autoreceptor function</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0361-9230%2801%2900628-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=11750791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=463-469&author=C.+Robertsauthor=G.+W.+Priceauthor=D.+N.+Middlemiss&title=Ligands+for+the+investigation+of+5-HT+autoreceptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands for the investigation of 5-HT autoreceptor function</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Middlemiss, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of multiple 5-HT autoreceptors in the central nervous system is now firmly established and they have been pharmacol. identified as belonging to the 5-HT1A, 5-HT1B, and 5-HT1D receptor subtypes.  In addn., 5-HT1F, 5-HT5A, and 5-HT7 receptors remain as potential candidates for addnl. autoreceptors.  The emergence of selective ligands, such as SB-224289 (5-HT1B receptor antagonist), BRL 15572 (5-HT1D receptor antagonist), GR 127935 (a mixed 5-HT1B/1D receptor antagonist), LY 334370 (5-HT1F receptor agonist), and SB-269970 (5-HT7 receptor antagonist), has aided the characterization of 5-HT autoreceptors and has highlighted the complexity of mechanisms which modulate the release of 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3Lk0_xEYELVg90H21EOLACvtfcHk0lg010ChKr3gWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D&md5=1b38f404662c50829d0f1d20bd313d84</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900628-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900628-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DLigands%2520for%2520the%2520investigation%2520of%25205-HT%2520autoreceptor%2520function%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D56%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span> </span><span class="NLM_article-title">5-HT autoreceptors: Pharmacological tools and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFSitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=251-264&author=L.+A.+Dawsonauthor=Z.+A.+Hughesauthor=J.+M.+Watsonauthor=R.+Arbanauthor=G.+W.+Price&title=5-HT+autoreceptors%3A+Pharmacological+tools+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT autoreceptors: Pharmacological tools and therapeutic potential</span></div><div class="casAuthors">Dawson, Lee A.; Hughes, Zoe A.; Watson, Jeannette M.; Arban, Roberto; Price, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-264</span>CODEN:
                <span class="NLM_cas:coden">CTPCF5</span>;
        ISSN:<span class="NLM_cas:issn">0972-4559</span>.
    
            (<span class="NLM_cas:orgname">Research Trends</span>)
        </div><div class="casAbstract">A review.  It is over 25 years since it was first suggested that presynaptic autoreceptors modulate 5-HT release.  These autoreceptors have since been subdivided into two categories: those that reside on serotonergic cell bodies and those on the fiber terminals.  The subsequent development of selective ligands led to the discovery that 5-HT autoreceptors belonged to the 5-HT1 subfamily, which is composed of 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F receptor subtypes which neg. couple to adenylyl cyclase via a no. of inhibitory G proteins.  With the advent of mol. biol. techniques these 5-HT autoreceptors have been cloned, sequenced and more fully characterized.  The interrelationship between 5-HT and depression was first alluded to in 1957, since then the role of 5-HT in the etiol. of psychiatric disorders, such as depression and anxiety has received substantial interest.  This has led to the development of a variety of selective ligands targeted at 5-HT autoreceptors as potential drug moieties for the treatment of these conditions.  Here we will review the development of these pharmacol. tools and their potential therapeutic utility in the treatment of psychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtkG6vJmp2S7Vg90H21EOLACvtfcHk0lg3iV0wLxab7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFSitL8%253D&md5=ba333a6fa7ebf913730338beef542dcf</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DArban%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26atitle%3D5-HT%2520autoreceptors%253A%2520Pharmacological%2520tools%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Pharmacol.%26date%3D2004%26volume%3D8%26spage%3D251%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>1</sub> receptor augmentation strategies as enhanced efficacy therapeutics for psychiatric disorders</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.2174%2F156802608785161439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=18691129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1008-1023&author=L.+A.+Dawsonauthor=S.+M.+Bromidge&title=5-HT1+receptor+augmentation+strategies+as+enhanced+efficacy+therapeutics+for+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1 receptor augmentation strategies as enhanced efficacy therapeutics for psychiatric disorders</span></div><div class="casAuthors">Dawson, Lee A.; Bromidge, Steve M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1008-1023</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the initial observations linking 5-HT to psychiatric illness, evidence for a role of 5-HT and, in particular, a decreased brain serotonergic function in the pathol. of a plethora of related disorders, has grown.  However, it is the role of 5-HT in the pathogenesis of anxiety disorders and depression and the mechanism of action of antidepressants which has received the most attention.  Thus enhanced serotonergic neurotransmission has become one of the unifying mechanisms of action of modern day antidepressants / anxiolytics such as monoamine oxidase inhibitors, tricyclic antidepressants, and serotonin reuptake inhibitors.  Interestingly all of these treatments are assocd. with a delay to therapeutic efficacy and in some cases treatment resistance, despite immediate enhancements in serotonergic neurotransmission.  The postulated reason for this is the need for temporal neuroplastic changes in the control of serotonergic neurotransmission, and more specifically changes in 5-HT1 autoreceptor function.  Thus significant research has gone into pharmacol. targeting these 5-HT1 autoreceptors as a means of augmenting the efficacy of current therapeutic mechanisms.  Here we will review the rationale behind the various augmentation strategies adopted and the progress made in identifying novel therapeutics for conditions such as depression and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMf53pfeDDRbVg90H21EOLACvtfcHk0lg3iV0wLxab7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLc%253D&md5=d8262b01f7af300831084bdf423f5da1</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F156802608785161439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161439%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26atitle%3D5-HT1%2520receptor%2520augmentation%2520strategies%2520as%2520enhanced%2520efficacy%2520therapeutics%2520for%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1008%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Simultaneous blockade of 5-HT<sub>1A/B</sub> receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT<sub>1A/B</sub> receptor antagonist/5-HT transport inhibitor SB-649915-B</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2007&pages=121-133&author=Z.+A.+Hughesauthor=K.+R.+Starrauthor=C.+M.+Scottauthor=M.+J.+Newsonauthor=T.+Sharpauthor=J.+M.+Watsonauthor=J.+J.+Haganauthor=L.+A.+Dawson&title=Simultaneous+blockade+of+5-HT1A%2FB+receptors+and+5-HT+transporters+results+in+acute+increases+in+extracellular+5-HT+in+both+rats+and+guinea+pigs%3A+in+vivo+characterization+of+the+novel+5-HT1A%2FB+receptor+antagonist%2F5-HT+transport+inhibitor+SB-649915-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DNewson%26aufirst%3DM.%2BJ.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DSimultaneous%2520blockade%2520of%25205-HT1A%252FB%2520receptors%2520and%25205-HT%2520transporters%2520results%2520in%2520acute%2520increases%2520in%2520extracellular%25205-HT%2520in%2520both%2520rats%2520and%2520guinea%2520pigs%253A%2520in%2520vivo%2520characterization%2520of%2520the%2520novel%25205-HT1A%252FB%2520receptor%2520antagonist%252F5-HT%2520transport%2520inhibitor%2520SB-649915-B%26jtitle%3DPsychopharmacology%26date%3D2007%26volume%3D192%26spage%3D121%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones as dual-acting 5-HT<sub>1A</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1033-1036&author=P.+J.+Lovellauthor=F.+E.+Blaneyauthor=C.+J.+Goodacreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=S.+E.+Wardauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+as+dual-acting+5-HT1A+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DGoodacre%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520as%2520dual-acting%25205-HT1A%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1033%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5214</span><span class="NLM_x">–</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5214-5217&author=S.+E.+Wardauthor=C.+N.+Johnsonauthor=P.+J.+Lovellauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=G.+Stempauthor=K.+M.+Thewlisauthor=A.+K.+Vongauthor=J.+M.+Watson&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5214%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Novel 5-HT<sub>1A/1B/1D</sub> receptors antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5581</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5581-5585&author=H.+T.+Serafinowskaauthor=F.+E.+Blaneyauthor=P.+J.+Lovellauthor=G.+Merloauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=J.+M.+Watson&title=Novel+5-HT1A%2F1B%2F1D+receptors+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DNovel%25205-HT1A%252F1B%252F1D%2520receptors%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5581%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bromidge, S M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesentini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">6-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: dual-acting 5-HT<sub>1</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5653-5656&author=S+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=S.+Faedoauthor=L.+J.+Gordonauthor=E.+Granciauthor=M.+Hillauthor=H.+R.+Marshallauthor=L.+P.+Stasiauthor=V.+Zucchelliauthor=G.+Merloauthor=A.+Vesentiniauthor=J.+M.+Watsonauthor=L.+Zonzini&title=6-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGranci%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DH.%2BR.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DVesentini%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D6-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozzoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">8-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: dual-acting 5-HT<sub>1</sub> receptor antagonists and serotonin reuptake inhibitors, part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2338</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2338-2342&author=S.+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=A.+Bozzoliauthor=S.+Faedoauthor=M.+Gianottiauthor=L.+J.+Gordonauthor=M.+Hillauthor=V.+Zucchelliauthor=J.+M.+Watsonauthor=L.+Zonzini&title=8-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors%2C+part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DBozzoli%26aufirst%3DA.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGianotti%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D8-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%252C%2520part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2338%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Bartsch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span> </span><span class="NLM_article-title">Studies on the chemistry of 1,4-oxazines. 18. Synthesis of tricyclic 1,4-benzoxazines via nucleophilic substitution of activated precursors</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=205-207&author=H.+Bartschauthor=T.+Erkerauthor=G.+Neubauer&title=Studies+on+the+chemistry+of+1%2C4-oxazines.+18.+Synthesis+of+tricyclic+1%2C4-benzoxazines+via+nucleophilic+substitution+of+activated+precursors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartsch%26aufirst%3DH.%26aulast%3DErker%26aufirst%3DT.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DStudies%2520on%2520the%2520chemistry%2520of%25201%252C4-oxazines.%252018.%2520Synthesis%2520of%2520tricyclic%25201%252C4-benzoxazines%2520via%2520nucleophilic%2520substitution%2520of%2520activated%2520precursors%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1989%26volume%3D26%26spage%3D205%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Rudorf, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janietz, D.</span><span> </span><span class="NLM_article-title">Intramolecular 1,3-dipolar cycloadditions of aryl azides with alkynyl substituents</span> <span class="citation_source-journal">J. Prakt. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1002%2Fprac.19873290108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaL2sXmtlKlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=55-61&author=W.+D.+Rudorfauthor=D.+Janietz&title=Intramolecular+1%2C3-dipolar+cycloadditions+of+aryl+azides+with+alkynyl+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular 1,3-dipolar cycloadditions of aryl azides with alkynyl substituents</span></div><div class="casAuthors">Rudorf, W. D.; Janietz, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">Condensation of ClCH2C≡CCH2OR (R = Me, Ac) with 2-HOC6H4NHAc or 2-HSC6H4NH2 gave 2-H2NC6H4XCH2C≡CCH2OR (X = O, S) which were converted into alkynyl substituted aryl azides, 2-N3C6H4XCH2C≡CCH2OR (I) by diazotization followed by reaction with NaN3.  Intramol. 1,3-dipolar cycloaddn. of I gave triazolobenzoxazines II.  In the same way cycloaddn. of 2-N3C6H4OCH2C≡CCH2OC6H4N3-2, prepd. from 2-HOC6H4NHAc and ClCH2C≡CCH2Cl, gave azidophenoxymethyltriazolobenzoxazine III.  Thermal decompn. of III gave triazolobenzoxazinylmethyleneaminophenol IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZx7rZegJprVg90H21EOLACvtfcHk0lgNWrufFRhrGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtlKlsLY%253D&md5=f19249c14c7213ccbaa93e45ef7b8d15</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fprac.19873290108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19873290108%26sid%3Dliteratum%253Aachs%26aulast%3DRudorf%26aufirst%3DW.%2BD.%26aulast%3DJanietz%26aufirst%3DD.%26atitle%3DIntramolecular%25201%252C3-dipolar%2520cycloadditions%2520of%2520aryl%2520azides%2520with%2520alkynyl%2520substituents%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1987%26volume%3D329%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x"> (</span><span class="NLM_issue">7083</span><span class="NLM_x">) </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&issue=7083&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0lgNWrufFRhrGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26issue%3D7083%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG Potassium Channels and the Structural Basis of Drug-Induced Arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+Potassium+Channels+and+the+Structural+Basis+of+Drug-Induced+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520Potassium%2520Channels%2520and%2520the%2520Structural%2520Basis%2520of%2520Drug-Induced%2520Arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_publisher-name">Aptuit Limited</span>, <span class="NLM_publisher-loc">3 Simpson Parkway, Livingston, West Lothian, EH54 7BH, Scotland</span>, <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2C+West+Lothian%2C+EH54+7BH%2C+Scotland%2C+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DAptuit%2520Limited" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Shamovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbahns, K.</span><span> </span><span class="NLM_article-title">Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070543k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1162-1178&author=I.+Shamovskyauthor=S.+Connollyauthor=L.+Davidauthor=S.+Ivanovaauthor=B.+Nord%C3%A9nauthor=B.+Springthorpeauthor=K.+Urbahns&title=Overcoming+Undesirable+hERG+Potency+of+Chemokine+Receptor+Antagonists+Using+Baseline+Lipophilicity+Relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships</span></div><div class="casAuthors">Shamovsky, Igor; Connolly, Stephen; David, Laurent; Ivanova, Svetlana; Norden, Bo; Springthorpe, Brian; Urbahns, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of the hERG channel by noncardiovascular drugs is a side effect that severely impedes the development of new medications.  To increase hERG selectivity of preclin. compds., the authors recommend the study of nondesolvation related interactions with the intended target and hERG using a baseline lipophilicity relationship approach.  While this approach is conventionally used in studies of potency, the authors demonstrate here that it can help in selectivity issues.  Studies of hERG selectivity in four inhouse classes of chemokine receptor (CCR) antagonists suggest that the selectivity is improved most effectively by structural alterations that increase the lipophilicity-adjusted primary potency, pIC50CCR - LogD.  Fragment-based QSAR anal. is performed using the lipophilicity-adjusted hERG potency, pIC50hERG - LogD, to identify moieties that form nonhydrophobic interactions with the hERG channel.  These moieties, which erode hERG selectivity, can then be avoided.  A novel two-dimensional fragment-based QSAR anal. helps visualizing the lipophilicity-adjusted hERG and CCR potencies within chem. series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1BNQlA8irybVg90H21EOLACvtfcHk0lieg2OAjesiuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslWju78%253D&md5=04596a9552c5cf3b47a3edf9c0bd5498</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm070543k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070543k%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DSpringthorpe%26aufirst%3DB.%26aulast%3DUrbahns%26aufirst%3DK.%26atitle%3DOvercoming%2520Undesirable%2520hERG%2520Potency%2520of%2520Chemokine%2520Receptor%2520Antagonists%2520Using%2520Baseline%2520Lipophilicity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1162%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Huang, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Habet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baweja, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckart, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colangelo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frucht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnaukhova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroum, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stifano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thummel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesko, L. J.</span><span> </span><span class="NLM_article-title">New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1177%2F0091270007312153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=18378963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Kitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=662-670&author=S+Huangauthor=J.+M.+Strongauthor=L.+Zhangauthor=K.+S.+Reynoldsauthor=S.+Nallaniauthor=R.+Templeauthor=S.+Abrahamauthor=S.+Al+Habetauthor=R.+K.+Bawejaauthor=G.+J.+Burckartauthor=S.+Chungauthor=P.+Colangeloauthor=D.+Fruchtauthor=M.+D.+Greenauthor=P.+Heppauthor=E.+Karnaukhovaauthor=H.+Koauthor=J.+Leeauthor=P.+J.+Marroumauthor=J.+M.+Nordenauthor=W.+Qiuauthor=A.+Rahmanauthor=S.+Sobelauthor=T.+Stifanoauthor=K.+Thummelauthor=X.+Weiauthor=S.+Yasudaauthor=J.+H.+Zhengauthor=H.+Zhaoauthor=L.+J.+Lesko&title=New+era+in+drug+interaction+evaluation%3A+US+Food+and+Drug+Administration+update+on+CYP+enzymes%2C+transporters%2C+and+the+guidance+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process</span></div><div class="casAuthors">Huang, Shiew-Mei; Strong, John M.; Zhang, Lei; Reynolds, Kellie S.; Nallani, Srikanth; Temple, Robert; Abraham, Sophia; Al Habet, Sayed; Baweja, Raman K.; Burckart, Gilbert J.; Chung, Sang; Colangelo, Philip; Frucht, David; Green, Martin D.; Hepp, Paul; Karnaukhova, Elena; Ko, Hon-Sum; Lee, Jang-Ik; Marroum, Patrick J.; Norden, Janet M.; Qiu, Wei; Rahman, Atiqur; Sobel, Solomon; Stifano, Toni; Thummel, Kenneth; Wei, Xiao-xiong; Yasuda, Sally; Zheng, Jenny H.; Zhao, Hong; Lesko, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-670</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Predicting clin. significant drug interactions during drug development is a challenge for the pharmaceutical industry and regulatory agencies.  Since the publication of the US Food and Drug Administration's (FDA's) first in vitro and in vivo drug interaction guidance documents in 1997 and 1999, researchers and clinicians have gained a better understanding of drug interactions.  This knowledge has enabled the FDA and the industry to progress and begin to overcome these challenges.  The FDA has continued its efforts to evaluate methodologies to study drug interactions and communicate recommendations regarding the conduct of drug interaction studies, particularly for CYP-based and transporter-based drug interactions, to the pharmaceutical industry.  A drug interaction Web site was established to document the FDA's current understanding of drug interactions (http://www.fda.gov/cder/drug/drugInteractions/default.htm).  This report provides an overview of the evolution of the drug interaction guidances, includes a synopsis of the steps taken by the FDA to revise the original drug interaction guidance documents, and summarizes and highlights updated sections in the current guidance document, Drug Interaction Studies-Study Design, Data Anal., and Implications for Dosing and Labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6SXwLu9y5LVg90H21EOLACvtfcHk0ljoo2W-veVCaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Kitr4%253D&md5=6821a9c12eed38bd2faba68d8a2d8240</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F0091270007312153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270007312153%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DK.%2BS.%26aulast%3DNallani%26aufirst%3DS.%26aulast%3DTemple%26aufirst%3DR.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DAl%2BHabet%26aufirst%3DS.%26aulast%3DBaweja%26aufirst%3DR.%2BK.%26aulast%3DBurckart%26aufirst%3DG.%2BJ.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DColangelo%26aufirst%3DP.%26aulast%3DFrucht%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DM.%2BD.%26aulast%3DHepp%26aufirst%3DP.%26aulast%3DKarnaukhova%26aufirst%3DE.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMarroum%26aufirst%3DP.%2BJ.%26aulast%3DNorden%26aufirst%3DJ.%2BM.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DSobel%26aufirst%3DS.%26aulast%3DStifano%26aufirst%3DT.%26aulast%3DThummel%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLesko%26aufirst%3DL.%2BJ.%26atitle%3DNew%2520era%2520in%2520drug%2520interaction%2520evaluation%253A%2520US%2520Food%2520and%2520Drug%2520Administration%2520update%2520on%2520CYP%2520enzymes%252C%2520transporters%252C%2520and%2520the%2520guidance%2520process%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2008%26volume%3D48%26spage%3D662%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK(1) receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+intramolecular+hydrogen+bond+to+increase+the+CNS+penetration+of+an+NK%281%29+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520increase%2520the%2520CNS%2520penetration%2520of%2520an%2520NK%25281%2529%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Centre de Recherches Biologiques, CERB, Chemin de Montfort, 18800 Bougy, France,</span><a href="http://www.cerb.fr" class="extLink">www.cerb.fr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Centre+de+Recherches+Biologiques%2C+CERB%2C+Chemin+de+Montfort%2C+18800+Bougy%2C+France%2Cwww.cerb.fr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">In vitro screening of 50 highly prescribed drugs for thiol adduct formation—comparison of potential for drug-induced toxicity and extent of adduct formation</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800368n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=690-698&author=J.+Ganauthor=Q.+Ruanauthor=B.+Heauthor=M.+Zhuauthor=W.+C.+Shyuauthor=W.+G.+Humphreys&title=In+vitro+screening+of+50+highly+prescribed+drugs+for+thiol+adduct+formation%E2%80%94comparison+of+potential+for+drug-induced+toxicity+and+extent+of+adduct+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx800368n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800368n%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DShyu%26aufirst%3DW.%2BC.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DIn%2520vitro%2520screening%2520of%252050%2520highly%2520prescribed%2520drugs%2520for%2520thiol%2520adduct%2520formation%25E2%2580%2594comparison%2520of%2520potential%2520for%2520drug-induced%2520toxicity%2520and%2520extent%2520of%2520adduct%2520formation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Stimulation of 5-HT<sub>1B</sub> receptors causes hypothermia in the guinea pig</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0014-2999%2897%2901055-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=9274976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaK2sXksFeitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1997&pages=169-174&author=J.+J.+Haganauthor=P.+D.+Sladeauthor=L.+Gasterauthor=P.+Jeffreyauthor=J.+P.+Hatcherauthor=D.+N.+Middlemiss&title=Stimulation+of+5-HT1B+receptors+causes+hypothermia+in+the+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig</span></div><div class="casAuthors">Hagan, Jim J.; Slade, Paula D.; Gaster, Laramie; Jeffrey, Phillip; Hatcher, Jonathan P.; Middlemiss, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">169-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The selective, brain penetrant, 5-HT1B/D (formerly 5-HT1Dβ/α) receptor agonist SKF-99101H (3-(2-dimethylaminoethyl)-4-chloro-5-propoxyindole hemifumarate) (30 mg/kg i.p.) causes a dose related fall in rectal temp. in guinea pigs which previous studies have shown to be blocked by the non-selective 5-HT1B/D receptor antagonist GR-127935 (N-[4-methoxy-3-(4-methyl-1-piperazinyl) phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1'biphenyl]-4-carboxamide oxalate).  The present study shows that the hypothermic response to SKF-99101H is dose-dependently blocked by SB-224289G (1'-methyl-5-(2'-methyl-4'-[(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl)-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4'-piperidone] hemioxalate) (0.3-10.0 mg/kg p.o.) (ED50 3.62 mg/kg), which is the first compd. to be described which is more than 60 fold selective for the 5-HT1B receptor over the 5-HT1D receptor.  SB-216641A (N-[3-(2-dimethylamino) ethoxy-4-methoxy-phenyl] 2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-carboxamide hydrochloride) (0.6-20.0 mg/kg i.p.), which is somewhat less selective (30 fold) for the 5-HT1B receptor over the 5-HT1D receptor had a similar effect (ED50 4.43 mg/kg).  The brain penetrant 5-HT1D selective receptor antagonist, BRL-15572 (4-(3-chlorophenyl)-α-(diphenylmethyl)-1-piperazineethanol dihydrochloride) (0.3-100.0 mg/kg i.p.) was inactive.  When administered alone neither BRL-15572 (0.1-10 mg/kg i.p.) nor SB-224289G (2.2-22 mg/kg p.o.) had an effect on body temp.  These data demonstrate that 5-HT1B (formerly 5-HT1Dβ) and not 5-HT1D (formerly 5-HT1Dα) receptors mediate the hypothermic response to SKF-99101H (30 mg/kg i.p.) in guinea pigs.  The compds. described are useful pharmacol. tools for distinguishing responses to 5-HT1B and 5-HT1D receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSUnPKPFmcyLVg90H21EOLACvtfcHk0ljuS8-XbDonDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFeitro%253D&md5=d2ce70b9959d4f176135a02494524f33</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901055-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901055-8%26sid%3Dliteratum%253Aachs%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DSlade%26aufirst%3DP.%2BD.%26aulast%3DGaster%26aufirst%3DL.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DStimulation%2520of%25205-HT1B%2520receptors%2520causes%2520hypothermia%2520in%2520the%2520guinea%2520pig%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D331%26spage%3D169%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLenachan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanhope, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childs, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlefell, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanfumey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Electrophysiological, biochemical,neurohormonal and behavioural studies with WAY-100635, a potent,selective and silent 5-HT<sub>1A</sub> receptor antagonist</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=337-353&author=A.+Fletcherauthor=E.+A.+Forsterauthor=D.+J.+Billauthor=G.+Brownauthor=I.+A.+Cliffeauthor=J.+E.+Hartleyauthor=D.+E.+Jonesauthor=A.+McLenachanauthor=K.+J.+Stanhopeauthor=D.+J.+P.+Critchleyauthor=K.+J.+Childsauthor=V.+C.+Middlefellauthor=L.+Lanfumeyauthor=R.+Corradettiauthor=A.+Laporteauthor=H.+Gozlanauthor=M.+Hamonauthor=C.+T.+Dourish&title=Electrophysiological%2C+biochemical%2Cneurohormonal+and+behavioural+studies+with+WAY-100635%2C+a+potent%2Cselective+and+silent+5-HT1A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DE.%2BA.%26aulast%3DBill%26aufirst%3DD.%2BJ.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DHartley%26aufirst%3DJ.%2BE.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DMcLenachan%26aufirst%3DA.%26aulast%3DStanhope%26aufirst%3DK.%2BJ.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DChilds%26aufirst%3DK.%2BJ.%26aulast%3DMiddlefell%26aufirst%3DV.%2BC.%26aulast%3DLanfumey%26aufirst%3DL.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DLaporte%26aufirst%3DA.%26aulast%3DGozlan%26aufirst%3DH.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DElectrophysiological%252C%2520biochemical%252Cneurohormonal%2520and%2520behavioural%2520studies%2520with%2520WAY-100635%252C%2520a%2520potent%252Cselective%2520and%2520silent%25205-HT1A%2520receptor%2520antagonist%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1996%26volume%3D73%26spage%3D337%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b','cit7c','cit7d'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 26 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongquan  Ning</span>, <span class="hlFld-ContribAuthor ">Nannan  Wu</span>, <span class="hlFld-ContribAuthor ">Haifeng  Yu</span>, <span class="hlFld-ContribAuthor ">Peiqiu  Liao</span>, <span class="hlFld-ContribAuthor ">Xingqi  Li</span>, and <span class="hlFld-ContribAuthor ">Xihe  Bi</span>  . </span><span class="cited-content_cbyCitation_article-title">Silver-Catalyzed Tandem Hydroazidation/Alkyne–Azide Cycloaddition of Diynes with TMS-N3: An Easy Access to 1,5-Fused 1,2,3-Triazole Frameworks. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (9)
                                     , 2198-2201. <a href="https://doi.org/10.1021/acs.orglett.5b00784" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b00784</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b00784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b00784%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSilver-Catalyzed%252BTandem%252BHydroazidation%25252FAlkyne%2525E2%252580%252593Azide%252BCycloaddition%252Bof%252BDiynes%252Bwith%252BTMS-N3%25253A%252BAn%252BEasy%252BAccess%252Bto%252B1%25252C5-Fused%252B1%25252C2%25252C3-Triazole%252BFrameworks%26aulast%3DNing%26aufirst%3DYongquan%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D18032015%26date%3D20042015%26date%3D01052015%26volume%3D17%26issue%3D9%26spage%3D2198%26epage%3D2201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akhilesh K.  Verma</span>, <span class="hlFld-ContribAuthor ">Deepak  Choudhary</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Saunthwal</span>, <span class="hlFld-ContribAuthor ">Vineeta  Rustagi</span>, <span class="hlFld-ContribAuthor ">Monika  Patel</span>, and <span class="hlFld-ContribAuthor ">Rakesh K.  Tiwari</span>  . </span><span class="cited-content_cbyCitation_article-title">On Water: Silver-Catalyzed Domino Approach for the Synthesis of Benzoxazine/Oxazine-Fused Isoquinolines and Naphthyridines from o-Alkynyl Aldehydes. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (13)
                                     , 6657-6669. <a href="https://doi.org/10.1021/jo4009639" title="DOI URL">https://doi.org/10.1021/jo4009639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4009639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4009639%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOn%252BWater%25253A%252BSilver-Catalyzed%252BDomino%252BApproach%252Bfor%252Bthe%252BSynthesis%252Bof%252BBenzoxazine%25252FOxazine-Fused%252BIsoquinolines%252Band%252BNaphthyridines%252Bfrom%252Bo-Alkynyl%252BAldehydes%26aulast%3DVerma%26aufirst%3DAkhilesh%2BK.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D03052013%26date%3D11062013%26date%3D12062013%26date%3D19062013%26date%3D05072013%26date%3D12062013%26volume%3D78%26issue%3D13%26spage%3D6657%26epage%3D6669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hee Jeong  Seo</span>, <span class="hlFld-ContribAuthor ">Eun-Jung  Park</span>, <span class="hlFld-ContribAuthor ">Min Ju  Kim</span>, <span class="hlFld-ContribAuthor ">Suk Youn  Kang</span>, <span class="hlFld-ContribAuthor ">Suk Ho  Lee</span>, <span class="hlFld-ContribAuthor ">Hyun Jung  Kim</span>, <span class="hlFld-ContribAuthor ">Ki Nam  Lee</span>, <span class="hlFld-ContribAuthor ">Myung Eun  Jung</span>, <span class="hlFld-ContribAuthor ">MinWoo  Lee</span>, <span class="hlFld-ContribAuthor ">Mi-Soon  Kim</span>, <span class="hlFld-ContribAuthor ">Eun-Jung  Son</span>, <span class="hlFld-ContribAuthor ">Woo-Kyu  Park</span>, <span class="hlFld-ContribAuthor ">Jeongmin  Kim</span>, and <span class="hlFld-ContribAuthor ">Jinhwa  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Novel Arylpiperazine Derivatives Containing the Imidazole Core Targeting 5-HT2A Receptor and 5-HT Transporter. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (18)
                                     , 6305-6318. <a href="https://doi.org/10.1021/jm200682b" title="DOI URL">https://doi.org/10.1021/jm200682b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200682b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200682b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BNovel%252BArylpiperazine%252BDerivatives%252BContaining%252Bthe%252BImidazole%252BCore%252BTargeting%252B5-HT2A%252BReceptor%252Band%252B5-HT%252BTransporter%26aulast%3DSeo%26aufirst%3DHee%2BJeong%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D30052011%26date%3D23082011%26date%3D22092011%26date%3D08082011%26volume%3D54%26issue%3D18%26spage%3D6305%26epage%3D6318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anton V.  Budeev</span>, <span class="hlFld-ContribAuthor ">Grigory  Kantin</span>, <span class="hlFld-ContribAuthor ">Dmitry  Dar’in</span>, <span class="hlFld-ContribAuthor ">Mikhail  Krasavin</span>. </span><span class="cited-content_cbyCitation_article-title">Continued Exploration of Trifunctional Alkyl 4-Chloro-2-diazo-3-oxobutanoates: Streamlined Entry into [1,2,3]Triazolo[5,1-c][1,4]benzoxazines and [1,2,3]Triazolo[5,1-c][1,4]benzoxazepines. </span><span class="cited-content_cbyCitation_journal-name">Synthesis</span><span> <strong>2021,</strong> <em>53 </em>
                                    (12)
                                     , 2155-2166. <a href="https://doi.org/10.1055/a-1348-9031" title="DOI URL">https://doi.org/10.1055/a-1348-9031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1055/a-1348-9031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1055%2Fa-1348-9031%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthesis%26atitle%3DContinued%252BExploration%252Bof%252BTrifunctional%252BAlkyl%252B4-Chloro-2-diazo-3-oxobutanoates%25253A%252BStreamlined%252BEntry%252Binto%252B%25255B1%25252C2%25252C3%25255DTriazolo%25255B5%25252C1-c%25255D%25255B1%25252C4%25255Dbenzoxazines%252Band%252B%25255B1%25252C2%25252C3%25255DTriazolo%25255B5%25252C1-c%25255D%25255B1%25252C4%25255Dbenzoxazepines%26aulast%3DBudeev%26aufirst%3DAnton%2BV.%26date%3D2021%26date%3D2021%26volume%3D53%26issue%3D12%26spage%3D2155%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh J.  Gharpure</span>, <span class="hlFld-ContribAuthor ">Sudi  Naveen</span>, <span class="hlFld-ContribAuthor ">Rupali S.  Chavan</span>, <span class="hlFld-ContribAuthor ">Padmaja</span>. </span><span class="cited-content_cbyCitation_article-title">Regioselective Synthesis of Halotriazoles and their Utility in Metal Catalyzed Coupling Reactions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (44)
                                     , 6870-6886. <a href="https://doi.org/10.1002/ejoc.202000973" title="DOI URL">https://doi.org/10.1002/ejoc.202000973</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202000973&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202000973%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRegioselective%252BSynthesis%252Bof%252BHalotriazoles%252Band%252Btheir%252BUtility%252Bin%252BMetal%252BCatalyzed%252BCoupling%252BReactions%26aulast%3DGharpure%26aufirst%3DSantosh%2BJ.%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D44%26spage%3D6870%26epage%3D6886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ali  Sharifi</span>, <span class="hlFld-ContribAuthor ">Maryam  Moazami</span>, <span class="hlFld-ContribAuthor ">M. Saeed  Abaee</span>, <span class="hlFld-ContribAuthor ">Mojtaba  Mirzaei</span>. </span><span class="cited-content_cbyCitation_article-title">[Omim]Cl/FeCl3-catalyzed cross-dehydrogenative-coupling of 1,4-benzoxazinones with various indoles. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Iranian Chemical Society</span><span> <strong>2020,</strong> <em>17 </em>
                                    (10)
                                     , 2471-2480. <a href="https://doi.org/10.1007/s13738-020-01941-y" title="DOI URL">https://doi.org/10.1007/s13738-020-01941-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13738-020-01941-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13738-020-01941-y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Iranian%2520Chemical%2520Society%26atitle%3D%25255BOmim%25255DCl%25252FFeCl3-catalyzed%252Bcross-dehydrogenative-coupling%252Bof%252B1%25252C4-benzoxazinones%252Bwith%252Bvarious%252Bindoles%26aulast%3DSharifi%26aufirst%3DAli%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D10%26spage%3D2471%26epage%3D2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadezhda M.  Vitkovskaya</span>, <span class="hlFld-ContribAuthor ">Alexander S.  Bobkov</span>, <span class="hlFld-ContribAuthor ">Svetlana V.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">Victoriya S.  Shcherbakova</span>, <span class="hlFld-ContribAuthor ">Andrey V.  Ivanov</span>. </span><span class="cited-content_cbyCitation_article-title">Base‐Promoted Formation of an Annelated Pyrrolo‐1,4‐oxazine Ensemble from 1
              H
              ‐pyrrol‐2‐ylmethanol and Propargyl Chloride: A Theoretical and Experimental Study. </span><span class="cited-content_cbyCitation_journal-name">ChemPlusChem</span><span> <strong>2020,</strong> <em>85 </em>
                                    (1)
                                     , 88-100. <a href="https://doi.org/10.1002/cplu.201900407" title="DOI URL">https://doi.org/10.1002/cplu.201900407</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cplu.201900407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcplu.201900407%26sid%3Dliteratum%253Aachs%26jtitle%3DChemPlusChem%26atitle%3DBase%2525E2%252580%252590Promoted%252BFormation%252Bof%252Ban%252BAnnelated%252BPyrrolo%2525E2%252580%2525901%25252C4%2525E2%252580%252590oxazine%252BEnsemble%252Bfrom%252B1%252BH%252B%2525E2%252580%252590pyrrol%2525E2%252580%2525902%2525E2%252580%252590ylmethanol%252Band%252BPropargyl%252BChloride%25253A%252BA%252BTheoretical%252Band%252BExperimental%252BStudy%26aulast%3DVitkovskaya%26aufirst%3DNadezhda%2BM.%26date%3D2020%26date%3D2019%26volume%3D85%26issue%3D1%26spage%3D88%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">György  Hajós</span>, <span class="hlFld-ContribAuthor ">Zsuzsanna  Riedl</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems With One Bridgehead Nitrogen Atom: Four Extra Heteroatoms 3:1 and 1:3. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14941-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14941-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14941-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14941-8%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%252BWith%252BOne%252BBridgehead%252BNitrogen%252BAtom%25253A%252BFour%252BExtra%252BHeteroatoms%252B3%25253A1%252Band%252B1%25253A3%26aulast%3DHaj%25C3%25B3s%26aufirst%3DGy%25C3%25B6rgy%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">Yanming  Zhang</span>, <span class="hlFld-ContribAuthor ">Xia  Du</span>, <span class="hlFld-ContribAuthor ">Teng  Ding</span>, <span class="hlFld-ContribAuthor ">Weiling  Gong</span>, <span class="hlFld-ContribAuthor ">Feng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>120 </em>, 109408. <a href="https://doi.org/10.1016/j.biopha.2019.109408" title="DOI URL">https://doi.org/10.1016/j.biopha.2019.109408</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2019.109408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2019.109408%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DReview%252Bof%252Bantidepressants%252Bin%252Bclinic%252Band%252Bactive%252Bingredients%252Bof%252Btraditional%252BChinese%252Bmedicine%252Btargeting%252B5-HT1A%252Breceptors%26aulast%3DWang%26aufirst%3DLe%26date%3D2019%26volume%3D120%26spage%3D109408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Costantino</span>, <span class="hlFld-ContribAuthor ">Daniela  Barlocco</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Approaches to Multitarget Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 161-205. <a href="https://doi.org/10.1002/9783527674381.ch7" title="DOI URL">https://doi.org/10.1002/9783527674381.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527674381.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527674381.ch7%26sid%3Dliteratum%253Aachs%26atitle%3DDesigning%252BApproaches%252Bto%252BMultitarget%252BDrugs%26aulast%3DCostantino%26aufirst%3DLuca%26date%3D2017%26date%3D2017%26spage%3D161%26epage%3D205%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DDrug%252BSelectivity%26aulast%3DHandler%26aufirst%3DNorbert%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingling  Lu</span>, <span class="hlFld-ContribAuthor ">Pan  Zhou</span>, <span class="hlFld-ContribAuthor ">Biao  Hu</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>, <span class="hlFld-ContribAuthor ">Fuchao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">An improved Pfitzinger reaction: Eco-efficient synthesis of quinaldine-4-carboxylates by TMSCl-mediated. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (37)
                                     , 3658-3661. <a href="https://doi.org/10.1016/j.tetlet.2017.08.014" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.08.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.08.014%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Bimproved%252BPfitzinger%252Breaction%25253A%252BEco-efficient%252Bsynthesis%252Bof%252Bquinaldine-4-carboxylates%252Bby%252BTMSCl-mediated%26aulast%3DLu%26aufirst%3DLingling%26date%3D2017%26volume%3D58%26issue%3D37%26spage%3D3658%26epage%3D3661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pradeep K.  Jaiswal</span>, <span class="hlFld-ContribAuthor ">Vashundhra  Sharma</span>, <span class="hlFld-ContribAuthor ">Jaroslav  Prikhodko</span>, <span class="hlFld-ContribAuthor ">Irina V.  Mashevskaya</span>, <span class="hlFld-ContribAuthor ">Sandeep  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">“On water” ultrasound-assisted one pot efficient synthesis of functionalized 2-oxo-benzo[1,4]oxazines: First application to the synthesis of anticancer indole alkaloid, Cephalandole A. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (22)
                                     , 2077-2083. <a href="https://doi.org/10.1016/j.tetlet.2017.03.048" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.03.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.03.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.03.048%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3D%2525E2%252580%25259COn%252Bwater%2525E2%252580%25259D%252Bultrasound-assisted%252Bone%252Bpot%252Befficient%252Bsynthesis%252Bof%252Bfunctionalized%252B2-oxo-benzo%25255B1%25252C4%25255Doxazines%25253A%252BFirst%252Bapplication%252Bto%252Bthe%252Bsynthesis%252Bof%252Banticancer%252Bindole%252Balkaloid%25252C%252BCephalandole%252BA%26aulast%3DJaiswal%26aufirst%3DPradeep%2BK.%26date%3D2017%26volume%3D58%26issue%3D22%26spage%3D2077%26epage%3D2083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay L.  Chandgude</span>, <span class="hlFld-ContribAuthor ">Alexander  Dömling</span>. </span><span class="cited-content_cbyCitation_article-title">Convergent Three-Component Tetrazole Synthesis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (14)
                                     , 2383-2387. <a href="https://doi.org/10.1002/ejoc.201600317" title="DOI URL">https://doi.org/10.1002/ejoc.201600317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600317%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConvergent%252BThree-Component%252BTetrazole%252BSynthesis%26aulast%3DChandgude%26aufirst%3DAjay%2BL.%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D14%26spage%3D2383%26epage%3D2387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moira L.  Bode</span>, <span class="hlFld-ContribAuthor ">David  Gravestock</span>, <span class="hlFld-ContribAuthor ">Amanda L.  Rousseau</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Reactions and Uses of Isocyanides in Organic Synthesis. An Update. </span><span class="cited-content_cbyCitation_journal-name">Organic Preparations and Procedures International</span><span> <strong>2016,</strong> <em>48 </em>
                                    (2)
                                     , 89-221. <a href="https://doi.org/10.1080/00304948.2016.1138072" title="DOI URL">https://doi.org/10.1080/00304948.2016.1138072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00304948.2016.1138072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00304948.2016.1138072%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Preparations%2520and%2520Procedures%2520International%26atitle%3DSynthesis%25252C%252BReactions%252Band%252BUses%252Bof%252BIsocyanides%252Bin%252BOrganic%252BSynthesis.%252BAn%252BUpdate%26aulast%3DBode%26aufirst%3DMoira%2BL.%26date%3D2016%26date%3D2016%26volume%3D48%26issue%3D2%26spage%3D89%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">MUTHUPANDI  NAGARAJ</span>, <span class="hlFld-ContribAuthor ">SHANMUGAM  MUTHUSUBRAMANIAN</span>. </span><span class="cited-content_cbyCitation_article-title">Transition metal-free, base-promoted hydroalkoxylation: Synthesis of substituted imidazo[2,1-c][1,4]oxazines. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2016,</strong> <em>128 </em>
                                    (3)
                                     , 451-458. <a href="https://doi.org/10.1007/s12039-016-1045-9" title="DOI URL">https://doi.org/10.1007/s12039-016-1045-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-016-1045-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-016-1045-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DTransition%252Bmetal-free%25252C%252Bbase-promoted%252Bhydroalkoxylation%25253A%252BSynthesis%252Bof%252Bsubstituted%252Bimidazo%25255B2%25252C1-c%25255D%25255B1%25252C4%25255Doxazines%26aulast%3DNAGARAJ%26aufirst%3DMUTHUPANDI%26date%3D2016%26date%3D2016%26volume%3D128%26issue%3D3%26spage%3D451%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>, <span class="hlFld-ContribAuthor ">Garima  Verma</span>, <span class="hlFld-ContribAuthor ">Akranth  Marella</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Sharba  Tasneem</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>. </span><span class="cited-content_cbyCitation_article-title">Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>102 </em>, 487-529. <a href="https://doi.org/10.1016/j.ejmech.2015.07.026" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.026%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPiperazine%252Bscaffold%25253A%252BA%252Bremarkable%252Btool%252Bin%252Bgeneration%252Bof%252Bdiverse%252Bpharmacological%252Bagents%26aulast%3DShaquiquzzaman%26aufirst%3DMohammad%26date%3D2015%26volume%3D102%26spage%3D487%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert A.  Comley</span>, <span class="hlFld-ContribAuthor ">Jasper  van der Aart</span>, <span class="hlFld-ContribAuthor ">Balázs  Gulyás</span>, <span class="hlFld-ContribAuthor ">Martine  Garnier</span>, <span class="hlFld-ContribAuthor ">Laura  Iavarone</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Eugenii A.  Rabiner</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2015,</strong> <em>92 </em>, 44-48. <a href="https://doi.org/10.1016/j.neuropharm.2014.11.017" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2014.11.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2014.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2014.11.017%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DIn%2525C2%2525A0vivo%252Boccupancy%252Bof%252Bthe%252B5-HT1A%252Breceptor%252Bby%252Ba%252Bnovel%252Bpan%252B5-HT1%252528A%25252FB%25252FD%252529%252Breceptor%252Bantagonist%25252C%252BGSK588045%25252C%252Busing%252Bpositron%252Bemission%252Btomography%26aulast%3DComley%26aufirst%3DRobert%2BA.%26date%3D2015%26volume%3D92%26spage%3D44%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mrityunjaya  Asthana</span>, <span class="hlFld-ContribAuthor ">Ritush  Kumar</span>, <span class="hlFld-ContribAuthor ">Tanu  Gupta</span>, <span class="hlFld-ContribAuthor ">Radhey M.  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Facile synthesis of functionalized 1H-pyrrolo[2,3-b]quinolines via Ugi four-component reaction followed by Cu-catalyzed aryl-amide, C–N bond coupling. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2015,</strong> <em>56 </em>
                                    (7)
                                     , 907-912. <a href="https://doi.org/10.1016/j.tetlet.2014.12.140" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.12.140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.12.140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.12.140%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DFacile%252Bsynthesis%252Bof%252Bfunctionalized%252B1H-pyrrolo%25255B2%25252C3-b%25255Dquinolines%252Bvia%252BUgi%252Bfour-component%252Breaction%252Bfollowed%252Bby%252BCu-catalyzed%252Baryl-amide%25252C%252BC%2525E2%252580%252593N%252Bbond%252Bcoupling%26aulast%3DAsthana%26aufirst%3DMrityunjaya%26date%3D2015%26volume%3D56%26issue%3D7%26spage%3D907%26epage%3D912" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khac Minh Huy  Nguyen</span>, <span class="hlFld-ContribAuthor ">Leslie  Schwendimann</span>, <span class="hlFld-ContribAuthor ">Pierre  Gressens</span>, <span class="hlFld-ContribAuthor ">Martine  Largeron</span>. </span><span class="cited-content_cbyCitation_article-title">Regiospecific synthesis of neuroprotective 1,4-benzoxazine derivatives through a tandem oxidation–Diels–Alder reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (12)
                                     , 3749-3756. <a href="https://doi.org/10.1039/C5OB00049A" title="DOI URL">https://doi.org/10.1039/C5OB00049A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB00049A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB00049A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DRegiospecific%252Bsynthesis%252Bof%252Bneuroprotective%252B1%25252C4-benzoxazine%252Bderivatives%252Bthrough%252Ba%252Btandem%252Boxidation%2525E2%252580%252593Diels%2525E2%252580%252593Alder%252Breaction%26aulast%3DNguyen%26aufirst%3DKhac%2BMinh%2BHuy%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D12%26spage%3D3749%26epage%3D3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Kurhade</span>, <span class="hlFld-ContribAuthor ">Parimi Atchuta  Ramaiah</span>, <span class="hlFld-ContribAuthor ">Philip  Prathipati</span>, <span class="hlFld-ContribAuthor ">Debnath  Bhuniya</span>. </span><span class="cited-content_cbyCitation_article-title">Unprecedented N→C[1,4] Boc migration: synthesis of 3-carboxyl functionalized 7-azaindolo[2,1-c][1,4]benzoxazine ring system. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (4)
                                     , 1354-1362. <a href="https://doi.org/10.1016/j.tet.2012.11.073" title="DOI URL">https://doi.org/10.1016/j.tet.2012.11.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2012.11.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2012.11.073%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DUnprecedented%252BN%2525E2%252586%252592C%25255B1%25252C4%25255D%252BBoc%252Bmigration%25253A%252Bsynthesis%252Bof%252B3-carboxyl%252Bfunctionalized%252B7-azaindolo%25255B2%25252C1-c%25255D%25255B1%25252C4%25255Dbenzoxazine%252Bring%252Bsystem%26aulast%3DKurhade%26aufirst%3DSantosh%26date%3D2013%26volume%3D69%26issue%3D4%26spage%3D1354%26epage%3D1362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aiping  Huang</span>, <span class="hlFld-ContribAuthor ">Huanhuan  Liu</span>, <span class="hlFld-ContribAuthor ">Chen  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of 6H-benzo[b]benzo[4,5]imidazo[1,2-d][1,4]oxazines via a copper-catalyzed process. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2013,</strong> <em>3 </em>
                                    (33)
                                     , 13976. <a href="https://doi.org/10.1039/c3ra42108b" title="DOI URL">https://doi.org/10.1039/c3ra42108b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra42108b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra42108b%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B6H-benzo%25255Bb%25255Dbenzo%25255B4%25252C5%25255Dimidazo%25255B1%25252C2-d%25255D%25255B1%25252C4%25255Doxazines%252Bvia%252Ba%252Bcopper-catalyzed%252Bprocess%26aulast%3DHuang%26aufirst%3DAiping%26date%3D2013%26volume%3D3%26issue%3D33%26spage%3D13976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanyi  Jin</span>, <span class="hlFld-ContribAuthor ">Jian  Zhang</span>, <span class="hlFld-ContribAuthor ">Dan  Fu</span>, <span class="hlFld-ContribAuthor ">Jingjing  Wu</span>, <span class="hlFld-ContribAuthor ">Song  Cao</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot, Three-Component Synthesis of 1,4,5-Trisubstituted 1,2,3-Triazoles Starting from Primary Alcohols. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>2012 </em>
                                    (28)
                                     , 5446-5449. <a href="https://doi.org/10.1002/ejoc.201200830" title="DOI URL">https://doi.org/10.1002/ejoc.201200830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201200830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201200830%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne-Pot%25252C%252BThree-Component%252BSynthesis%252Bof%252B1%25252C4%25252C5-Trisubstituted%252B1%25252C2%25252C3-Triazoles%252BStarting%252Bfrom%252BPrimary%252BAlcohols%26aulast%3DJin%26aufirst%3DGuanyi%26date%3D2012%26date%3D2012%26volume%3D2012%26issue%3D28%26spage%3D5446%26epage%3D5449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip G.  Agalave</span>, <span class="hlFld-ContribAuthor ">Suleman R.  Maujan</span>, <span class="hlFld-ContribAuthor ">Vandana S.  Pore</span>. </span><span class="cited-content_cbyCitation_article-title">Click Chemistry: 1,2,3-Triazoles as Pharmacophores. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - An Asian Journal</span><span> <strong>2011,</strong> <em>6 </em>
                                    (10)
                                     , 2696-2718. <a href="https://doi.org/10.1002/asia.201100432" title="DOI URL">https://doi.org/10.1002/asia.201100432</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/asia.201100432&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fasia.201100432%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520An%2520Asian%2520Journal%26atitle%3DClick%252BChemistry%25253A%252B1%25252C2%25252C3-Triazoles%252Bas%252BPharmacophores%26aulast%3DAgalave%26aufirst%3DSandip%2BG.%26date%3D2011%26date%3D2011%26volume%3D6%26issue%3D10%26spage%3D2696%26epage%3D2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donn G.  Wishka</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Walker</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (±)-6-oxa-3-azabicyclo[3.1.1]heptan-2-thione: a potential synthon for the preparation of novel heteroaryl-annulated bicyclic morpholines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (37)
                                     , 4713-4715. <a href="https://doi.org/10.1016/j.tetlet.2011.07.017" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528%2525C2%2525B1%252529-6-oxa-3-azabicyclo%25255B3.1.1%25255Dheptan-2-thione%25253A%252Ba%252Bpotential%252Bsynthon%252Bfor%252Bthe%252Bpreparation%252Bof%252Bnovel%252Bheteroaryl-annulated%252Bbicyclic%252Bmorpholines%26aulast%3DWishka%26aufirst%3DDonn%2BG.%26date%3D2011%26volume%3D52%26issue%3D37%26spage%3D4713%26epage%3D4715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Kurhade</span>, <span class="hlFld-ContribAuthor ">Rahul D.  Kaduskar</span>, <span class="hlFld-ContribAuthor ">Bhavesh  Dave</span>, <span class="hlFld-ContribAuthor ">Parimi Atchuta  Ramaiah</span>, <span class="hlFld-ContribAuthor ">Venkata P.  Palle</span>, <span class="hlFld-ContribAuthor ">Debnath  Bhuniya</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a novel tetracyclic azaindolo[2,1-c][1,4]benzoxazine ring system. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (16)
                                     , 1874-1877. <a href="https://doi.org/10.1016/j.tetlet.2011.02.020" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.02.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.02.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.02.020%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Ba%252Bnovel%252Btetracyclic%252Bazaindolo%25255B2%25252C1-c%25255D%25255B1%25252C4%25255Dbenzoxazine%252Bring%252Bsystem%26aulast%3DKurhade%26aufirst%3DSantosh%26date%3D2011%26volume%3D52%26issue%3D16%26spage%3D1874%26epage%3D1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chinmay  Chowdhury</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Biswajit  Chakraborty</span>, <span class="hlFld-ContribAuthor ">Basudeb  Achari</span>. </span><span class="cited-content_cbyCitation_article-title">A rapid and facile method for the general synthesis of 3-aryl substituted 4,5,6,7-tetrahydro[1,2,3]triazolo[1,5-a]pyrazines and their ring fused analogues. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2011,</strong> <em>9 </em>
                                    (16)
                                     , 5856. <a href="https://doi.org/10.1039/c1ob05255a" title="DOI URL">https://doi.org/10.1039/c1ob05255a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c1ob05255a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc1ob05255a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DA%252Brapid%252Band%252Bfacile%252Bmethod%252Bfor%252Bthe%252Bgeneral%252Bsynthesis%252Bof%252B3-aryl%252Bsubstituted%252B4%25252C5%25252C6%25252C7-tetrahydro%25255B1%25252C2%25252C3%25255Dtriazolo%25255B1%25252C5-a%25255Dpyrazines%252Band%252Btheir%252Bring%252Bfused%252Banalogues%26aulast%3DChowdhury%26aufirst%3DChinmay%26date%3D2011%26volume%3D9%26issue%3D16%26spage%3D5856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Chemical structures of different series of 5-HT <sub>1A/B/D</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthetic Route for Compounds <b>6</b> and <b>7</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Lawesson’s reagent, toluene, reflux, 1 h; (b) MeI, KOH, acetone, reflux, 2 h; (c) NH<sub>2</sub>CH<sub>2</sub>CH(OMe)<sub>2</sub>, EtOH, reflux, 9 h; (d) conc HCl, MeOH, reflux, 3 h; (e) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N</i>-oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) aq Na<sub>2</sub>SO<sub>3</sub>, room temp, 30 min; (f) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (g) NaH, 1-chloro-2-propanone, DMF, 0 °C to room temp, 7 h; (h) NH<sub>4</sub>OAc, AcOH, microwave 150 °C, 10 min; (i) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compounds <b>8</b> and <b>9</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3-Chloro-2-butanone, K<sub>2</sub>CO<sub>3</sub>, acetone, reflux, 4 h; (b) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (c) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (d) NH<sub>4</sub>OAc, AcOH, microwave 150 °C, 10 min; (e) NaH, methyl bromoacetate, DMF, 0 °C to room temp, 6 h; (f) NaOH, MeOH, room temp, 4 h; (g) (i) oxalyl chloride, DMF, toluene, 60 °C, 3 h; (ii) trifluoroacetic anhydride, pyridine, room temp, 2 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthetic Route for Compounds <b>10</b>, <b>14</b>, <b>17</b>, and <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) KO<sup>t</sup>Bu, diethyl chlorophosphate, DMF, 0 °C, 10 min then ethyl isocyanoacetate, 60 °C, 6 h; (b) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (c) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (d) NaOH, MeOH, 60 °C, 30 min; (e) 1,2-dichlorobenzene, microwave 250 °C, 10 min; (f) HOBT, EDC, NHR<sub>1</sub>R<sub>2</sub>, DMF/CH<sub>2</sub>Cl<sub>2</sub>, room temp, 4 h; (g) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N-</i>oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) NaIO<sub>4</sub>, THF/H<sub>2</sub>O, room temp, 1 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route for Compound <b>15</b>−<b>16</b>, <b>18−19</b>, <b>21</b>−<b>23</b>, and <b>25</b>−<b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NaOH, MeOH/H<sub>2</sub>O, microwave 120 °C, 5 min; (b) DIPEA, TBTU, hexamethyldisilazane, DMF, room temp, 1 h; (c) (CF<sub>3</sub>)<sub>2</sub>CO, pyridine/THF, 0 °C, 1 h; (d) DIPEA, TBTU, NHR<sub>1</sub>R<sub>2</sub>, DMF, room temp, 1 h; (e) DIPEA, TBTU, NHMeOMe·HCl, DMF, room temp, 1 h; (f) MeMgBr, THF, 0 °C, 1 h; (g) NH<sub>2</sub>OMe·HCl, pyridine/EtOH, reflux, 2 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Route for Compounds <b>11</b> and <b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) NH<sub>2</sub>NH<sub>2</sub>·H<sub>2</sub>O, EtOH, 80 °C, 2 h; (b) MeC(OMe)<sub>3</sub>, microwave 150 °C, 10 min; (c) (i) OsO<sub>4</sub>, 4-methylmorpholine <i>N</i>-oxide, acetone/H<sub>2</sub>O, room temp, 36 h; (ii) NaIO<sub>4</sub>, THF/H<sub>2</sub>O, room temp, 1 h; (d) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h; (e) NaNO<sub>2</sub>, aq HCl, 5 °C, 4 h; (f) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route for Compound <b>12</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) K<sub>2</sub>CO<sub>3</sub>, 1-bromo-2-butyne, acetone, reflux, 4 h; (b) Fe powder, AcOH, room temp, 16 h; (c) (i) NaNO<sub>2</sub>, aq HCl, 0 °C, 30 min; (ii) NaN<sub>3</sub>, H<sub>2</sub>O, 5 °C, 30 min; (d) toluene, reflux, 2.5 h; (e) OsO<sub>4</sub>, NaIO<sub>4</sub>, THF/water, room temp, 2 h; (f) 2-methyl-5-piperazin-1-ylquinoline, 1,2-dichloroethane, NaB(OAc)<sub>3</sub>H, room temp, 3 h.</p></p></figure><figure data-id="fig2" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect of <b>20</b> on 8-OH-DPAT-induced hyperlocomotion in rat. Data represent mean ± SEM of 8 animals per group; * <i>p</i> < 0.05, ** <i>p</i> < 0.01, ANOVA for completely randomized measures versus 8-OH-DPAT group, followed by Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>20</b> on SKF-99101H-induced hypothermia in guinea pig. Data represent mean ± SEM of 8 animals per group; ** = <i>p</i> < 0.01, ANOVA for completely randomized measures versus vehicle treated animals, followed by Dunnett’s test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/medium/jm-2010-00482n_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Occupancy at 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptors by <b>20</b> in guinea pig cortex together with brain and plasma exposure.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-15/jm100482n/production/images/large/jm-2010-00482n_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100482n&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i85">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02462" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02462" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hirschfeld, R. M. A.</span><span> </span><span class="NLM_article-title">History and evolution of the monoamine hypothesis of depression</span> <span class="citation_source-journal">J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 6</span><span class="NLM_x">) </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=10775017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2000&pages=4-6&issue=Suppl.+6&author=R.+M.+A.+Hirschfeld&title=History+and+evolution+of+the+monoamine+hypothesis+of+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">History and evolution of the monoamine hypothesis of depression</span></div><div class="casAuthors">Hirschfeld, Robert M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychiatry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 6</span>),
    <span class="NLM_cas:pages">4-6</span>CODEN:
                <span class="NLM_cas:coden">JCLPDE</span>;
        ISSN:<span class="NLM_cas:issn">0160-6689</span>.
    
            (<span class="NLM_cas:orgname">Physicians Postgraduate Press, Inc.</span>)
        </div><div class="casAbstract">A review, with 24 refs.  The symptoms of depression can be improved by agents that act by various mechanisms to increase synaptic concns. of monoamines.  This finding led to the adoption of the monoamine hypothesis of depression, first put forward over 30 yr ago, which proposes that the underlying biol. or neuroanatomical basis for depression is a deficiency of central noradrenergic and/or serotonergic systems and that targeting this neuronal lesion with an antidepressant would tend to restore normal function in depressed patients.  The hypothesis has enjoyed considerable support, since it attempts to provide a pathophysiol. explanation of the actions of antidepressants.  However, in its original form it is clearly inadequate, as it does not provide a complete explanation for the actions of antidepressants, and the pathophysiol. of depression itself remains unknown.  The hypothesis has evolved over the years to include, for example, adaptive changes in receptors to explain why there should be only a gradual clin. response to antidepressant treatment when the increase in availability of monoamines is rapid.  Still, the monoamine hypothesis does not address key issues such as why antidepressants are also effective in other disorders such as panic disorder, obsessive-compulsive disorder, and bulimia, or why all drugs that enhance serotonergic or noradrenergic transmission are not necessarily effective in depression.  Despite these limitations, however, it is clear that the development of the monoamine hypothesis has been of great importance in understanding depression and in the development of safe and effective pharmacol. agents for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZF-M-PX4Qp7Vg90H21EOLACvtfcHk0li2JtsYlUCwAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjtV2itL4%253D&md5=0bddf7611fade8f2fd1148ec216066f2</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHirschfeld%26aufirst%3DR.%2BM.%2BA.%26atitle%3DHistory%2520and%2520evolution%2520of%2520the%2520monoamine%2520hypothesis%2520of%2520depression%26jtitle%3DJ.%2520Clin.%2520Psychiatry%26date%3D2000%26volume%3D61%26issue%3DSuppl.%25206%26spage%3D4%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lucki, I.</span><span> </span><span class="NLM_article-title">The spectrum of behaviors influenced by serotonin</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0006-3223%2898%2900139-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=9693387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1998&pages=151-162&author=I.+Lucki&title=The+spectrum+of+behaviors+influenced+by+serotonin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The spectrum of behaviors influenced by serotonin</span></div><div class="casAuthors">Lucki, Irwin</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">151-162</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with 110 refs., on the diverse array of behavioral effects of serotonin form the basis for understanding its potential role as an etiol. marker in psychiatric disorders and for the successful pharmacol. intervention of drugs regulating serotonin neurotransmission in behavior.  General theories of the behavioral functions of serotonin have implicated serotonin as a general inhibitor of behavioral responding and in modulating motor behavior.  The ability of serotonin to regulate behavioral satiety and macronutrient selection provides the basis for pharmacol. treatment of obesity and eating disorders.  The role of serotonin in behavioral suppression may be important in social behavior involving aggression and anxiety.  The role of serotonin in neuroendocrine regulation provides a basis for understanding serotonin dysregulation in depression.  Animal behavior tests are being used to better understand the neural substrates underlying the behavioral effects of antidepressant drugs and to address important issues in clin. treatment.  The integration of information between basic and clin. studies provides the basis for future development of more sophisticated pharmacol. treatments of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGHI5Ew2l3Y7Vg90H21EOLACvtfcHk0li2JtsYlUCwAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsVOhsb8%253D&md5=888b9d7d85a45ed3e65e0ef718b5b288</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0006-3223%2898%2900139-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3223%252898%252900139-5%26sid%3Dliteratum%253Aachs%26aulast%3DLucki%26aufirst%3DI.%26atitle%3DThe%2520spectrum%2520of%2520behaviors%2520influenced%2520by%2520serotonin%26jtitle%3DBiol.%2520Psychiatry%26date%3D1998%26volume%3D44%26spage%3D151%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Naughton, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulrooney, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, B. E.</span><span> </span><span class="NLM_article-title">A review of the role of serotonin receptors in psychiatric disorders</span> <span class="citation_source-journal">Human Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">397</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12404302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2000&pages=397-415&author=M+Naughtonauthor=J.+B.+Mulrooneyauthor=B.+E.+Leonard&title=A+review+of+the+role+of+serotonin+receptors+in+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">A review of the role of serotonin receptors in psychiatric disorders</span></div><div class="casAuthors">Naughton, Marie; Mulrooney, Jane B.; Leonard, Brian E.</div><div class="citationInfo"><span class="NLM_cas:title">Human Psychopharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">397-415</span>CODEN:
                <span class="NLM_cas:coden">HUPSEC</span>;
        ISSN:<span class="NLM_cas:issn">0885-6222</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review with many refs.  Serotonin (5-hydroxytryptamine, 5-HT) mediates a wide variety of physiol. functions by activating multiple receptors, and abnormalities of these receptor systems was implicated in many psychiatric disorders including anxiety, depression, psychosis, migraine, disorders of sexual functioning, sleep, cognition, and feeding.  Many of the currently used treatments for these disorders act by affecting the serotonergic system.  Observation of serotonin receptor alterations, before and following effective treatments, may yield important insights into the etiol. of these psychiatric disorders and may ultimately lead to more selective and effective therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEhSNrDcM0h7Vg90H21EOLACvtfcHk0lgi5lwCMrW-pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntFCiurw%253D&md5=18be55930836492c6f605103ea4cc7b1</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1002%2F1099-1077%28200008%2915%3A6%3C397%3A%3AAID-HUP212%3E3.0.CO%3B2-L&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F1099-1077%2528200008%252915%253A6%253C397%253A%253AAID-HUP212%253E3.0.CO%253B2-L%26sid%3Dliteratum%253Aachs%26aulast%3DNaughton%26aufirst%3DM%26aulast%3DMulrooney%26aufirst%3DJ.%2BB.%26aulast%3DLeonard%26aufirst%3DB.%2BE.%26atitle%3DA%2520review%2520of%2520the%2520role%2520of%2520serotonin%2520receptors%2520in%2520psychiatric%2520disorders%26jtitle%3DHuman%2520Psychopharmacol.%26date%3D2000%26volume%3D15%26spage%3D397%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Vaswani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linda, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramesh, S.</span><span> </span><span class="NLM_article-title">Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review</span> <span class="citation_source-journal">Prog. Neuro-Psychopharm. Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">85</span><span class="NLM_x">–</span> <span class="NLM_lpage">102</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0278-5846%2802%2900338-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12551730" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsFakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2003&pages=85-102&author=M.+Vaswaniauthor=F.+K.+Lindaauthor=S.+Ramesh&title=Role+of+selective+serotonin+reuptake+inhibitors+in+psychiatric+disorders%3A+a+comprehensive+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review</span></div><div class="casAuthors">Vaswani, Meera; Linda, Farzana Kadar; Ramesh, Subramanyam</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">85-102</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The selective serotonin reuptake inhibitors (SSRIs) have emerged as a major therapeutic advance in psychopharmacol.  As a result, the discovery of these agents marks a milestone in neuropsychopharmacol. and rational drug design, and has launched a new era in psychotropic drug development.  Prior to the SSRIs, all psychotropic medications were the result of chance observation.  In an attempt to develop a SSRI, researchers discovered a no. of nontricyclic agents with amine-uptake inhibitory properties, acting on both noradrenergic and serotonergic neurons with considerable differences in potency.  A given drug may affect one or more sites over its clin. relevant dosing range and may produce multiple and different clin. effects.  The enhanced safety profile includes a reduced likelihood of pharmacodynamically mediated adverse drug-drug interactions by avoiding affects on sites that are not essential to the intended outcome.  SSRIs were developed for inhibition of the neuronal uptake pump for serotonin (5-HT), a property shared with the TCAs, but without affecting the other various neuroreceptors or fast sodium channels.  The therapeutic mechanism of action of SSRIs involves alteration in the 5-HT system.  The plethora of biol. substrates, receptors and pathways for 5-HT are candidates to mediate not only the therapeutic actions of SSRIs, but also their side effects.  A hypothesis to explain these immediate side effects is that 5-HT is increased at specific 5-HT receptor subtypes in discrete regions of the body where the relevant physiol. processes are regulated.  Marked differences exist between the SSRIs with regard to effects on specific cytochrome P 450 (CYP) enzymes, and thus the likelihood of clin. important pharmacokinetic drug-drug interactions.  Although no clear relationship exists between the clin. efficacy, plasma concn. of SSRIs, nor any threshold that defines toxic concns., but therapeutic drug monitoring (TDM) may be useful in special populations, such as in elderly patients, poor metabolizers (PM) of sparteine (CYP2D6) or mephenytoin (CYP2C19), and patients with liver and kidney impairment.  Several meta-analyses have reviewed the comparative efficacy of TCAs and SSRIs, and concluded that both TCAs and SSRIs have similar efficacy in the treatment of depression.  SSRIs have demonstrated better efficacy and tolerability in the treatment of obsessive compulsive disorder (OCD).  They have also been found to be effective in the treatment for social anxiety disorder both in reducing total levels of social anxiety and in improving overall clin. condition.  The benefit of SSRIs in anorexia nervosa (AN) is apparently short-term unless medication is given in the context of nutritional or behavioral therapy.  No single antidepressant can ever be recommended for every patient, but in a vast majority of patients, SSRIs should be considered as one of the first-line drugs in the treatment of depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr4vX5ZOlhe7Vg90H21EOLACvtfcHk0lgi5lwCMrW-pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsFakuw%253D%253D&md5=d54426dbfceb38e9808ab7ca5faaaa07</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0278-5846%2802%2900338-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0278-5846%252802%252900338-X%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DM.%26aulast%3DLinda%26aufirst%3DF.%2BK.%26aulast%3DRamesh%26aufirst%3DS.%26atitle%3DRole%2520of%2520selective%2520serotonin%2520reuptake%2520inhibitors%2520in%2520psychiatric%2520disorders%253A%2520a%2520comprehensive%2520review%26jtitle%3DProg.%2520Neuro-Psychopharm.%2520Biol.%2520Psychiatry%26date%3D2003%26volume%3D27%26spage%3D85%26epage%3D102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Therapeutic potential of serotonin antagonists in depressive disorders</span> <span class="citation_source-journal">Exp. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">467</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2002&pages=457-467&author=M.+D.+Woodauthor=D.+R.+Thomasauthor=J.+M.+Watson&title=Therapeutic+potential+of+serotonin+antagonists+in+depressive+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DM.%2BD.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DTherapeutic%2520potential%2520of%2520serotonin%2520antagonists%2520in%2520depressive%2520disorders%26jtitle%3DExp.%2520Opin.%2520Invest.%2520Drugs%26date%3D2002%26volume%3D11%26spage%3D457%26epage%3D467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Blier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Montigny, C.</span><span> </span><span class="NLM_article-title">Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">98S</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=1999&pages=91-98S&author=P.+Blierauthor=C.+De+Montigny&title=Serotonin+and+drug-induced+therapeutic+responses+in+major+depression%2C+obsessive-compulsive+and+panic+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlier%26aufirst%3DP.%26aulast%3DDe%2BMontigny%26aufirst%3DC.%26atitle%3DSerotonin%2520and%2520drug-induced%2520therapeutic%2520responses%2520in%2520major%2520depression%252C%2520obsessive-compulsive%2520and%2520panic%2520disorders%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D21%26spage%3D91%26epage%3D98S" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Beyer, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boikess, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in vivo microdialysis study</span> <span class="citation_source-journal">J. Psychopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1177%2F026988110201600403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=12503828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2002&pages=297-304&author=C.+E.+Beyerauthor=S.+Boikessauthor=B.+Luoauthor=L.+A.+Dawson&title=Comparison+of+the+effects+of+antidepressants+on+norepinephrine+and+serotonin+concentrations+in+the+rat+frontal+cortex%3A+an+in+vivo+microdialysis+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study</span></div><div class="casAuthors">Beyer, Chad E.; Boikess, Steve; Luo, Bin; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Psychopharmacology (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">297-304</span>CODEN:
                <span class="NLM_cas:coden">JOPSEQ</span>;
        ISSN:<span class="NLM_cas:issn">0269-8811</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">The present study employed in-vivo microdialysis techniques in the freely moving rat to systematically compare the neurochem. effects of various antidepressant agents on extracellular concns. of norepinephrine (NE) and serotonin (5-HT) in the frontal cortex.  We found that acute administration of the tricyclic antidepressant, desipramine (3-30 mg/kg, s.c.) and the dual serotonin/norepinephrine reuptake inhibitor, venlafaxine (3-30 mg/kg, s.c.), produced dose-dependent and robust increases in cortical NE concns. (498% and 403%, resp.).  Conversely, acute injection of the selective serotonin reuptake inhibitors, fluoxetine (30 mg/kg, s.c.) and paroxetine (1-10 mg/kg, s.c.), did not alter forebrain NE concns.  However, paroxetine did produce a significant increase in cortical NE concns. (164%) when administered at 30 mg/kg.  These changes in NE were not paralleled by 5-HT, which showed no increase following administration of desipramine, venlafaxine, paroxetine or fluoxetine.  Combination treatment with the 5-HT1A receptor antagonist, WAY-100635 (0.3 mg/kg, s.c.), significantly enhanced extracellular 5-HT concns. following venlafaxine (10 and 30 mg/kg), fluoxetine (30 mg/kg) and paroxetine (3-30 mg/kg).  Alternatively, WAY-100635 produced no augmentation of the antidepressant-induced changes in extracellular NE.  Collectively, these studies show that paroxetine, at low to intermediate doses, and fluoxetine are selective for 5-HT vs. NE systems, whereas venlafaxine produces similar effects on both 5-HT and NE levels at the EDs tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqKBQ9tr1B2rVg90H21EOLACvtfcHk0liDqQQSqNY5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlvFarsw%253D%253D&md5=a1675211169ec4b13feb6ae7e5803f64</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1177%2F026988110201600403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F026988110201600403%26sid%3Dliteratum%253Aachs%26aulast%3DBeyer%26aufirst%3DC.%2BE.%26aulast%3DBoikess%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DComparison%2520of%2520the%2520effects%2520of%2520antidepressants%2520on%2520norepinephrine%2520and%2520serotonin%2520concentrations%2520in%2520the%2520rat%2520frontal%2520cortex%253A%2520an%2520in%2520vivo%2520microdialysis%2520study%26jtitle%3DJ.%2520Psychopharm.%26date%3D2002%26volume%3D16%26spage%3D297%26epage%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Roberts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Ligands for the investigation of 5-HT autoreceptor function</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0361-9230%2801%2900628-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=11750791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=463-469&author=C.+Robertsauthor=G.+W.+Priceauthor=D.+N.+Middlemiss&title=Ligands+for+the+investigation+of+5-HT+autoreceptor+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands for the investigation of 5-HT autoreceptor function</span></div><div class="casAuthors">Roberts, Claire; Price, Gary W.; Middlemiss, Derek N.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of multiple 5-HT autoreceptors in the central nervous system is now firmly established and they have been pharmacol. identified as belonging to the 5-HT1A, 5-HT1B, and 5-HT1D receptor subtypes.  In addn., 5-HT1F, 5-HT5A, and 5-HT7 receptors remain as potential candidates for addnl. autoreceptors.  The emergence of selective ligands, such as SB-224289 (5-HT1B receptor antagonist), BRL 15572 (5-HT1D receptor antagonist), GR 127935 (a mixed 5-HT1B/1D receptor antagonist), LY 334370 (5-HT1F receptor agonist), and SB-269970 (5-HT7 receptor antagonist), has aided the characterization of 5-HT autoreceptors and has highlighted the complexity of mechanisms which modulate the release of 5-HT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoh3Lk0_xEYELVg90H21EOLACvtfcHk0liDqQQSqNY5pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFylt7s%253D&md5=1b38f404662c50829d0f1d20bd313d84</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2801%2900628-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252801%252900628-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DC.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DLigands%2520for%2520the%2520investigation%2520of%25205-HT%2520autoreceptor%2520function%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2001%26volume%3D56%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arban, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span> </span><span class="NLM_article-title">5-HT autoreceptors: Pharmacological tools and therapeutic potential</span> <span class="citation_source-journal">Curr. Top. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFSitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=251-264&author=L.+A.+Dawsonauthor=Z.+A.+Hughesauthor=J.+M.+Watsonauthor=R.+Arbanauthor=G.+W.+Price&title=5-HT+autoreceptors%3A+Pharmacological+tools+and+therapeutic+potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT autoreceptors: Pharmacological tools and therapeutic potential</span></div><div class="casAuthors">Dawson, Lee A.; Hughes, Zoe A.; Watson, Jeannette M.; Arban, Roberto; Price, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-264</span>CODEN:
                <span class="NLM_cas:coden">CTPCF5</span>;
        ISSN:<span class="NLM_cas:issn">0972-4559</span>.
    
            (<span class="NLM_cas:orgname">Research Trends</span>)
        </div><div class="casAbstract">A review.  It is over 25 years since it was first suggested that presynaptic autoreceptors modulate 5-HT release.  These autoreceptors have since been subdivided into two categories: those that reside on serotonergic cell bodies and those on the fiber terminals.  The subsequent development of selective ligands led to the discovery that 5-HT autoreceptors belonged to the 5-HT1 subfamily, which is composed of 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E and 5-HT1F receptor subtypes which neg. couple to adenylyl cyclase via a no. of inhibitory G proteins.  With the advent of mol. biol. techniques these 5-HT autoreceptors have been cloned, sequenced and more fully characterized.  The interrelationship between 5-HT and depression was first alluded to in 1957, since then the role of 5-HT in the etiol. of psychiatric disorders, such as depression and anxiety has received substantial interest.  This has led to the development of a variety of selective ligands targeted at 5-HT autoreceptors as potential drug moieties for the treatment of these conditions.  Here we will review the development of these pharmacol. tools and their potential therapeutic utility in the treatment of psychiatric disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtkG6vJmp2S7Vg90H21EOLACvtfcHk0liTLteqB-XWWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFSitL8%253D&md5=ba333a6fa7ebf913730338beef542dcf</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DArban%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26atitle%3D5-HT%2520autoreceptors%253A%2520Pharmacological%2520tools%2520and%2520therapeutic%2520potential%26jtitle%3DCurr.%2520Top.%2520Pharmacol.%26date%3D2004%26volume%3D8%26spage%3D251%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Dawson, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span> </span><span class="NLM_article-title">5-HT<sub>1</sub> receptor augmentation strategies as enhanced efficacy therapeutics for psychiatric disorders</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.2174%2F156802608785161439" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=18691129" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1008-1023&author=L.+A.+Dawsonauthor=S.+M.+Bromidge&title=5-HT1+receptor+augmentation+strategies+as+enhanced+efficacy+therapeutics+for+psychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT1 receptor augmentation strategies as enhanced efficacy therapeutics for psychiatric disorders</span></div><div class="casAuthors">Dawson, Lee A.; Bromidge, Steve M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1008-1023</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the initial observations linking 5-HT to psychiatric illness, evidence for a role of 5-HT and, in particular, a decreased brain serotonergic function in the pathol. of a plethora of related disorders, has grown.  However, it is the role of 5-HT in the pathogenesis of anxiety disorders and depression and the mechanism of action of antidepressants which has received the most attention.  Thus enhanced serotonergic neurotransmission has become one of the unifying mechanisms of action of modern day antidepressants / anxiolytics such as monoamine oxidase inhibitors, tricyclic antidepressants, and serotonin reuptake inhibitors.  Interestingly all of these treatments are assocd. with a delay to therapeutic efficacy and in some cases treatment resistance, despite immediate enhancements in serotonergic neurotransmission.  The postulated reason for this is the need for temporal neuroplastic changes in the control of serotonergic neurotransmission, and more specifically changes in 5-HT1 autoreceptor function.  Thus significant research has gone into pharmacol. targeting these 5-HT1 autoreceptors as a means of augmenting the efficacy of current therapeutic mechanisms.  Here we will review the rationale behind the various augmentation strategies adopted and the progress made in identifying novel therapeutics for conditions such as depression and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMf53pfeDDRbVg90H21EOLACvtfcHk0liTLteqB-XWWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXps1OhtLc%253D&md5=d8262b01f7af300831084bdf423f5da1</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.2174%2F156802608785161439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802608785161439%26sid%3Dliteratum%253Aachs%26aulast%3DDawson%26aufirst%3DL.%2BA.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26atitle%3D5-HT1%2520receptor%2520augmentation%2520strategies%2520as%2520enhanced%2520efficacy%2520therapeutics%2520for%2520psychiatric%2520disorders%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2008%26volume%3D8%26spage%3D1008%26epage%3D1023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Atkinson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duxon, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadley, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">North, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rami, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones are 5-HT<sub>1A</sub> receptor antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">741</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=737-741&author=P.+J.+Atkinsonauthor=S.+M.+Bromidgeauthor=M.+S.+Duxonauthor=L.+M.+Gasterauthor=M.+S.+Hadleyauthor=B.+Hammondauthor=C.+N.+Johnsonauthor=D.+N.+Middlemissauthor=S.+E.+Northauthor=G.+W.+Priceauthor=H.+K.+Ramiauthor=G.+J.+Rileyauthor=C.+M.+Scottauthor=T.+E.+Shawauthor=K.+R.+Starrauthor=G.+Stempauthor=K.+M.+Thewlisauthor=D.+R.+Thomasauthor=M.+Thompsonauthor=A.+K.+K.+Vongauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+are+5-HT1A+receptor+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAtkinson%26aufirst%3DP.%2BJ.%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DDuxon%26aufirst%3DM.%2BS.%26aulast%3DGaster%26aufirst%3DL.%2BM.%26aulast%3DHadley%26aufirst%3DM.%2BS.%26aulast%3DHammond%26aufirst%3DB.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26aulast%3DNorth%26aufirst%3DS.%2BE.%26aulast%3DPrice%26aufirst%3DG.%2BW.%26aulast%3DRami%26aufirst%3DH.%2BK.%26aulast%3DRiley%26aufirst%3DG.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DShaw%26aufirst%3DT.%2BE.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DThomas%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520are%25205-HT1A%2520receptor%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D737%26epage%3D741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hughes, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Simultaneous blockade of 5-HT<sub>1A/B</sub> receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT<sub>1A/B</sub> receptor antagonist/5-HT transport inhibitor SB-649915-B</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">192</span><span class="NLM_x">, </span> <span class="NLM_fpage">121</span><span class="NLM_x">–</span> <span class="NLM_lpage">133</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2007&pages=121-133&author=Z.+A.+Hughesauthor=K.+R.+Starrauthor=C.+M.+Scottauthor=M.+J.+Newsonauthor=T.+Sharpauthor=J.+M.+Watsonauthor=J.+J.+Haganauthor=L.+A.+Dawson&title=Simultaneous+blockade+of+5-HT1A%2FB+receptors+and+5-HT+transporters+results+in+acute+increases+in+extracellular+5-HT+in+both+rats+and+guinea+pigs%3A+in+vivo+characterization+of+the+novel+5-HT1A%2FB+receptor+antagonist%2F5-HT+transport+inhibitor+SB-649915-B"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DZ.%2BA.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DNewson%26aufirst%3DM.%2BJ.%26aulast%3DSharp%26aufirst%3DT.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DSimultaneous%2520blockade%2520of%25205-HT1A%252FB%2520receptors%2520and%25205-HT%2520transporters%2520results%2520in%2520acute%2520increases%2520in%2520extracellular%25205-HT%2520in%2520both%2520rats%2520and%2520guinea%2520pigs%253A%2520in%2520vivo%2520characterization%2520of%2520the%2520novel%25205-HT1A%252FB%2520receptor%2520antagonist%252F5-HT%2520transport%2520inhibitor%2520SB-649915-B%26jtitle%3DPsychopharmacology%26date%3D2007%26volume%3D192%26spage%3D121%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodacre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">3,4-Dihydro-2<i>H</i>-benzoxazinones as dual-acting 5-HT<sub>1A</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1036</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1033-1036&author=P.+J.+Lovellauthor=F.+E.+Blaneyauthor=C.+J.+Goodacreauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=K.+M.+Thewlisauthor=A.+K.+K.+Vongauthor=S.+E.+Wardauthor=J.+M.+Watson&title=3%2C4-Dihydro-2H-benzoxazinones+as+dual-acting+5-HT1A+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DGoodacre%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%2BK.%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3D3%252C4-Dihydro-2H-benzoxazinones%2520as%2520dual-acting%25205-HT1A%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1033%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stemp, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vong, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Studies on a series of potent, orally bioavailable, 5-HT<sub>1</sub> receptor ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5214</span><span class="NLM_x">–</span> <span class="NLM_lpage">5217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5214-5217&author=S.+E.+Wardauthor=C.+N.+Johnsonauthor=P.+J.+Lovellauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=G.+Stempauthor=K.+M.+Thewlisauthor=A.+K.+Vongauthor=J.+M.+Watson&title=Studies+on+a+series+of+potent%2C+orally+bioavailable%2C+5-HT1+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStemp%26aufirst%3DG.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DVong%26aufirst%3DA.%2BK.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DStudies%2520on%2520a%2520series%2520of%2520potent%252C%2520orally%2520bioavailable%252C%25205-HT1%2520receptor%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5214%26epage%3D5217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Serafinowska, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaney, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span> </span><span class="NLM_article-title">Novel 5-HT<sub>1A/1B/1D</sub> receptors antagonists with potent 5-HT reuptake inhibitory activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5581</span><span class="NLM_x">–</span> <span class="NLM_lpage">5585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5581-5585&author=H.+T.+Serafinowskaauthor=F.+E.+Blaneyauthor=P.+J.+Lovellauthor=G.+Merloauthor=C.+M.+Scottauthor=P.+W.+Smithauthor=K.+R.+Starrauthor=J.+M.+Watson&title=Novel+5-HT1A%2F1B%2F1D+receptors+antagonists+with+potent+5-HT+reuptake+inhibitory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerafinowska%26aufirst%3DH.%2BT.%26aulast%3DBlaney%26aufirst%3DF.%2BE.%26aulast%3DLovell%26aufirst%3DP.%2BJ.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DScott%26aufirst%3DC.%2BM.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DStarr%26aufirst%3DK.%2BR.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26atitle%3DNovel%25205-HT1A%252F1B%252F1D%2520receptors%2520antagonists%2520with%2520potent%25205-HT%2520reuptake%2520inhibitory%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5581%26epage%3D5585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bromidge, S M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Granci, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stasi, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vesentini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">6-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: dual-acting 5-HT<sub>1</sub> receptor antagonists and serotonin reuptake inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5653</span><span class="NLM_x">–</span> <span class="NLM_lpage">5656</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5653-5656&author=S+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=S.+Faedoauthor=L.+J.+Gordonauthor=E.+Granciauthor=M.+Hillauthor=H.+R.+Marshallauthor=L.+P.+Stasiauthor=V.+Zucchelliauthor=G.+Merloauthor=A.+Vesentiniauthor=J.+M.+Watsonauthor=L.+Zonzini&title=6-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DGranci%26aufirst%3DE.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DH.%2BR.%26aulast%3DStasi%26aufirst%3DL.%2BP.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DVesentini%26aufirst%3DA.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D6-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5653%26epage%3D5656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bromidge, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borriello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bozzoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faedo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianotti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zucchelli, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zonzini, L.</span><span> </span><span class="NLM_article-title">8-[2-(4-Aryl-1-piperazinyl)ethyl]-2<i>H</i>-1,4-benzoxazin-3(4<i>H</i>)-ones: dual-acting 5-HT<sub>1</sub> receptor antagonists and serotonin reuptake inhibitors, part II</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2338</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2338-2342&author=S.+M.+Bromidgeauthor=B.+Bertaniauthor=M.+Borrielloauthor=A.+Bozzoliauthor=S.+Faedoauthor=M.+Gianottiauthor=L.+J.+Gordonauthor=M.+Hillauthor=V.+Zucchelliauthor=J.+M.+Watsonauthor=L.+Zonzini&title=8-%5B2-%284-Aryl-1-piperazinyl%29ethyl%5D-2H-1%2C4-benzoxazin-3%284H%29-ones%3A+dual-acting+5-HT1+receptor+antagonists+and+serotonin+reuptake+inhibitors%2C+part+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromidge%26aufirst%3DS.%2BM.%26aulast%3DBertani%26aufirst%3DB.%26aulast%3DBorriello%26aufirst%3DM.%26aulast%3DBozzoli%26aufirst%3DA.%26aulast%3DFaedo%26aufirst%3DS.%26aulast%3DGianotti%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DL.%2BJ.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DZucchelli%26aufirst%3DV.%26aulast%3DWatson%26aufirst%3DJ.%2BM.%26aulast%3DZonzini%26aufirst%3DL.%26atitle%3D8-%255B2-%25284-Aryl-1-piperazinyl%2529ethyl%255D-2H-1%252C4-benzoxazin-3%25284H%2529-ones%253A%2520dual-acting%25205-HT1%2520receptor%2520antagonists%2520and%2520serotonin%2520reuptake%2520inhibitors%252C%2520part%2520II%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2338%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Bartsch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erker, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span> </span><span class="NLM_article-title">Studies on the chemistry of 1,4-oxazines. 18. Synthesis of tricyclic 1,4-benzoxazines via nucleophilic substitution of activated precursors</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1989&pages=205-207&author=H.+Bartschauthor=T.+Erkerauthor=G.+Neubauer&title=Studies+on+the+chemistry+of+1%2C4-oxazines.+18.+Synthesis+of+tricyclic+1%2C4-benzoxazines+via+nucleophilic+substitution+of+activated+precursors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartsch%26aufirst%3DH.%26aulast%3DErker%26aufirst%3DT.%26aulast%3DNeubauer%26aufirst%3DG.%26atitle%3DStudies%2520on%2520the%2520chemistry%2520of%25201%252C4-oxazines.%252018.%2520Synthesis%2520of%2520tricyclic%25201%252C4-benzoxazines%2520via%2520nucleophilic%2520substitution%2520of%2520activated%2520precursors%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1989%26volume%3D26%26spage%3D205%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Rudorf, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janietz, D.</span><span> </span><span class="NLM_article-title">Intramolecular 1,3-dipolar cycloadditions of aryl azides with alkynyl substituents</span> <span class="citation_source-journal">J. Prakt. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1002%2Fprac.19873290108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaL2sXmtlKlsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=1987&pages=55-61&author=W.+D.+Rudorfauthor=D.+Janietz&title=Intramolecular+1%2C3-dipolar+cycloadditions+of+aryl+azides+with+alkynyl+substituents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Intramolecular 1,3-dipolar cycloadditions of aryl azides with alkynyl substituents</span></div><div class="casAuthors">Rudorf, W. D.; Janietz, D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">Condensation of ClCH2C≡CCH2OR (R = Me, Ac) with 2-HOC6H4NHAc or 2-HSC6H4NH2 gave 2-H2NC6H4XCH2C≡CCH2OR (X = O, S) which were converted into alkynyl substituted aryl azides, 2-N3C6H4XCH2C≡CCH2OR (I) by diazotization followed by reaction with NaN3.  Intramol. 1,3-dipolar cycloaddn. of I gave triazolobenzoxazines II.  In the same way cycloaddn. of 2-N3C6H4OCH2C≡CCH2OC6H4N3-2, prepd. from 2-HOC6H4NHAc and ClCH2C≡CCH2Cl, gave azidophenoxymethyltriazolobenzoxazine III.  Thermal decompn. of III gave triazolobenzoxazinylmethyleneaminophenol IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonZx7rZegJprVg90H21EOLACvtfcHk0ljIRh5IJbze0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmtlKlsLY%253D&md5=f19249c14c7213ccbaa93e45ef7b8d15</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fprac.19873290108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19873290108%26sid%3Dliteratum%253Aachs%26aulast%3DRudorf%26aufirst%3DW.%2BD.%26aulast%3DJanietz%26aufirst%3DD.%26atitle%3DIntramolecular%25201%252C3-dipolar%2520cycloadditions%2520of%2520aryl%2520azides%2520with%2520alkynyl%2520substituents%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1987%26volume%3D329%26spage%3D55%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sanguinetti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tristani-Firouzi, M.</span><span> </span><span class="NLM_article-title">hERG potassium channels and cardiac arrhythmia</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">440</span><span class="NLM_x"> (</span><span class="NLM_issue">7083</span><span class="NLM_x">) </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">469</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1038%2Fnature04710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=16554806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=440&publication_year=2006&pages=463-469&issue=7083&author=M.+C.+Sanguinettiauthor=M.+Tristani-Firouzi&title=hERG+potassium+channels+and+cardiac+arrhythmia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">hERG potassium channels and cardiac arrhythmia</span></div><div class="casAuthors">Sanguinetti, Michael C.; Tristani-Firouzi, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">440</span>
        (<span class="NLM_cas:issue">7083</span>),
    <span class="NLM_cas:pages">463-469</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  HERG potassium channels are essential for normal elec. activity in the heart.  Inherited mutations in the HERG gene cause long QT syndrome, a disorder that predisposes individuals to life-threatening arrhythmias.  Arrhythmia can also be induced by a blockage of hERG channels by a surprisingly diverse group of drugs.  This side effect is a common reason for drug failure in preclin. safety trials.  Insights gained from the crystal structures of other potassium channels have helped our understanding of the block of hERG channels and the mechanisms of gating.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopS3WBEpuAUrVg90H21EOLACvtfcHk0ljIRh5IJbze0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1OlsLs%253D&md5=3f355dcd51da3488d73c7c91cbe8d3b8</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1038%2Fnature04710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature04710%26sid%3Dliteratum%253Aachs%26aulast%3DSanguinetti%26aufirst%3DM.%2BC.%26aulast%3DTristani-Firouzi%26aufirst%3DM.%26atitle%3DhERG%2520potassium%2520channels%2520and%2520cardiac%2520arrhythmia%26jtitle%3DNature%26date%3D2006%26volume%3D440%26issue%3D7083%26spage%3D463%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mitcheson, J. S.</span><span> </span><span class="NLM_article-title">hERG Potassium Channels and the Structural Basis of Drug-Induced Arrhythmias</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1005</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800035b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=1005-1010&author=J.+S.+Mitcheson&title=hERG+Potassium+Channels+and+the+Structural+Basis+of+Drug-Induced+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Ftx800035b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800035b%26sid%3Dliteratum%253Aachs%26aulast%3DMitcheson%26aufirst%3DJ.%2BS.%26atitle%3DhERG%2520Potassium%2520Channels%2520and%2520the%2520Structural%2520Basis%2520of%2520Drug-Induced%2520Arrhythmias%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2008%26volume%3D21%26spage%3D1005%26epage%3D1010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_publisher-name">Aptuit Limited</span>, <span class="NLM_publisher-loc">3 Simpson Parkway, Livingston, West Lothian, EH54 7BH, Scotland</span>, <a href="http://www.aptuit.uk" class="extLink">www.aptuit.uk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Aptuit+Limited%2C+3+Simpson+Parkway%2C+Livingston%2C+West+Lothian%2C+EH54+7BH%2C+Scotland%2C+www.aptuit.uk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26pub%3DAptuit%2520Limited" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Shamovsky, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanova, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbahns, K.</span><span> </span><span class="NLM_article-title">Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1162</span><span class="NLM_x">–</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070543k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhslWju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1162-1178&author=I.+Shamovskyauthor=S.+Connollyauthor=L.+Davidauthor=S.+Ivanovaauthor=B.+Nord%C3%A9nauthor=B.+Springthorpeauthor=K.+Urbahns&title=Overcoming+Undesirable+hERG+Potency+of+Chemokine+Receptor+Antagonists+Using+Baseline+Lipophilicity+Relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming Undesirable hERG Potency of Chemokine Receptor Antagonists Using Baseline Lipophilicity Relationships</span></div><div class="casAuthors">Shamovsky, Igor; Connolly, Stephen; David, Laurent; Ivanova, Svetlana; Norden, Bo; Springthorpe, Brian; Urbahns, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1162-1178</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibition of the hERG channel by noncardiovascular drugs is a side effect that severely impedes the development of new medications.  To increase hERG selectivity of preclin. compds., the authors recommend the study of nondesolvation related interactions with the intended target and hERG using a baseline lipophilicity relationship approach.  While this approach is conventionally used in studies of potency, the authors demonstrate here that it can help in selectivity issues.  Studies of hERG selectivity in four inhouse classes of chemokine receptor (CCR) antagonists suggest that the selectivity is improved most effectively by structural alterations that increase the lipophilicity-adjusted primary potency, pIC50CCR - LogD.  Fragment-based QSAR anal. is performed using the lipophilicity-adjusted hERG potency, pIC50hERG - LogD, to identify moieties that form nonhydrophobic interactions with the hERG channel.  These moieties, which erode hERG selectivity, can then be avoided.  A novel two-dimensional fragment-based QSAR anal. helps visualizing the lipophilicity-adjusted hERG and CCR potencies within chem. series.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1BNQlA8irybVg90H21EOLACvtfcHk0lgUhQDmJd8wcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhslWju78%253D&md5=04596a9552c5cf3b47a3edf9c0bd5498</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm070543k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070543k%26sid%3Dliteratum%253Aachs%26aulast%3DShamovsky%26aufirst%3DI.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DDavid%26aufirst%3DL.%26aulast%3DIvanova%26aufirst%3DS.%26aulast%3DNord%25C3%25A9n%26aufirst%3DB.%26aulast%3DSpringthorpe%26aufirst%3DB.%26aulast%3DUrbahns%26aufirst%3DK.%26atitle%3DOvercoming%2520Undesirable%2520hERG%2520Potency%2520of%2520Chemokine%2520Receptor%2520Antagonists%2520Using%2520Baseline%2520Lipophilicity%2520Relationships%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1162%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Huang, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strong, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nallani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Temple, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al Habet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baweja, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burckart, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colangelo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frucht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hepp, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnaukhova, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marroum, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sobel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stifano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thummel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesko, L. J.</span><span> </span><span class="NLM_article-title">New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process</span> <span class="citation_source-journal">J. Clin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">662</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1177%2F0091270007312153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=18378963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1Kitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2008&pages=662-670&author=S+Huangauthor=J.+M.+Strongauthor=L.+Zhangauthor=K.+S.+Reynoldsauthor=S.+Nallaniauthor=R.+Templeauthor=S.+Abrahamauthor=S.+Al+Habetauthor=R.+K.+Bawejaauthor=G.+J.+Burckartauthor=S.+Chungauthor=P.+Colangeloauthor=D.+Fruchtauthor=M.+D.+Greenauthor=P.+Heppauthor=E.+Karnaukhovaauthor=H.+Koauthor=J.+Leeauthor=P.+J.+Marroumauthor=J.+M.+Nordenauthor=W.+Qiuauthor=A.+Rahmanauthor=S.+Sobelauthor=T.+Stifanoauthor=K.+Thummelauthor=X.+Weiauthor=S.+Yasudaauthor=J.+H.+Zhengauthor=H.+Zhaoauthor=L.+J.+Lesko&title=New+era+in+drug+interaction+evaluation%3A+US+Food+and+Drug+Administration+update+on+CYP+enzymes%2C+transporters%2C+and+the+guidance+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process</span></div><div class="casAuthors">Huang, Shiew-Mei; Strong, John M.; Zhang, Lei; Reynolds, Kellie S.; Nallani, Srikanth; Temple, Robert; Abraham, Sophia; Al Habet, Sayed; Baweja, Raman K.; Burckart, Gilbert J.; Chung, Sang; Colangelo, Philip; Frucht, David; Green, Martin D.; Hepp, Paul; Karnaukhova, Elena; Ko, Hon-Sum; Lee, Jang-Ik; Marroum, Patrick J.; Norden, Janet M.; Qiu, Wei; Rahman, Atiqur; Sobel, Solomon; Stifano, Toni; Thummel, Kenneth; Wei, Xiao-xiong; Yasuda, Sally; Zheng, Jenny H.; Zhao, Hong; Lesko, Lawrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">662-670</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Predicting clin. significant drug interactions during drug development is a challenge for the pharmaceutical industry and regulatory agencies.  Since the publication of the US Food and Drug Administration's (FDA's) first in vitro and in vivo drug interaction guidance documents in 1997 and 1999, researchers and clinicians have gained a better understanding of drug interactions.  This knowledge has enabled the FDA and the industry to progress and begin to overcome these challenges.  The FDA has continued its efforts to evaluate methodologies to study drug interactions and communicate recommendations regarding the conduct of drug interaction studies, particularly for CYP-based and transporter-based drug interactions, to the pharmaceutical industry.  A drug interaction Web site was established to document the FDA's current understanding of drug interactions (http://www.fda.gov/cder/drug/drugInteractions/default.htm).  This report provides an overview of the evolution of the drug interaction guidances, includes a synopsis of the steps taken by the FDA to revise the original drug interaction guidance documents, and summarizes and highlights updated sections in the current guidance document, Drug Interaction Studies-Study Design, Data Anal., and Implications for Dosing and Labeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok6SXwLu9y5LVg90H21EOLACvtfcHk0lgUhQDmJd8wcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1Kitr4%253D&md5=6821a9c12eed38bd2faba68d8a2d8240</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1177%2F0091270007312153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270007312153%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DS%26aulast%3DStrong%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DReynolds%26aufirst%3DK.%2BS.%26aulast%3DNallani%26aufirst%3DS.%26aulast%3DTemple%26aufirst%3DR.%26aulast%3DAbraham%26aufirst%3DS.%26aulast%3DAl%2BHabet%26aufirst%3DS.%26aulast%3DBaweja%26aufirst%3DR.%2BK.%26aulast%3DBurckart%26aufirst%3DG.%2BJ.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DColangelo%26aufirst%3DP.%26aulast%3DFrucht%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DM.%2BD.%26aulast%3DHepp%26aufirst%3DP.%26aulast%3DKarnaukhova%26aufirst%3DE.%26aulast%3DKo%26aufirst%3DH.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMarroum%26aufirst%3DP.%2BJ.%26aulast%3DNorden%26aufirst%3DJ.%2BM.%26aulast%3DQiu%26aufirst%3DW.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DSobel%26aufirst%3DS.%26aulast%3DStifano%26aufirst%3DT.%26aulast%3DThummel%26aufirst%3DK.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DJ.%2BH.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DLesko%26aufirst%3DL.%2BJ.%26atitle%3DNew%2520era%2520in%2520drug%2520interaction%2520evaluation%253A%2520US%2520Food%2520and%2520Drug%2520Administration%2520update%2520on%2520CYP%2520enzymes%252C%2520transporters%252C%2520and%2520the%2520guidance%2520process%26jtitle%3DJ.%2520Clin.%2520Pharm.%26date%3D2008%26volume%3D48%26spage%3D662%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Ashwood, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Field, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horwell, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julien-Larose, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewthwaite, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCleary, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pritchard, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, L.</span><span> </span><span class="NLM_article-title">Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK(1) receptor antagonist</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">2276</span><span class="NLM_x">–</span> <span class="NLM_lpage">2285</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010825z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=2276-2285&author=V.+A.+Ashwoodauthor=M.+J.+Fieldauthor=D.+C.+Horwellauthor=C.+Julien-Laroseauthor=R.+A.+Lewthwaiteauthor=S.+McClearyauthor=M.+C.+Pritchardauthor=J.+Raphyauthor=L.+Singh&title=Utilization+of+an+intramolecular+hydrogen+bond+to+increase+the+CNS+penetration+of+an+NK%281%29+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm010825z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010825z%26sid%3Dliteratum%253Aachs%26aulast%3DAshwood%26aufirst%3DV.%2BA.%26aulast%3DField%26aufirst%3DM.%2BJ.%26aulast%3DHorwell%26aufirst%3DD.%2BC.%26aulast%3DJulien-Larose%26aufirst%3DC.%26aulast%3DLewthwaite%26aufirst%3DR.%2BA.%26aulast%3DMcCleary%26aufirst%3DS.%26aulast%3DPritchard%26aufirst%3DM.%2BC.%26aulast%3DRaphy%26aufirst%3DJ.%26aulast%3DSingh%26aufirst%3DL.%26atitle%3DUtilization%2520of%2520an%2520intramolecular%2520hydrogen%2520bond%2520to%2520increase%2520the%2520CNS%2520penetration%2520of%2520an%2520NK%25281%2529%2520receptor%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D2276%26epage%3D2285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Centre de Recherches Biologiques, CERB, Chemin de Montfort, 18800 Bougy, France,</span><a href="http://www.cerb.fr" class="extLink">www.cerb.fr</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Centre+de+Recherches+Biologiques%2C+CERB%2C+Chemin+de+Montfort%2C+18800+Bougy%2C+France%2Cwww.cerb.fr."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shyu, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphreys, W. G.</span><span> </span><span class="NLM_article-title">In vitro screening of 50 highly prescribed drugs for thiol adduct formation—comparison of potential for drug-induced toxicity and extent of adduct formation</span> <span class="citation_source-journal">Chem. Res. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">690</span><span class="NLM_x">–</span> <span class="NLM_lpage">698</span></span><div class="citationLinks">[<a href="/doi/10.1021/tx800368n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2009&pages=690-698&author=J.+Ganauthor=Q.+Ruanauthor=B.+Heauthor=M.+Zhuauthor=W.+C.+Shyuauthor=W.+G.+Humphreys&title=In+vitro+screening+of+50+highly+prescribed+drugs+for+thiol+adduct+formation%E2%80%94comparison+of+potential+for+drug-induced+toxicity+and+extent+of+adduct+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Ftx800368n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx800368n%26sid%3Dliteratum%253Aachs%26aulast%3DGan%26aufirst%3DJ.%26aulast%3DRuan%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DShyu%26aufirst%3DW.%2BC.%26aulast%3DHumphreys%26aufirst%3DW.%2BG.%26atitle%3DIn%2520vitro%2520screening%2520of%252050%2520highly%2520prescribed%2520drugs%2520for%2520thiol%2520adduct%2520formation%25E2%2580%2594comparison%2520of%2520potential%2520for%2520drug-induced%2520toxicity%2520and%2520extent%2520of%2520adduct%2520formation%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2009%26volume%3D22%26spage%3D690%26epage%3D698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hagan, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slade, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaster, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffrey, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatcher, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlemiss, D. N.</span><span> </span><span class="NLM_article-title">Stimulation of 5-HT<sub>1B</sub> receptors causes hypothermia in the guinea pig</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">331</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm100482n&amp;key=10.1016%2FS0014-2999%2897%2901055-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm100482n&amp;key=9274976" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm100482n&amp;key=1%3ACAS%3A528%3ADyaK2sXksFeitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=331&publication_year=1997&pages=169-174&author=J.+J.+Haganauthor=P.+D.+Sladeauthor=L.+Gasterauthor=P.+Jeffreyauthor=J.+P.+Hatcherauthor=D.+N.+Middlemiss&title=Stimulation+of+5-HT1B+receptors+causes+hypothermia+in+the+guinea+pig"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig</span></div><div class="casAuthors">Hagan, Jim J.; Slade, Paula D.; Gaster, Laramie; Jeffrey, Phillip; Hatcher, Jonathan P.; Middlemiss, D. N.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">331</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">169-174</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The selective, brain penetrant, 5-HT1B/D (formerly 5-HT1Dβ/α) receptor agonist SKF-99101H (3-(2-dimethylaminoethyl)-4-chloro-5-propoxyindole hemifumarate) (30 mg/kg i.p.) causes a dose related fall in rectal temp. in guinea pigs which previous studies have shown to be blocked by the non-selective 5-HT1B/D receptor antagonist GR-127935 (N-[4-methoxy-3-(4-methyl-1-piperazinyl) phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl) [1,1'biphenyl]-4-carboxamide oxalate).  The present study shows that the hypothermic response to SKF-99101H is dose-dependently blocked by SB-224289G (1'-methyl-5-(2'-methyl-4'-[(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl)-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4'-piperidone] hemioxalate) (0.3-10.0 mg/kg p.o.) (ED50 3.62 mg/kg), which is the first compd. to be described which is more than 60 fold selective for the 5-HT1B receptor over the 5-HT1D receptor.  SB-216641A (N-[3-(2-dimethylamino) ethoxy-4-methoxy-phenyl] 2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-(1,1'-biphenyl)-4-carboxamide hydrochloride) (0.6-20.0 mg/kg i.p.), which is somewhat less selective (30 fold) for the 5-HT1B receptor over the 5-HT1D receptor had a similar effect (ED50 4.43 mg/kg).  The brain penetrant 5-HT1D selective receptor antagonist, BRL-15572 (4-(3-chlorophenyl)-α-(diphenylmethyl)-1-piperazineethanol dihydrochloride) (0.3-100.0 mg/kg i.p.) was inactive.  When administered alone neither BRL-15572 (0.1-10 mg/kg i.p.) nor SB-224289G (2.2-22 mg/kg p.o.) had an effect on body temp.  These data demonstrate that 5-HT1B (formerly 5-HT1Dβ) and not 5-HT1D (formerly 5-HT1Dα) receptors mediate the hypothermic response to SKF-99101H (30 mg/kg i.p.) in guinea pigs.  The compds. described are useful pharmacol. tools for distinguishing responses to 5-HT1B and 5-HT1D receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSUnPKPFmcyLVg90H21EOLACvtfcHk0lhdGzLBt_CL6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXksFeitro%253D&md5=d2ce70b9959d4f176135a02494524f33</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2897%2901055-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252897%252901055-8%26sid%3Dliteratum%253Aachs%26aulast%3DHagan%26aufirst%3DJ.%2BJ.%26aulast%3DSlade%26aufirst%3DP.%2BD.%26aulast%3DGaster%26aufirst%3DL.%26aulast%3DJeffrey%26aufirst%3DP.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DMiddlemiss%26aufirst%3DD.%2BN.%26atitle%3DStimulation%2520of%25205-HT1B%2520receptors%2520causes%2520hypothermia%2520in%2520the%2520guinea%2520pig%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D331%26spage%3D169%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forster, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLenachan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanhope, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchley, D. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Childs, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middlefell, V. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanfumey, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corradetti, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laporte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Electrophysiological, biochemical,neurohormonal and behavioural studies with WAY-100635, a potent,selective and silent 5-HT<sub>1A</sub> receptor antagonist</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1996&pages=337-353&author=A.+Fletcherauthor=E.+A.+Forsterauthor=D.+J.+Billauthor=G.+Brownauthor=I.+A.+Cliffeauthor=J.+E.+Hartleyauthor=D.+E.+Jonesauthor=A.+McLenachanauthor=K.+J.+Stanhopeauthor=D.+J.+P.+Critchleyauthor=K.+J.+Childsauthor=V.+C.+Middlefellauthor=L.+Lanfumeyauthor=R.+Corradettiauthor=A.+Laporteauthor=H.+Gozlanauthor=M.+Hamonauthor=C.+T.+Dourish&title=Electrophysiological%2C+biochemical%2Cneurohormonal+and+behavioural+studies+with+WAY-100635%2C+a+potent%2Cselective+and+silent+5-HT1A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DForster%26aufirst%3DE.%2BA.%26aulast%3DBill%26aufirst%3DD.%2BJ.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DHartley%26aufirst%3DJ.%2BE.%26aulast%3DJones%26aufirst%3DD.%2BE.%26aulast%3DMcLenachan%26aufirst%3DA.%26aulast%3DStanhope%26aufirst%3DK.%2BJ.%26aulast%3DCritchley%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DChilds%26aufirst%3DK.%2BJ.%26aulast%3DMiddlefell%26aufirst%3DV.%2BC.%26aulast%3DLanfumey%26aufirst%3DL.%26aulast%3DCorradetti%26aufirst%3DR.%26aulast%3DLaporte%26aufirst%3DA.%26aulast%3DGozlan%26aufirst%3DH.%26aulast%3DHamon%26aufirst%3DM.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DElectrophysiological%252C%2520biochemical%252Cneurohormonal%2520and%2520behavioural%2520studies%2520with%2520WAY-100635%252C%2520a%2520potent%252Cselective%2520and%2520silent%25205-HT1A%2520receptor%2520antagonist%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D1996%26volume%3D73%26spage%3D337%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i84"><a href="/doi/suppl/10.1021/jm100482n">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20823"></div></div></div></div></div><hr /></hr><p class="last">Experimental and supporting data for compounds <b>7</b>−<b>9</b>, <b>15</b>−<b>18</b>, and <b>21</b>−<b>29</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100482n/suppl_file/jm100482n_si_001.pdf">jm100482n_si_001.pdf (110.23 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100482n&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-15%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm100482n%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100482n" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799257d4b33124c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
